id	sid	tid	token	lemma	pos
dpc-4022	1	1	dermatology	dermatology	NOUN
dpc-4022	1	2	:	:	PUNCT
dpc-4022	1	3	practical	practical	ADJ
dpc-4022	1	4	and	and	CCONJ
dpc-4022	1	5	conceptual	conceptual	ADJ
dpc-4022	1	6	original	original	ADJ
dpc-4022	1	7	article	article	NOUN
dpc-4022	1	8	|	|	ADV
dpc-4022	1	9	dermatol	dermatol	ADJ
dpc-4022	1	10	pract	pract	NOUN
dpc-4022	1	11	concept	concept	NOUN
dpc-4022	1	12	.	.	PUNCT
dpc-4022	2	1	2024;14(3):e2024135	2024;14(3):e2024135	NUM
dpc-4022	2	2	1	1	NUM
dpc-4022	2	3	evaluation	evaluation	NOUN
dpc-4022	2	4	of	of	ADP
dpc-4022	2	5	demographic	demographic	ADJ
dpc-4022	2	6	and	and	CCONJ
dpc-4022	2	7	clinical	clinical	ADJ
dpc-4022	2	8	characteristics	characteristic	NOUN
dpc-4022	2	9	of	of	ADP
dpc-4022	2	10	turkish	turkish	ADJ
dpc-4022	2	11	patients	patient	NOUN
dpc-4022	2	12	with	with	ADP
dpc-4022	2	13	primary	primary	ADJ
dpc-4022	2	14	cutaneous	cutaneous	ADJ
dpc-4022	2	15	melanoma	melanoma	NOUN
dpc-4022	2	16	:	:	PUNCT
dpc-4022	2	17	a	a	DET
dpc-4022	2	18	5	5	NUM
dpc-4022	2	19	-	-	PUNCT
dpc-4022	2	20	year	year	NOUN
dpc-4022	2	21	experience	experience	NOUN
dpc-4022	2	22	of	of	ADP
dpc-4022	2	23	a	a	DET
dpc-4022	2	24	tertiary	tertiary	ADJ
dpc-4022	2	25	referral	referral	NOUN
dpc-4022	2	26	center	center	NOUN
dpc-4022	2	27	irfan	irfan	PROPN
dpc-4022	2	28	gahramanov1	gahramanov1	PROPN
dpc-4022	2	29	,	,	PUNCT
dpc-4022	2	30	gulsen	gulsen	VERB
dpc-4022	2	31	akoglu1	akoglu1	NOUN
dpc-4022	2	32	,	,	PUNCT
dpc-4022	2	33	eda	eda	PROPN
dpc-4022	2	34	karaismailoglu2	karaismailoglu2	PROPN
dpc-4022	2	35	,	,	PUNCT
dpc-4022	2	36	nuri	nuri	PROPN
dpc-4022	2	37	karadurmus3	karadurmus3	PROPN
dpc-4022	2	38	1	1	NUM
dpc-4022	2	39	department	department	NOUN
dpc-4022	2	40	of	of	ADP
dpc-4022	2	41	dermatovenereology	dermatovenereology	NOUN
dpc-4022	2	42	,	,	PUNCT
dpc-4022	2	43	university	university	PROPN
dpc-4022	2	44	of	of	ADP
dpc-4022	2	45	health	health	PROPN
dpc-4022	2	46	sciences	sciences	PROPN
dpc-4022	2	47	,	,	PUNCT
dpc-4022	2	48	gulhane	gulhane	NOUN
dpc-4022	2	49	school	school	NOUN
dpc-4022	2	50	of	of	ADP
dpc-4022	2	51	medicine	medicine	NOUN
dpc-4022	2	52	,	,	PUNCT
dpc-4022	2	53	ankara	ankara	PROPN
dpc-4022	2	54	,	,	PUNCT
dpc-4022	2	55	turkey	turkey	PROPN
dpc-4022	2	56	2	2	NUM
dpc-4022	2	57	department	department	NOUN
dpc-4022	2	58	of	of	ADP
dpc-4022	2	59	medical	medical	ADJ
dpc-4022	2	60	informatics	informatic	NOUN
dpc-4022	2	61	,	,	PUNCT
dpc-4022	2	62	university	university	PROPN
dpc-4022	2	63	of	of	ADP
dpc-4022	2	64	health	health	PROPN
dpc-4022	2	65	sciences	sciences	PROPN
dpc-4022	2	66	,	,	PUNCT
dpc-4022	2	67	gulhane	gulhane	NOUN
dpc-4022	2	68	school	school	NOUN
dpc-4022	2	69	of	of	ADP
dpc-4022	2	70	medicine	medicine	NOUN
dpc-4022	2	71	,	,	PUNCT
dpc-4022	2	72	ankara	ankara	PROPN
dpc-4022	2	73	,	,	PUNCT
dpc-4022	2	74	turkey	turkey	PROPN
dpc-4022	2	75	3	3	NUM
dpc-4022	2	76	department	department	NOUN
dpc-4022	2	77	of	of	ADP
dpc-4022	2	78	medical	medical	ADJ
dpc-4022	2	79	oncology	oncology	NOUN
dpc-4022	2	80	,	,	PUNCT
dpc-4022	2	81	university	university	NOUN
dpc-4022	2	82	of	of	ADP
dpc-4022	2	83	health	health	PROPN
dpc-4022	2	84	sciences	sciences	PROPN
dpc-4022	2	85	,	,	PUNCT
dpc-4022	2	86	gulhane	gulhane	NOUN
dpc-4022	2	87	school	school	NOUN
dpc-4022	2	88	of	of	ADP
dpc-4022	2	89	medicine	medicine	NOUN
dpc-4022	2	90	,	,	PUNCT
dpc-4022	2	91	ankara	ankara	PROPN
dpc-4022	2	92	,	,	PUNCT
dpc-4022	2	93	turkey	turkey	PROPN
dpc-4022	2	94	key	key	ADJ
dpc-4022	2	95	words	word	NOUN
dpc-4022	2	96	:	:	PUNCT
dpc-4022	2	97	melanoma	melanoma	NOUN
dpc-4022	2	98	,	,	PUNCT
dpc-4022	2	99	primary	primary	ADJ
dpc-4022	2	100	cutaneous	cutaneous	ADJ
dpc-4022	2	101	melanoma	melanoma	NOUN
dpc-4022	2	102	,	,	PUNCT
dpc-4022	2	103	staging	staging	NOUN
dpc-4022	2	104	,	,	PUNCT
dpc-4022	2	105	survival	survival	NOUN
dpc-4022	2	106	citation	citation	NOUN
dpc-4022	2	107	:	:	PUNCT
dpc-4022	2	108	gahramanov	gahramanov	PROPN
dpc-4022	2	109	i	i	PROPN
dpc-4022	2	110	,	,	PUNCT
dpc-4022	2	111	akoglu	akoglu	PROPN
dpc-4022	2	112	g	g	PROPN
dpc-4022	2	113	,	,	PUNCT
dpc-4022	2	114	karaismailoglu	karaismailoglu	PROPN
dpc-4022	2	115	e	e	PROPN
dpc-4022	2	116	,	,	PUNCT
dpc-4022	2	117	karadurmus	karadurmus	PROPN
dpc-4022	2	118	n.	n.	PROPN
dpc-4022	2	119	evaluation	evaluation	NOUN
dpc-4022	2	120	of	of	ADP
dpc-4022	2	121	demographic	demographic	ADJ
dpc-4022	2	122	and	and	CCONJ
dpc-4022	2	123	clinical	clinical	ADJ
dpc-4022	2	124	characteristics	characteristic	NOUN
dpc-4022	2	125	of	of	ADP
dpc-4022	2	126	turkish	turkish	ADJ
dpc-4022	2	127	patients	patient	NOUN
dpc-4022	2	128	with	with	ADP
dpc-4022	2	129	primary	primary	ADJ
dpc-4022	2	130	cutaneous	cutaneous	ADJ
dpc-4022	2	131	melanoma	melanoma	NOUN
dpc-4022	2	132	:	:	PUNCT
dpc-4022	2	133	a	a	DET
dpc-4022	2	134	5	5	NUM
dpc-4022	2	135	-	-	PUNCT
dpc-4022	2	136	year	year	NOUN
dpc-4022	2	137	experience	experience	NOUN
dpc-4022	2	138	of	of	ADP
dpc-4022	2	139	a	a	DET
dpc-4022	2	140	tertiary	tertiary	ADJ
dpc-4022	2	141	referral	referral	NOUN
dpc-4022	2	142	center	center	NOUN
dpc-4022	2	143	.	.	PUNCT
dpc-4022	3	1	dermatol	dermatol	NOUN
dpc-4022	3	2	pract	pract	PROPN
dpc-4022	3	3	concept	concept	NOUN
dpc-4022	3	4	.	.	PUNCT
dpc-4022	4	1	2024;14(3):e2024135	2024;14(3):e2024135	X
dpc-4022	4	2	.	.	X
dpc-4022	4	3	doi	doi	PROPN
dpc-4022	4	4	:	:	PUNCT
dpc-4022	4	5	https://doi.org/10.5826/dpc.1403a135	https://doi.org/10.5826/dpc.1403a135	PROPN
dpc-4022	4	6	accepted	accept	VERB
dpc-4022	4	7	:	:	PUNCT
dpc-4022	4	8	january	january	PROPN
dpc-4022	4	9	3	3	NUM
dpc-4022	4	10	,	,	PUNCT
dpc-4022	4	11	2024	2024	NUM
dpc-4022	4	12	;	;	PUNCT
dpc-4022	4	13	published	publish	VERB
dpc-4022	4	14	:	:	PUNCT
dpc-4022	5	1	july	july	PROPN
dpc-4022	5	2	2024	2024	NUM
dpc-4022	5	3	copyright	copyright	NOUN
dpc-4022	5	4	:	:	PUNCT
dpc-4022	5	5	©	©	PROPN
dpc-4022	5	6	2024	2024	NUM
dpc-4022	5	7	gahramanov	gahramanov	PROPN
dpc-4022	5	8	et	et	PROPN
dpc-4022	5	9	al	al	PROPN
dpc-4022	5	10	.	.	PUNCT
dpc-4022	6	1	this	this	PRON
dpc-4022	6	2	is	be	AUX
dpc-4022	6	3	an	an	DET
dpc-4022	6	4	open	open	ADJ
dpc-4022	6	5	-	-	PUNCT
dpc-4022	6	6	access	access	NOUN
dpc-4022	6	7	article	article	NOUN
dpc-4022	6	8	distributed	distribute	VERB
dpc-4022	6	9	under	under	ADP
dpc-4022	6	10	the	the	DET
dpc-4022	6	11	terms	term	NOUN
dpc-4022	6	12	of	of	ADP
dpc-4022	6	13	the	the	DET
dpc-4022	6	14	creative	creative	ADJ
dpc-4022	6	15	commons	common	NOUN
dpc-4022	6	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-4022	6	17	license	license	NOUN
dpc-4022	6	18	(	(	PUNCT
dpc-4022	6	19	by	by	ADP
dpc-4022	6	20	-	-	PUNCT
dpc-4022	6	21	nc-4.0	nc-4.0	NOUN
dpc-4022	6	22	)	)	PUNCT
dpc-4022	6	23	,	,	PUNCT
dpc-4022	6	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-4022	6	25	,	,	PUNCT
dpc-4022	6	26	which	which	PRON
dpc-4022	6	27	permits	permit	VERB
dpc-4022	6	28	unrestricted	unrestricted	ADJ
dpc-4022	6	29	noncommercial	noncommercial	ADJ
dpc-4022	6	30	use	use	NOUN
dpc-4022	6	31	,	,	PUNCT
dpc-4022	6	32	distribution	distribution	NOUN
dpc-4022	6	33	,	,	PUNCT
dpc-4022	6	34	and	and	CCONJ
dpc-4022	6	35	reproduction	reproduction	NOUN
dpc-4022	6	36	in	in	ADP
dpc-4022	6	37	any	any	DET
dpc-4022	6	38	medium	medium	NOUN
dpc-4022	6	39	,	,	PUNCT
dpc-4022	6	40	provided	provide	VERB
dpc-4022	6	41	the	the	DET
dpc-4022	6	42	original	original	ADJ
dpc-4022	6	43	authors	author	NOUN
dpc-4022	6	44	and	and	CCONJ
dpc-4022	6	45	source	source	NOUN
dpc-4022	6	46	are	be	AUX
dpc-4022	6	47	credited	credit	VERB
dpc-4022	6	48	.	.	PUNCT
dpc-4022	7	1	funding	funding	NOUN
dpc-4022	7	2	:	:	PUNCT
dpc-4022	7	3	none	none	NOUN
dpc-4022	7	4	.	.	PUNCT
dpc-4022	8	1	competing	compete	VERB
dpc-4022	8	2	interests	interest	NOUN
dpc-4022	8	3	:	:	PUNCT
dpc-4022	8	4	none	none	NOUN
dpc-4022	8	5	.	.	PUNCT
dpc-4022	9	1	authorship	authorship	NOUN
dpc-4022	9	2	:	:	PUNCT
dpc-4022	9	3	all	all	DET
dpc-4022	9	4	authors	author	NOUN
dpc-4022	9	5	have	have	AUX
dpc-4022	9	6	contributed	contribute	VERB
dpc-4022	9	7	significantly	significantly	ADV
dpc-4022	9	8	to	to	ADP
dpc-4022	9	9	this	this	DET
dpc-4022	9	10	publication	publication	NOUN
dpc-4022	9	11	.	.	PUNCT
dpc-4022	10	1	corresponding	correspond	VERB
dpc-4022	10	2	author	author	NOUN
dpc-4022	10	3	:	:	PUNCT
dpc-4022	10	4	gulsen	gulsen	PROPN
dpc-4022	10	5	akoglu	akoglu	PROPN
dpc-4022	10	6	,	,	PUNCT
dpc-4022	10	7	md	md	PROPN
dpc-4022	10	8	,	,	PUNCT
dpc-4022	10	9	 	 	SPACE
dpc-4022	10	10	msc	msc	PROPN
dpc-4022	10	11	,	,	PUNCT
dpc-4022	10	12	university	university	PROPN
dpc-4022	10	13	of	of	ADP
dpc-4022	10	14	health	health	PROPN
dpc-4022	10	15	sciences	sciences	PROPN
dpc-4022	10	16	,	,	PUNCT
dpc-4022	10	17	gulhane	gulhane	NOUN
dpc-4022	10	18	school	school	NOUN
dpc-4022	10	19	of	of	ADP
dpc-4022	10	20	medicine	medicine	NOUN
dpc-4022	10	21	,	,	PUNCT
dpc-4022	10	22	ankara	ankara	PROPN
dpc-4022	10	23	,	,	PUNCT
dpc-4022	10	24	turkiye	turkiye	PROPN
dpc-4022	10	25	.	.	PUNCT
dpc-4022	11	1	e	e	X
dpc-4022	11	2	-	-	NOUN
dpc-4022	11	3	mail	mail	NOUN
dpc-4022	11	4	:	:	PUNCT
dpc-4022	11	5	 	 	SPACE
dpc-4022	11	6	gusemd@yahoo.com	gusemd@yahoo.com	PROPN
dpc-4022	11	7	,	,	PUNCT
dpc-4022	11	8	 	 	SPACE
dpc-4022	11	9	drakoglu@gmail.com	drakoglu@gmail.com	PROPN
dpc-4022	12	1	introduction	introduction	NOUN
dpc-4022	12	2	:	:	PUNCT
dpc-4022	12	3	data	datum	NOUN
dpc-4022	12	4	about	about	ADP
dpc-4022	12	5	the	the	DET
dpc-4022	12	6	demographic	demographic	ADJ
dpc-4022	12	7	and	and	CCONJ
dpc-4022	12	8	clinical	clinical	ADJ
dpc-4022	12	9	characteristics	characteristic	NOUN
dpc-4022	12	10	of	of	ADP
dpc-4022	12	11	melanoma	melanoma	NOUN
dpc-4022	12	12	patients	patient	NOUN
dpc-4022	12	13	in	in	ADP
dpc-4022	12	14	turkey	turkey	NOUN
dpc-4022	12	15	is	be	AUX
dpc-4022	12	16	limited	limited	ADJ
dpc-4022	12	17	.	.	PUNCT
dpc-4022	13	1	objectives	objective	NOUN
dpc-4022	13	2	:	:	PUNCT
dpc-4022	13	3	data	datum	NOUN
dpc-4022	13	4	about	about	ADP
dpc-4022	13	5	the	the	DET
dpc-4022	13	6	demographic	demographic	ADJ
dpc-4022	13	7	and	and	CCONJ
dpc-4022	13	8	clinical	clinical	ADJ
dpc-4022	13	9	characteristics	characteristic	NOUN
dpc-4022	13	10	of	of	ADP
dpc-4022	13	11	melanoma	melanoma	NOUN
dpc-4022	13	12	patients	patient	NOUN
dpc-4022	13	13	in	in	ADP
dpc-4022	13	14	turkey	turkey	NOUN
dpc-4022	13	15	is	be	AUX
dpc-4022	13	16	limited	limited	ADJ
dpc-4022	13	17	.	.	PUNCT
dpc-4022	14	1	we	we	PRON
dpc-4022	14	2	aimed	aim	VERB
dpc-4022	14	3	to	to	PART
dpc-4022	14	4	review	review	VERB
dpc-4022	14	5	the	the	DET
dpc-4022	14	6	features	feature	NOUN
dpc-4022	14	7	of	of	ADP
dpc-4022	14	8	patients	patient	NOUN
dpc-4022	14	9	with	with	ADP
dpc-4022	14	10	primary	primary	ADJ
dpc-4022	14	11	cutaneous	cutaneous	ADJ
dpc-4022	14	12	melanoma	melanoma	NOUN
dpc-4022	14	13	(	(	PUNCT
dpc-4022	14	14	pcm	pcm	NOUN
dpc-4022	14	15	)	)	PUNCT
dpc-4022	14	16	diagnosed	diagnose	VERB
dpc-4022	14	17	and	and	CCONJ
dpc-4022	14	18	treated	treat	VERB
dpc-4022	14	19	in	in	ADP
dpc-4022	14	20	a	a	DET
dpc-4022	14	21	tertiary	tertiary	ADJ
dpc-4022	14	22	referral	referral	NOUN
dpc-4022	14	23	center	center	NOUN
dpc-4022	14	24	.	.	PUNCT
dpc-4022	15	1	methods	method	NOUN
dpc-4022	15	2	:	:	PUNCT
dpc-4022	15	3	the	the	DET
dpc-4022	15	4	medical	medical	ADJ
dpc-4022	15	5	records	record	NOUN
dpc-4022	15	6	of	of	ADP
dpc-4022	15	7	melanoma	melanoma	NOUN
dpc-4022	15	8	patients	patient	NOUN
dpc-4022	15	9	followed	follow	VERB
dpc-4022	15	10	up	up	ADP
dpc-4022	15	11	by	by	ADP
dpc-4022	15	12	the	the	DET
dpc-4022	15	13	departments	department	NOUN
dpc-4022	15	14	of	of	ADP
dpc-4022	15	15	dermatology	dermatology	NOUN
dpc-4022	15	16	and	and	CCONJ
dpc-4022	15	17	medical	medical	ADJ
dpc-4022	15	18	oncology	oncology	NOUN
dpc-4022	15	19	were	be	AUX
dpc-4022	15	20	retrospectively	retrospectively	ADV
dpc-4022	15	21	reviewed	review	VERB
dpc-4022	15	22	.	.	PUNCT
dpc-4022	16	1	results	result	NOUN
dpc-4022	16	2	:	:	PUNCT
dpc-4022	16	3	within	within	ADP
dpc-4022	16	4	a	a	DET
dpc-4022	16	5	5	5	NUM
dpc-4022	16	6	-	-	PUNCT
dpc-4022	16	7	year	year	NOUN
dpc-4022	16	8	period	period	NOUN
dpc-4022	16	9	,	,	PUNCT
dpc-4022	16	10	180	180	NUM
dpc-4022	16	11	patients	patient	NOUN
dpc-4022	16	12	had	have	AUX
dpc-4022	16	13	been	be	AUX
dpc-4022	16	14	diagnosed	diagnose	VERB
dpc-4022	16	15	with	with	ADP
dpc-4022	16	16	melanoma	melanoma	NOUN
dpc-4022	16	17	.	.	PUNCT
dpc-4022	17	1	of	of	ADP
dpc-4022	17	2	all	all	PRON
dpc-4022	17	3	,	,	PUNCT
dpc-4022	17	4	158	158	NUM
dpc-4022	17	5	(	(	PUNCT
dpc-4022	17	6	87.8	87.8	NUM
dpc-4022	17	7	%	%	NOUN
dpc-4022	17	8	)	)	PUNCT
dpc-4022	17	9	had	have	VERB
dpc-4022	17	10	pcm	pcm	ADJ
dpc-4022	17	11	,	,	PUNCT
dpc-4022	17	12	9	9	NUM
dpc-4022	17	13	(	(	PUNCT
dpc-4022	17	14	5	5	NUM
dpc-4022	17	15	%	%	NOUN
dpc-4022	17	16	)	)	PUNCT
dpc-4022	17	17	had	have	VERB
dpc-4022	17	18	mucosal	mucosal	ADJ
dpc-4022	17	19	melanoma	melanoma	NOUN
dpc-4022	17	20	,	,	PUNCT
dpc-4022	17	21	9	9	NUM
dpc-4022	17	22	(	(	PUNCT
dpc-4022	17	23	5	5	NUM
dpc-4022	17	24	%	%	NOUN
dpc-4022	17	25	)	)	PUNCT
dpc-4022	18	1	had	have	VERB
dpc-4022	18	2	unknown	unknown	ADJ
dpc-4022	18	3	primary	primary	ADJ
dpc-4022	18	4	melanoma	melanoma	NOUN
dpc-4022	18	5	,	,	PUNCT
dpc-4022	18	6	and	and	CCONJ
dpc-4022	18	7	4	4	NUM
dpc-4022	18	8	(	(	PUNCT
dpc-4022	18	9	2.2	2.2	NUM
dpc-4022	18	10	%	%	NOUN
dpc-4022	18	11	)	)	PUNCT
dpc-4022	18	12	 	 	SPACE
dpc-4022	18	13	had	have	VERB
dpc-4022	18	14	ocular	ocular	ADJ
dpc-4022	18	15	melanoma	melanoma	NOUN
dpc-4022	18	16	.	.	PUNCT
dpc-4022	19	1	of	of	ADP
dpc-4022	19	2	146	146	NUM
dpc-4022	19	3	patients	patient	NOUN
dpc-4022	19	4	with	with	ADP
dpc-4022	19	5	pcm	pcm	NOUN
dpc-4022	19	6	,	,	PUNCT
dpc-4022	19	7	32.9	32.9	NUM
dpc-4022	19	8	%	%	NOUN
dpc-4022	19	9	had	have	VERB
dpc-4022	19	10	stage	stage	NOUN
dpc-4022	19	11	i	i	PRON
dpc-4022	19	12	,	,	PUNCT
dpc-4022	19	13	28.8	28.8	NUM
dpc-4022	19	14	%	%	NOUN
dpc-4022	19	15	had	have	VERB
dpc-4022	19	16	stage	stage	NOUN
dpc-4022	19	17	 	 	SPACE
dpc-4022	19	18	ii	ii	PROPN
dpc-4022	19	19	,	,	PUNCT
dpc-4022	19	20	17.8	17.8	NUM
dpc-4022	19	21	%	%	NOUN
dpc-4022	19	22	had	have	VERB
dpc-4022	19	23	stage	stage	NOUN
dpc-4022	19	24	iii	iii	NOUN
dpc-4022	19	25	,	,	PUNCT
dpc-4022	19	26	and	and	CCONJ
dpc-4022	19	27	20.5	20.5	NUM
dpc-4022	19	28	%	%	NOUN
dpc-4022	19	29	had	have	VERB
dpc-4022	19	30	stage	stage	NOUN
dpc-4022	19	31	iv	iv	NUM
dpc-4022	19	32	disease	disease	NOUN
dpc-4022	19	33	.	.	PUNCT
dpc-4022	20	1	the	the	DET
dpc-4022	20	2	most	most	ADV
dpc-4022	20	3	common	common	ADJ
dpc-4022	20	4	subtype	subtype	NOUN
dpc-4022	20	5	was	be	AUX
dpc-4022	20	6	superficial	superficial	ADJ
dpc-4022	20	7	spreading	spread	VERB
dpc-4022	20	8	melanoma	melanoma	NOUN
dpc-4022	20	9	(	(	PUNCT
dpc-4022	20	10	38.8	38.8	NUM
dpc-4022	20	11	%	%	NOUN
dpc-4022	20	12	)	)	PUNCT
dpc-4022	20	13	.	.	PUNCT
dpc-4022	21	1	a	a	DET
dpc-4022	21	2	statistically	statistically	ADV
dpc-4022	21	3	significant	significant	ADJ
dpc-4022	21	4	correlation	correlation	NOUN
dpc-4022	21	5	was	be	AUX
dpc-4022	21	6	found	find	VERB
dpc-4022	21	7	between	between	ADP
dpc-4022	21	8	the	the	DET
dpc-4022	21	9	patients	patient	NOUN
dpc-4022	21	10	breslow	breslow	VERB
dpc-4022	21	11	thickness	thickness	NOUN
dpc-4022	21	12	and	and	CCONJ
dpc-4022	21	13	lymph	lymph	NOUN
dpc-4022	21	14	node	node	NOUN
dpc-4022	21	15	involvement	involvement	NOUN
dpc-4022	21	16	,	,	PUNCT
dpc-4022	21	17	histopathological	histopathological	ADJ
dpc-4022	21	18	subtype	subtype	NOUN
dpc-4022	21	19	,	,	PUNCT
dpc-4022	21	20	and	and	CCONJ
dpc-4022	21	21	tumor	tumor	NOUN
dpc-4022	21	22	ulceration	ulceration	NOUN
dpc-4022	21	23	(	(	PUNCT
dpc-4022	21	24	p	p	X
dpc-4022	21	25	<	<	X
dpc-4022	21	26	0.001	0.001	NUM
dpc-4022	21	27	)	)	PUNCT
dpc-4022	21	28	.	.	PUNCT
dpc-4022	22	1	among	among	ADP
dpc-4022	22	2	all	all	DET
dpc-4022	22	3	pcm	pcm	ADJ
dpc-4022	22	4	patients	patient	NOUN
dpc-4022	22	5	,	,	PUNCT
dpc-4022	22	6	those	those	DET
dpc-4022	22	7	in	in	ADP
dpc-4022	22	8	stage	stage	NOUN
dpc-4022	22	9	iv	iv	NUM
dpc-4022	22	10	had	have	VERB
dpc-4022	22	11	the	the	DET
dpc-4022	22	12	lowest	low	ADJ
dpc-4022	22	13	5	5	NUM
dpc-4022	22	14	-	-	PUNCT
dpc-4022	22	15	year	year	NOUN
dpc-4022	22	16	survival	survival	NOUN
dpc-4022	22	17	rate	rate	NOUN
dpc-4022	22	18	when	when	SCONJ
dpc-4022	22	19	compared	compare	VERB
dpc-4022	22	20	to	to	ADP
dpc-4022	22	21	the	the	DET
dpc-4022	22	22	other	other	ADJ
dpc-4022	22	23	disease	disease	NOUN
dpc-4022	22	24	stages	stage	NOUN
dpc-4022	22	25	(	(	PUNCT
dpc-4022	22	26	p	p	X
dpc-4022	22	27	<	<	X
dpc-4022	22	28	0.001	0.001	NUM
dpc-4022	22	29	)	)	PUNCT
dpc-4022	22	30	.	.	PUNCT
dpc-4022	23	1	abstract	abstract	ADJ
dpc-4022	23	2	2	2	NUM
dpc-4022	23	3	original	original	ADJ
dpc-4022	23	4	article	article	NOUN
dpc-4022	23	5	|	|	ADV
dpc-4022	23	6	dermatol	dermatol	ADJ
dpc-4022	23	7	pract	pract	NOUN
dpc-4022	23	8	concept	concept	NOUN
dpc-4022	23	9	.	.	PUNCT
dpc-4022	24	1	2024;14(3):e2024135	2024;14(3):e2024135	NUM
dpc-4022	24	2	introduction	introduction	NOUN
dpc-4022	24	3	various	various	ADJ
dpc-4022	24	4	genetic	genetic	ADJ
dpc-4022	24	5	and	and	CCONJ
dpc-4022	24	6	environmental	environmental	ADJ
dpc-4022	24	7	factors	factor	NOUN
dpc-4022	24	8	,	,	PUNCT
dpc-4022	24	9	such	such	ADJ
dpc-4022	24	10	as	as	ADP
dpc-4022	24	11	uv	uv	NOUN
dpc-4022	24	12	radiation	radiation	NOUN
dpc-4022	24	13	,	,	PUNCT
dpc-4022	24	14	induce	induce	VERB
dpc-4022	24	15	uncontrolled	uncontrolled	ADJ
dpc-4022	24	16	malignant	malignant	ADJ
dpc-4022	24	17	proliferation	proliferation	NOUN
dpc-4022	24	18	of	of	ADP
dpc-4022	24	19	melanocytes	melanocyte	NOUN
dpc-4022	24	20	,	,	PUNCT
dpc-4022	24	21	resulting	result	VERB
dpc-4022	24	22	in	in	ADP
dpc-4022	24	23	melanoma	melanoma	NOUN
dpc-4022	24	24	.	.	PUNCT
dpc-4022	25	1	although	although	SCONJ
dpc-4022	25	2	the	the	DET
dpc-4022	25	3	frequency	frequency	NOUN
dpc-4022	25	4	of	of	ADP
dpc-4022	25	5	melanoma	melanoma	NOUN
dpc-4022	25	6	is	be	AUX
dpc-4022	25	7	as	as	ADV
dpc-4022	25	8	low	low	ADJ
dpc-4022	25	9	as	as	ADP
dpc-4022	25	10	1.3	1.3	NUM
dpc-4022	25	11	%	%	NOUN
dpc-4022	25	12	among	among	ADP
dpc-4022	25	13	all	all	DET
dpc-4022	25	14	skin	skin	NOUN
dpc-4022	25	15	cancers	cancer	NOUN
dpc-4022	25	16	,	,	PUNCT
dpc-4022	25	17	it	it	PRON
dpc-4022	25	18	is	be	AUX
dpc-4022	25	19	responsible	responsible	ADJ
dpc-4022	25	20	for	for	ADP
dpc-4022	25	21	about	about	ADV
dpc-4022	25	22	75	75	NUM
dpc-4022	25	23	%	%	NOUN
dpc-4022	25	24	of	of	ADP
dpc-4022	25	25	skin	skin	NOUN
dpc-4022	25	26	cancer	cancer	NOUN
dpc-4022	25	27	-	-	PUNCT
dpc-4022	25	28	related	relate	VERB
dpc-4022	25	29	deaths	death	NOUN
dpc-4022	25	30	[	[	X
dpc-4022	25	31	1	1	NUM
dpc-4022	25	32	]	]	PUNCT
dpc-4022	25	33	.	.	PUNCT
dpc-4022	26	1	the	the	DET
dpc-4022	26	2	incidence	incidence	NOUN
dpc-4022	26	3	of	of	ADP
dpc-4022	26	4	melanoma	melanoma	NOUN
dpc-4022	26	5	is	be	AUX
dpc-4022	26	6	variable	variable	ADJ
dpc-4022	26	7	due	due	ADJ
dpc-4022	26	8	to	to	ADP
dpc-4022	26	9	geographical	geographical	ADJ
dpc-4022	26	10	and	and	CCONJ
dpc-4022	26	11	ethnic	ethnic	ADJ
dpc-4022	26	12	factors	factor	NOUN
dpc-4022	26	13	;	;	PUNCT
dpc-4022	26	14	however	however	ADV
dpc-4022	26	15	,	,	PUNCT
dpc-4022	26	16	current	current	ADJ
dpc-4022	26	17	data	datum	NOUN
dpc-4022	26	18	points	point	VERB
dpc-4022	26	19	out	out	ADP
dpc-4022	26	20	a	a	DET
dpc-4022	26	21	remarkable	remarkable	ADJ
dpc-4022	26	22	increase	increase	NOUN
dpc-4022	26	23	every	every	DET
dpc-4022	26	24	year	year	NOUN
dpc-4022	26	25	around	around	ADP
dpc-4022	26	26	the	the	DET
dpc-4022	26	27	world	world	NOUN
dpc-4022	26	28	.	.	PUNCT
dpc-4022	27	1	there	there	PRON
dpc-4022	27	2	are	be	VERB
dpc-4022	27	3	few	few	ADJ
dpc-4022	27	4	studies	study	NOUN
dpc-4022	27	5	on	on	ADP
dpc-4022	27	6	melanoma	melanoma	NOUN
dpc-4022	27	7	patients	patient	NOUN
dpc-4022	27	8	’	'	PUNCT
dpc-4022	27	9	demographic	demographic	ADJ
dpc-4022	27	10	and	and	CCONJ
dpc-4022	27	11	clinical	clinical	ADJ
dpc-4022	27	12	characteristics	characteristic	NOUN
dpc-4022	27	13	in	in	ADP
dpc-4022	27	14	turkey	turkey	NOUN
dpc-4022	28	1	[	[	X
dpc-4022	28	2	2	2	NUM
dpc-4022	28	3	-	-	SYM
dpc-4022	28	4	5	5	NUM
dpc-4022	28	5	]	]	PUNCT
dpc-4022	28	6	.	.	PUNCT
dpc-4022	29	1	therefore	therefore	ADV
dpc-4022	29	2	,	,	PUNCT
dpc-4022	29	3	in	in	ADP
dpc-4022	29	4	this	this	DET
dpc-4022	29	5	study	study	NOUN
dpc-4022	29	6	,	,	PUNCT
dpc-4022	29	7	we	we	PRON
dpc-4022	29	8	aimed	aim	VERB
dpc-4022	29	9	to	to	PART
dpc-4022	29	10	analyze	analyze	VERB
dpc-4022	29	11	the	the	DET
dpc-4022	29	12	demographic	demographic	ADJ
dpc-4022	29	13	and	and	CCONJ
dpc-4022	29	14	clinicopathological	clinicopathological	ADJ
dpc-4022	29	15	characteristics	characteristic	NOUN
dpc-4022	29	16	of	of	ADP
dpc-4022	29	17	turkish	turkish	ADJ
dpc-4022	29	18	patients	patient	NOUN
dpc-4022	29	19	with	with	ADP
dpc-4022	29	20	primary	primary	ADJ
dpc-4022	29	21	cutaneous	cutaneous	ADJ
dpc-4022	29	22	melanoma	melanoma	NOUN
dpc-4022	30	1	[	[	X
dpc-4022	30	2	pcm	pcm	NOUN
dpc-4022	30	3	]	]	X
dpc-4022	30	4	who	who	PRON
dpc-4022	30	5	were	be	AUX
dpc-4022	30	6	diagnosed	diagnose	VERB
dpc-4022	30	7	and	and	CCONJ
dpc-4022	30	8	followed	follow	VERB
dpc-4022	30	9	up	up	ADP
dpc-4022	30	10	in	in	ADP
dpc-4022	30	11	a	a	DET
dpc-4022	30	12	tertiary	tertiary	ADJ
dpc-4022	30	13	referral	referral	NOUN
dpc-4022	30	14	hospital	hospital	NOUN
dpc-4022	30	15	over	over	ADP
dpc-4022	30	16	5	5	NUM
dpc-4022	30	17	years	year	NOUN
dpc-4022	30	18	.	.	PUNCT
dpc-4022	31	1	objectives	objective	NOUN
dpc-4022	31	2	we	we	PRON
dpc-4022	31	3	aimed	aim	VERB
dpc-4022	31	4	to	to	PART
dpc-4022	31	5	review	review	VERB
dpc-4022	31	6	the	the	DET
dpc-4022	31	7	features	feature	NOUN
dpc-4022	31	8	of	of	ADP
dpc-4022	31	9	patients	patient	NOUN
dpc-4022	31	10	with	with	ADP
dpc-4022	31	11	primary	primary	ADJ
dpc-4022	31	12	cutaneous	cutaneous	ADJ
dpc-4022	31	13	melanoma	melanoma	NOUN
dpc-4022	31	14	(	(	PUNCT
dpc-4022	31	15	pcm	pcm	NOUN
dpc-4022	31	16	)	)	PUNCT
dpc-4022	31	17	diagnosed	diagnose	VERB
dpc-4022	31	18	and	and	CCONJ
dpc-4022	31	19	treated	treat	VERB
dpc-4022	31	20	in	in	ADP
dpc-4022	31	21	a	a	DET
dpc-4022	31	22	tertiary	tertiary	ADJ
dpc-4022	31	23	referral	referral	NOUN
dpc-4022	31	24	center	center	NOUN
dpc-4022	31	25	.	.	PUNCT
dpc-4022	32	1	methods	method	NOUN
dpc-4022	32	2	the	the	DET
dpc-4022	32	3	medical	medical	ADJ
dpc-4022	32	4	records	record	NOUN
dpc-4022	32	5	of	of	ADP
dpc-4022	32	6	melanoma	melanoma	NOUN
dpc-4022	32	7	patients	patient	NOUN
dpc-4022	32	8	who	who	PRON
dpc-4022	32	9	sought	seek	VERB
dpc-4022	32	10	care	care	NOUN
dpc-4022	32	11	at	at	ADP
dpc-4022	32	12	our	our	PRON
dpc-4022	32	13	center	center	NOUN
dpc-4022	32	14	from	from	ADP
dpc-4022	32	15	october	october	PROPN
dpc-4022	32	16	2016	2016	NUM
dpc-4022	32	17	to	to	ADP
dpc-4022	32	18	october	october	PROPN
dpc-4022	32	19	2021	2021	NUM
dpc-4022	32	20	underwent	undergo	VERB
dpc-4022	32	21	a	a	DET
dpc-4022	32	22	comprehensive	comprehensive	ADJ
dpc-4022	32	23	review	review	NOUN
dpc-4022	32	24	.	.	PUNCT
dpc-4022	33	1	demographic	demographic	ADJ
dpc-4022	33	2	,	,	PUNCT
dpc-4022	33	3	clinical	clinical	ADJ
dpc-4022	33	4	(	(	PUNCT
dpc-4022	33	5	age	age	NOUN
dpc-4022	33	6	at	at	ADP
dpc-4022	33	7	the	the	DET
dpc-4022	33	8	time	time	NOUN
dpc-4022	33	9	of	of	ADP
dpc-4022	33	10	diagnosis	diagnosis	NOUN
dpc-4022	33	11	,	,	PUNCT
dpc-4022	33	12	survival	survival	NOUN
dpc-4022	33	13	time	time	NOUN
dpc-4022	33	14	,	,	PUNCT
dpc-4022	33	15	localization	localization	NOUN
dpc-4022	33	16	of	of	ADP
dpc-4022	33	17	the	the	DET
dpc-4022	33	18	tumor	tumor	NOUN
dpc-4022	33	19	,	,	PUNCT
dpc-4022	33	20	stage	stage	NOUN
dpc-4022	33	21	of	of	ADP
dpc-4022	33	22	the	the	DET
dpc-4022	33	23	disease	disease	NOUN
dpc-4022	33	24	according	accord	VERB
dpc-4022	33	25	to	to	ADP
dpc-4022	33	26	the	the	DET
dpc-4022	33	27	ajcc	ajcc	PROPN
dpc-4022	33	28	8th	8th	ADJ
dpc-4022	33	29	melanoma	melanoma	NOUN
dpc-4022	33	30	staging	staging	NOUN
dpc-4022	33	31	system	system	NOUN
dpc-4022	33	32	;	;	PUNCT
dpc-4022	33	33	the	the	DET
dpc-4022	33	34	number	number	NOUN
dpc-4022	33	35	of	of	ADP
dpc-4022	33	36	lymph	lymph	NOUN
dpc-4022	33	37	nodes	node	NOUN
dpc-4022	33	38	and	and	CCONJ
dpc-4022	33	39	metastatic	metastatic	ADJ
dpc-4022	33	40	organ	organ	NOUN
dpc-4022	33	41	involvement	involvement	NOUN
dpc-4022	33	42	.	.	PUNCT
dpc-4022	33	43	)	)	PUNCT
dpc-4022	33	44	,	,	PUNCT
dpc-4022	33	45	and	and	CCONJ
dpc-4022	33	46	histopathological	histopathological	ADJ
dpc-4022	33	47	features	feature	NOUN
dpc-4022	33	48	(	(	PUNCT
dpc-4022	33	49	breslow	breslow	NOUN
dpc-4022	33	50	thickness	thickness	NOUN
dpc-4022	33	51	,	,	PUNCT
dpc-4022	33	52	tumor	tumor	NOUN
dpc-4022	33	53	ulceration	ulceration	NOUN
dpc-4022	33	54	status	status	NOUN
dpc-4022	33	55	,	,	PUNCT
dpc-4022	33	56	melanoma	melanoma	NOUN
dpc-4022	33	57	subtype	subtype	NOUN
dpc-4022	33	58	,	,	PUNCT
dpc-4022	33	59	braf	braf	NOUN
dpc-4022	33	60	mutation	mutation	NOUN
dpc-4022	33	61	status	status	NOUN
dpc-4022	33	62	if	if	SCONJ
dpc-4022	33	63	available	available	ADJ
dpc-4022	33	64	)	)	PUNCT
dpc-4022	33	65	of	of	ADP
dpc-4022	33	66	the	the	DET
dpc-4022	33	67	patients	patient	NOUN
dpc-4022	33	68	were	be	AUX
dpc-4022	33	69	all	all	PRON
dpc-4022	33	70	noted	note	VERB
dpc-4022	33	71	.	.	PUNCT
dpc-4022	34	1	statistical	statistical	ADJ
dpc-4022	34	2	analyses	analysis	NOUN
dpc-4022	34	3	were	be	AUX
dpc-4022	34	4	performed	perform	VERB
dpc-4022	34	5	with	with	ADP
dpc-4022	34	6	the	the	DET
dpc-4022	34	7	ibm	ibm	PROPN
dpc-4022	34	8	spss	spss	PROPN
dpc-4022	34	9	25.0	25.0	NUM
dpc-4022	34	10	(	(	PUNCT
dpc-4022	34	11	spss	spss	PROPN
dpc-4022	34	12	inc	inc	PROPN
dpc-4022	34	13	)	)	PUNCT
dpc-4022	34	14	program	program	NOUN
dpc-4022	34	15	.	.	PUNCT
dpc-4022	35	1	mean	mean	NOUN
dpc-4022	35	2	±	±	NUM
dpc-4022	35	3	standard	standard	ADJ
dpc-4022	35	4	deviation	deviation	NOUN
dpc-4022	35	5	(	(	PUNCT
dpc-4022	35	6	sd	sd	NOUN
dpc-4022	35	7	)	)	PUNCT
dpc-4022	35	8	or	or	CCONJ
dpc-4022	35	9	median	median	NOUN
dpc-4022	35	10	and	and	CCONJ
dpc-4022	35	11	minimum	minimum	ADJ
dpc-4022	35	12	-	-	PUNCT
dpc-4022	35	13	maximum	maximum	ADJ
dpc-4022	35	14	values	value	NOUN
dpc-4022	35	15	were	be	AUX
dpc-4022	35	16	used	use	VERB
dpc-4022	35	17	for	for	ADP
dpc-4022	35	18	continuous	continuous	ADJ
dpc-4022	35	19	variables	variable	NOUN
dpc-4022	35	20	,	,	PUNCT
dpc-4022	35	21	and	and	CCONJ
dpc-4022	35	22	frequencies	frequency	NOUN
dpc-4022	35	23	(	(	PUNCT
dpc-4022	35	24	n	n	CCONJ
dpc-4022	35	25	)	)	PUNCT
dpc-4022	35	26	and	and	CCONJ
dpc-4022	35	27	percentages	percentage	NOUN
dpc-4022	35	28	(	(	PUNCT
dpc-4022	35	29	%	%	INTJ
dpc-4022	35	30	)	)	PUNCT
dpc-4022	35	31	were	be	AUX
dpc-4022	35	32	used	use	VERB
dpc-4022	35	33	for	for	ADP
dpc-4022	35	34	categorical	categorical	ADJ
dpc-4022	35	35	variables	variable	NOUN
dpc-4022	35	36	.	.	PUNCT
dpc-4022	36	1	categorical	categorical	ADJ
dpc-4022	36	2	variables	variable	NOUN
dpc-4022	36	3	were	be	AUX
dpc-4022	36	4	compared	compare	VERB
dpc-4022	36	5	by	by	ADP
dpc-4022	36	6	pearson	pearson	PROPN
dpc-4022	36	7	chi	chi	PROPN
dpc-4022	36	8	-	-	PUNCT
dpc-4022	36	9	square	square	PROPN
dpc-4022	36	10	or	or	CCONJ
dpc-4022	36	11	fisher	fisher	PROPN
dpc-4022	36	12	exact	exact	ADJ
dpc-4022	36	13	test	test	NOUN
dpc-4022	36	14	.	.	PUNCT
dpc-4022	37	1	the	the	DET
dpc-4022	37	2	normality	normality	NOUN
dpc-4022	37	3	of	of	ADP
dpc-4022	37	4	the	the	DET
dpc-4022	37	5	continuous	continuous	ADJ
dpc-4022	37	6	variables	variable	NOUN
dpc-4022	37	7	was	be	AUX
dpc-4022	37	8	evaluated	evaluate	VERB
dpc-4022	37	9	by	by	ADP
dpc-4022	37	10	kolmogorov	kolmogorov	ADJ
dpc-4022	37	11	-	-	PUNCT
dpc-4022	37	12	smirnov	smirnov	ADJ
dpc-4022	37	13	test	test	NOUN
dpc-4022	37	14	.	.	PUNCT
dpc-4022	38	1	differences	difference	NOUN
dpc-4022	38	2	between	between	ADP
dpc-4022	38	3	the	the	DET
dpc-4022	38	4	groups	group	NOUN
dpc-4022	38	5	for	for	ADP
dpc-4022	38	6	continuous	continuous	ADJ
dpc-4022	38	7	variables	variable	NOUN
dpc-4022	38	8	were	be	AUX
dpc-4022	38	9	determined	determine	VERB
dpc-4022	38	10	by	by	ADP
dpc-4022	38	11	independent	independent	ADJ
dpc-4022	38	12	samples	sample	NOUN
dpc-4022	38	13	t	t	NOUN
dpc-4022	38	14	-	-	PUNCT
dpc-4022	38	15	test	test	NOUN
dpc-4022	38	16	.	.	PUNCT
dpc-4022	39	1	overall	overall	ADJ
dpc-4022	39	2	survival	survival	NOUN
dpc-4022	39	3	was	be	AUX
dpc-4022	39	4	estimated	estimate	VERB
dpc-4022	39	5	by	by	ADP
dpc-4022	39	6	the	the	DET
dpc-4022	39	7	kaplan	kaplan	PROPN
dpc-4022	39	8	-	-	PUNCT
dpc-4022	39	9	meier	meier	PROPN
dpc-4022	39	10	method	method	PROPN
dpc-4022	39	11	and	and	CCONJ
dpc-4022	39	12	survival	survival	NOUN
dpc-4022	39	13	curves	curve	NOUN
dpc-4022	39	14	were	be	AUX
dpc-4022	39	15	compared	compare	VERB
dpc-4022	39	16	by	by	ADP
dpc-4022	39	17	the	the	DET
dpc-4022	39	18	log	log	NOUN
dpc-4022	39	19	-	-	PUNCT
dpc-4022	39	20	rank	rank	NOUN
dpc-4022	39	21	test	test	NOUN
dpc-4022	39	22	.	.	PUNCT
dpc-4022	40	1	p	p	NOUN
dpc-4022	40	2	values	value	NOUN
dpc-4022	40	3	of	of	ADP
dpc-4022	40	4	0.05	0.05	NUM
dpc-4022	40	5	and	and	CCONJ
dpc-4022	40	6	below	below	ADV
dpc-4022	40	7	were	be	AUX
dpc-4022	40	8	considered	consider	VERB
dpc-4022	40	9	statistically	statistically	ADV
dpc-4022	40	10	significant	significant	ADJ
dpc-4022	40	11	.	.	PUNCT
dpc-4022	41	1	the	the	DET
dpc-4022	41	2	study	study	NOUN
dpc-4022	41	3	was	be	AUX
dpc-4022	41	4	approved	approve	VERB
dpc-4022	41	5	by	by	ADP
dpc-4022	41	6	the	the	DET
dpc-4022	41	7	local	local	ADJ
dpc-4022	41	8	ethics	ethic	NOUN
dpc-4022	41	9	committee	committee	PROPN
dpc-4022	41	10	(	(	PUNCT
dpc-4022	41	11	date	date	NOUN
dpc-4022	41	12	:	:	PUNCT
dpc-4022	41	13	25/11/2021	25/11/2021	NUM
dpc-4022	41	14	;	;	PUNCT
dpc-4022	41	15	#	#	SYM
dpc-4022	41	16	379	379	NUM
dpc-4022	41	17	)	)	PUNCT
dpc-4022	41	18	.	.	PUNCT
dpc-4022	42	1	results	result	NOUN
dpc-4022	42	2	of	of	ADP
dpc-4022	42	3	180	180	NUM
dpc-4022	42	4	patients	patient	NOUN
dpc-4022	42	5	,	,	PUNCT
dpc-4022	42	6	158	158	NUM
dpc-4022	42	7	(	(	PUNCT
dpc-4022	42	8	87.8	87.8	NUM
dpc-4022	42	9	%	%	NOUN
dpc-4022	42	10	)	)	PUNCT
dpc-4022	42	11	had	have	VERB
dpc-4022	42	12	pcm	pcm	ADJ
dpc-4022	42	13	,	,	PUNCT
dpc-4022	42	14	9	9	NUM
dpc-4022	42	15	(	(	PUNCT
dpc-4022	42	16	5	5	NUM
dpc-4022	42	17	%	%	NOUN
dpc-4022	42	18	)	)	PUNCT
dpc-4022	42	19	had	have	VERB
dpc-4022	42	20	mucosal	mucosal	ADJ
dpc-4022	42	21	melanoma	melanoma	NOUN
dpc-4022	42	22	,	,	PUNCT
dpc-4022	42	23	9	9	NUM
dpc-4022	42	24	(	(	PUNCT
dpc-4022	42	25	5	5	NUM
dpc-4022	42	26	%	%	NOUN
dpc-4022	42	27	)	)	PUNCT
dpc-4022	42	28	had	have	VERB
dpc-4022	42	29	melanoma	melanoma	NOUN
dpc-4022	42	30	of	of	ADP
dpc-4022	42	31	unknown	unknown	ADJ
dpc-4022	42	32	primary	primary	NOUN
dpc-4022	42	33	,	,	PUNCT
dpc-4022	42	34	and	and	CCONJ
dpc-4022	42	35	4	4	NUM
dpc-4022	42	36	(	(	PUNCT
dpc-4022	42	37	2.2	2.2	NUM
dpc-4022	42	38	%	%	NOUN
dpc-4022	42	39	)	)	PUNCT
dpc-4022	42	40	had	have	VERB
dpc-4022	42	41	ocular	ocular	ADJ
dpc-4022	42	42	melanoma	melanoma	NOUN
dpc-4022	42	43	.	.	PUNCT
dpc-4022	43	1	the	the	DET
dpc-4022	43	2	age	age	NOUN
dpc-4022	43	3	of	of	ADP
dpc-4022	43	4	diagnosis	diagnosis	NOUN
dpc-4022	43	5	ranged	range	VERB
dpc-4022	43	6	from	from	ADP
dpc-4022	43	7	4	4	NUM
dpc-4022	43	8	years	year	NOUN
dpc-4022	43	9	to	to	ADP
dpc-4022	43	10	92	92	NUM
dpc-4022	43	11	years	year	NOUN
dpc-4022	43	12	(	(	PUNCT
dpc-4022	43	13	n=177	n=177	ADV
dpc-4022	43	14	;	;	PUNCT
dpc-4022	43	15	mean	mean	NOUN
dpc-4022	43	16	±	±	NUM
dpc-4022	43	17	sd	sd	NOUN
dpc-4022	43	18	:	:	PUNCT
dpc-4022	43	19	54.7	54.7	NUM
dpc-4022	43	20	±	±	NUM
dpc-4022	43	21	18.7	18.7	NUM
dpc-4022	43	22	years	year	NOUN
dpc-4022	43	23	)	)	PUNCT
dpc-4022	43	24	.	.	PUNCT
dpc-4022	44	1	the	the	DET
dpc-4022	44	2	mean	mean	ADJ
dpc-4022	44	3	age	age	NOUN
dpc-4022	44	4	at	at	ADP
dpc-4022	44	5	diagnosis	diagnosis	NOUN
dpc-4022	44	6	was	be	AUX
dpc-4022	44	7	statistically	statistically	ADV
dpc-4022	44	8	similar	similar	ADJ
dpc-4022	44	9	in	in	ADP
dpc-4022	44	10	both	both	DET
dpc-4022	44	11	genders	gender	NOUN
dpc-4022	44	12	(	(	PUNCT
dpc-4022	44	13	55.5±18.1	55.5±18.1	NUM
dpc-4022	44	14	years	year	NOUN
dpc-4022	44	15	for	for	ADP
dpc-4022	44	16	males	male	NOUN
dpc-4022	44	17	versus	versus	ADP
dpc-4022	44	18	53.7±19.5	53.7±19.5	NUM
dpc-4022	44	19	years	year	NOUN
dpc-4022	44	20	for	for	ADP
dpc-4022	44	21	females	female	NOUN
dpc-4022	44	22	;	;	PUNCT
dpc-4022	44	23	p	p	X
dpc-4022	44	24	=	=	NOUN
dpc-4022	44	25	0.540	0.540	NUM
dpc-4022	44	26	)	)	PUNCT
dpc-4022	44	27	.	.	PUNCT
dpc-4022	45	1	when	when	SCONJ
dpc-4022	45	2	the	the	DET
dpc-4022	45	3	characteristics	characteristic	NOUN
dpc-4022	45	4	of	of	ADP
dpc-4022	45	5	patients	patient	NOUN
dpc-4022	45	6	with	with	ADP
dpc-4022	45	7	pcm	pcm	NOUN
dpc-4022	45	8	were	be	AUX
dpc-4022	45	9	detailed	detail	VERB
dpc-4022	45	10	(	(	PUNCT
dpc-4022	45	11	table	table	NOUN
dpc-4022	45	12	1	1	NUM
dpc-4022	45	13	)	)	PUNCT
dpc-4022	45	14	,	,	PUNCT
dpc-4022	45	15	81	81	NUM
dpc-4022	45	16	were	be	AUX
dpc-4022	45	17	males	male	NOUN
dpc-4022	45	18	and	and	CCONJ
dpc-4022	45	19	77	77	NUM
dpc-4022	45	20	were	be	AUX
dpc-4022	45	21	females	female	NOUN
dpc-4022	45	22	(	(	PUNCT
dpc-4022	45	23	1.05/1	1.05/1	NUM
dpc-4022	45	24	)	)	PUNCT
dpc-4022	45	25	.	.	PUNCT
dpc-4022	46	1	the	the	DET
dpc-4022	46	2	age	age	NOUN
dpc-4022	46	3	of	of	ADP
dpc-4022	46	4	pcm	pcm	ADJ
dpc-4022	46	5	diagnosis	diagnosis	NOUN
dpc-4022	46	6	ranged	range	VERB
dpc-4022	46	7	from	from	ADP
dpc-4022	46	8	4	4	NUM
dpc-4022	46	9	to	to	PART
dpc-4022	46	10	92	92	NUM
dpc-4022	46	11	years	year	NOUN
dpc-4022	46	12	(	(	PUNCT
dpc-4022	46	13	mean	mean	PROPN
dpc-4022	46	14	±	±	NUM
dpc-4022	46	15	sd	sd	NOUN
dpc-4022	46	16	:	:	PUNCT
dpc-4022	46	17	53.8	53.8	NUM
dpc-4022	46	18	±	±	NUM
dpc-4022	46	19	19	19	NUM
dpc-4022	46	20	years	year	NOUN
dpc-4022	46	21	)	)	PUNCT
dpc-4022	46	22	;	;	PUNCT
dpc-4022	46	23	the	the	DET
dpc-4022	46	24	mean	mean	ADJ
dpc-4022	46	25	age	age	NOUN
dpc-4022	46	26	at	at	ADP
dpc-4022	46	27	diagnosis	diagnosis	NOUN
dpc-4022	46	28	was	be	AUX
dpc-4022	46	29	statistically	statistically	ADV
dpc-4022	46	30	similar	similar	ADJ
dpc-4022	46	31	in	in	ADP
dpc-4022	46	32	both	both	DET
dpc-4022	46	33	genders	gender	NOUN
dpc-4022	46	34	(	(	PUNCT
dpc-4022	46	35	mean	mean	NOUN
dpc-4022	47	1	±s	±s	PRON
dpc-4022	47	2	d	d	NOUN
dpc-4022	47	3	:	:	PUNCT
dpc-4022	47	4	54.8	54.8	NUM
dpc-4022	47	5	±	±	NUM
dpc-4022	47	6	18.8	18.8	NUM
dpc-4022	47	7	years	year	NOUN
dpc-4022	47	8	for	for	ADP
dpc-4022	47	9	males	male	NOUN
dpc-4022	47	10	versus	versus	ADP
dpc-4022	47	11	mean	mean	NOUN
dpc-4022	47	12	±	±	NUM
dpc-4022	47	13	sd	sd	NOUN
dpc-4022	47	14	:	:	PUNCT
dpc-4022	47	15	52.3	52.3	NUM
dpc-4022	47	16	±	±	NUM
dpc-4022	47	17	19.5	19.5	NUM
dpc-4022	47	18	years	year	NOUN
dpc-4022	47	19	for	for	ADP
dpc-4022	47	20	females	female	NOUN
dpc-4022	47	21	p	p	X
dpc-4022	47	22	=	=	NOUN
dpc-4022	47	23	0.440	0.440	NUM
dpc-4022	47	24	)	)	PUNCT
dpc-4022	47	25	.	.	PUNCT
dpc-4022	48	1	the	the	DET
dpc-4022	48	2	most	most	ADV
dpc-4022	48	3	common	common	ADJ
dpc-4022	48	4	histopathological	histopathological	ADJ
dpc-4022	48	5	subtype	subtype	NOUN
dpc-4022	48	6	was	be	AUX
dpc-4022	48	7	superficial	superficial	ADJ
dpc-4022	48	8	spreading	spread	VERB
dpc-4022	48	9	melanoma	melanoma	NOUN
dpc-4022	48	10	(	(	PUNCT
dpc-4022	48	11	ssm	ssm	PROPN
dpc-4022	48	12	)	)	PUNCT
dpc-4022	48	13	(	(	PUNCT
dpc-4022	48	14	38.8	38.8	NUM
dpc-4022	48	15	%	%	NOUN
dpc-4022	48	16	)	)	PUNCT
dpc-4022	48	17	.	.	PUNCT
dpc-4022	49	1	when	when	SCONJ
dpc-4022	49	2	evaluated	evaluate	VERB
dpc-4022	49	3	according	accord	VERB
dpc-4022	49	4	to	to	ADP
dpc-4022	49	5	the	the	DET
dpc-4022	49	6	ajcc	ajcc	PROPN
dpc-4022	49	7	8th	8th	ADJ
dpc-4022	49	8	guideline	guideline	NOUN
dpc-4022	49	9	,	,	PUNCT
dpc-4022	49	10	most	most	ADJ
dpc-4022	49	11	patients	patient	NOUN
dpc-4022	49	12	(	(	PUNCT
dpc-4022	49	13	61.7	61.7	NUM
dpc-4022	49	14	%	%	NOUN
dpc-4022	49	15	)	)	PUNCT
dpc-4022	49	16	were	be	AUX
dpc-4022	49	17	in	in	ADP
dpc-4022	49	18	the	the	DET
dpc-4022	49	19	early	early	ADJ
dpc-4022	49	20	local	local	ADJ
dpc-4022	49	21	stage	stage	NOUN
dpc-4022	49	22	(	(	PUNCT
dpc-4022	49	23	i	i	NOUN
dpc-4022	49	24	and	and	CCONJ
dpc-4022	49	25	ii	ii	PROPN
dpc-4022	49	26	)	)	PUNCT
dpc-4022	49	27	,	,	PUNCT
dpc-4022	49	28	17.8	17.8	NUM
dpc-4022	49	29	%	%	NOUN
dpc-4022	49	30	of	of	ADP
dpc-4022	49	31	the	the	DET
dpc-4022	49	32	patients	patient	NOUN
dpc-4022	49	33	were	be	AUX
dpc-4022	49	34	in	in	ADP
dpc-4022	49	35	the	the	DET
dpc-4022	49	36	nodal	nodal	NOUN
dpc-4022	49	37	stage	stage	NOUN
dpc-4022	49	38	(	(	PUNCT
dpc-4022	49	39	iii	iii	NOUN
dpc-4022	49	40	)	)	PUNCT
dpc-4022	49	41	and	and	CCONJ
dpc-4022	49	42	20.5	20.5	NUM
dpc-4022	49	43	%	%	NOUN
dpc-4022	49	44	of	of	ADP
dpc-4022	49	45	the	the	DET
dpc-4022	49	46	patients	patient	NOUN
dpc-4022	49	47	were	be	AUX
dpc-4022	49	48	diagnosed	diagnose	VERB
dpc-4022	49	49	with	with	ADP
dpc-4022	49	50	metastatic	metastatic	ADJ
dpc-4022	49	51	melanoma	melanoma	NOUN
dpc-4022	49	52	(	(	PUNCT
dpc-4022	49	53	iv	iv	NUM
dpc-4022	49	54	)	)	PUNCT
dpc-4022	49	55	,	,	PUNCT
dpc-4022	49	56	respectively	respectively	ADV
dpc-4022	49	57	(	(	PUNCT
dpc-4022	49	58	table	table	NOUN
dpc-4022	49	59	 	 	SPACE
dpc-4022	49	60	1	1	NUM
dpc-4022	49	61	)	)	PUNCT
dpc-4022	49	62	.	.	PUNCT
dpc-4022	50	1	anatomical	anatomical	ADJ
dpc-4022	50	2	localization	localization	NOUN
dpc-4022	50	3	of	of	ADP
dpc-4022	50	4	pcm	pcm	NOUN
dpc-4022	50	5	was	be	AUX
dpc-4022	50	6	similar	similar	ADJ
dpc-4022	50	7	in	in	ADP
dpc-4022	50	8	both	both	DET
dpc-4022	50	9	genders	gender	NOUN
dpc-4022	50	10	(	(	PUNCT
dpc-4022	50	11	p	p	NOUN
dpc-4022	50	12	=	=	NOUN
dpc-4022	50	13	0.341	0.341	NUM
dpc-4022	50	14	)	)	PUNCT
dpc-4022	50	15	.	.	PUNCT
dpc-4022	51	1	the	the	DET
dpc-4022	51	2	lower	low	ADJ
dpc-4022	51	3	extremities	extremity	NOUN
dpc-4022	51	4	were	be	AUX
dpc-4022	51	5	the	the	DET
dpc-4022	51	6	most	most	ADV
dpc-4022	51	7	frequently	frequently	ADV
dpc-4022	51	8	involved	involve	VERB
dpc-4022	51	9	,	,	PUNCT
dpc-4022	51	10	followed	follow	VERB
dpc-4022	51	11	by	by	ADP
dpc-4022	51	12	trunk	trunk	NOUN
dpc-4022	51	13	involvement	involvement	NOUN
dpc-4022	51	14	(	(	PUNCT
dpc-4022	51	15	table	table	NOUN
dpc-4022	51	16	 	 	SPACE
dpc-4022	51	17	2	2	NUM
dpc-4022	51	18	)	)	PUNCT
dpc-4022	51	19	.	.	PUNCT
dpc-4022	52	1	the	the	DET
dpc-4022	52	2	range	range	NOUN
dpc-4022	52	3	of	of	ADP
dpc-4022	52	4	tumor	tumor	NOUN
dpc-4022	52	5	breslow	breslow	NOUN
dpc-4022	52	6	thickness	thickness	NOUN
dpc-4022	52	7	was	be	AUX
dpc-4022	52	8	0.15	0.15	NUM
dpc-4022	52	9	-	-	SYM
dpc-4022	52	10	20.00	20.00	NUM
dpc-4022	52	11	mm	mm	NOUN
dpc-4022	52	12	(	(	PUNCT
dpc-4022	52	13	mean	mean	PROPN
dpc-4022	52	14	±	±	NUM
dpc-4022	52	15	sd	sd	NOUN
dpc-4022	52	16	:	:	PUNCT
dpc-4022	52	17	3.72	3.72	NUM
dpc-4022	52	18	±	±	NUM
dpc-4022	52	19	3.98	3.98	NUM
dpc-4022	52	20	mm	mm	NOUN
dpc-4022	52	21	)	)	PUNCT
dpc-4022	52	22	in	in	ADP
dpc-4022	52	23	137	137	NUM
dpc-4022	52	24	patients	patient	NOUN
dpc-4022	52	25	.	.	PUNCT
dpc-4022	53	1	the	the	DET
dpc-4022	53	2	most	most	ADV
dpc-4022	53	3	common	common	ADJ
dpc-4022	53	4	t	t	NOUN
dpc-4022	53	5	stages	stage	NOUN
dpc-4022	53	6	in	in	ADP
dpc-4022	53	7	men	man	NOUN
dpc-4022	53	8	were	be	AUX
dpc-4022	53	9	t3	t3	NOUN
dpc-4022	53	10	(	(	PUNCT
dpc-4022	53	11	64.1	64.1	NUM
dpc-4022	53	12	%	%	NOUN
dpc-4022	53	13	)	)	PUNCT
dpc-4022	53	14	and	and	CCONJ
dpc-4022	53	15	t4	t4	PROPN
dpc-4022	53	16	(	(	PUNCT
dpc-4022	53	17	55.3	55.3	NUM
dpc-4022	53	18	%	%	NOUN
dpc-4022	53	19	)	)	PUNCT
dpc-4022	53	20	,	,	PUNCT
dpc-4022	53	21	while	while	SCONJ
dpc-4022	53	22	t1	t1	PROPN
dpc-4022	53	23	(	(	PUNCT
dpc-4022	53	24	58.8	58.8	NUM
dpc-4022	53	25	%	%	NOUN
dpc-4022	53	26	)	)	PUNCT
dpc-4022	53	27	and	and	CCONJ
dpc-4022	53	28	t2	t2	PROPN
dpc-4022	53	29	(	(	PUNCT
dpc-4022	53	30	56.0	56.0	NUM
dpc-4022	53	31	%	%	NOUN
dpc-4022	53	32	)	)	PUNCT
dpc-4022	53	33	stages	stage	NOUN
dpc-4022	53	34	were	be	AUX
dpc-4022	53	35	most	most	ADV
dpc-4022	53	36	common	common	ADJ
dpc-4022	53	37	in	in	ADP
dpc-4022	53	38	women	woman	NOUN
dpc-4022	53	39	(	(	PUNCT
dpc-4022	53	40	table	table	NOUN
dpc-4022	53	41	  	  	SPACE
dpc-4022	53	42	3	3	NUM
dpc-4022	53	43	)	)	PUNCT
dpc-4022	53	44	.	.	PUNCT
dpc-4022	54	1	however	however	ADV
dpc-4022	54	2	,	,	PUNCT
dpc-4022	54	3	the	the	DET
dpc-4022	54	4	t	t	NOUN
dpc-4022	54	5	stage	stage	NOUN
dpc-4022	54	6	did	do	AUX
dpc-4022	54	7	not	not	PART
dpc-4022	54	8	differ	differ	VERB
dpc-4022	54	9	between	between	ADP
dpc-4022	54	10	genders	gender	NOUN
dpc-4022	54	11	(	(	PUNCT
dpc-4022	54	12	p	p	X
dpc-4022	54	13	 	 	SPACE
dpc-4022	54	14	=	=	SYM
dpc-4022	54	15	0.196	0.196	NUM
dpc-4022	54	16	)	)	PUNCT
dpc-4022	54	17	.	.	PUNCT
dpc-4022	55	1	while	while	SCONJ
dpc-4022	55	2	breslow	breslow	ADJ
dpc-4022	55	3	thickness	thickness	NOUN
dpc-4022	55	4	correlated	correlate	VERB
dpc-4022	55	5	considerably	considerably	ADV
dpc-4022	55	6	with	with	ADP
dpc-4022	55	7	histopathological	histopathological	ADJ
dpc-4022	55	8	subtype	subtype	NOUN
dpc-4022	55	9	(	(	PUNCT
dpc-4022	55	10	p	p	X
dpc-4022	55	11	  	  	SPACE
dpc-4022	55	12	<	<	X
dpc-4022	55	13	  	  	SPACE
dpc-4022	55	14	0.001	0.001	NUM
dpc-4022	55	15	)	)	PUNCT
dpc-4022	55	16	(	(	PUNCT
dpc-4022	55	17	table	table	NOUN
dpc-4022	55	18	3	3	NUM
dpc-4022	55	19	)	)	PUNCT
dpc-4022	55	20	,	,	PUNCT
dpc-4022	55	21	lymph	lymph	NOUN
dpc-4022	55	22	node	node	NOUN
dpc-4022	55	23	involvement	involvement	NOUN
dpc-4022	55	24	(	(	PUNCT
dpc-4022	55	25	p	p	X
dpc-4022	55	26	<	<	X
dpc-4022	55	27	 	 	SPACE
dpc-4022	55	28	0.001	0.001	NUM
dpc-4022	55	29	)	)	PUNCT
dpc-4022	55	30	,	,	PUNCT
dpc-4022	55	31	ulceration	ulceration	NOUN
dpc-4022	55	32	(	(	PUNCT
dpc-4022	55	33	p	p	X
dpc-4022	55	34	<	<	X
dpc-4022	55	35	0.001	0.001	NUM
dpc-4022	55	36	)	)	PUNCT
dpc-4022	55	37	,	,	PUNCT
dpc-4022	55	38	and	and	CCONJ
dpc-4022	55	39	5	5	NUM
dpc-4022	55	40	-	-	PUNCT
dpc-4022	55	41	year	year	NOUN
dpc-4022	55	42	overall	overall	ADJ
dpc-4022	55	43	survival	survival	NOUN
dpc-4022	55	44	(	(	PUNCT
dpc-4022	55	45	p	p	X
dpc-4022	55	46	=	=	NOUN
dpc-4022	55	47	0.014	0.014	NUM
dpc-4022	55	48	)	)	PUNCT
dpc-4022	55	49	,	,	PUNCT
dpc-4022	55	50	no	no	DET
dpc-4022	55	51	correlation	correlation	NOUN
dpc-4022	55	52	was	be	AUX
dpc-4022	55	53	found	find	VERB
dpc-4022	55	54	with	with	ADP
dpc-4022	55	55	anatomical	anatomical	ADJ
dpc-4022	55	56	location	location	NOUN
dpc-4022	55	57	and	and	CCONJ
dpc-4022	55	58	breslow	breslow	ADJ
dpc-4022	55	59	thickness	thickness	NOUN
dpc-4022	55	60	.	.	PUNCT
dpc-4022	56	1	due	due	ADP
dpc-4022	56	2	to	to	ADP
dpc-4022	56	3	technical	technical	ADJ
dpc-4022	56	4	and	and	CCONJ
dpc-4022	56	5	insurance	insurance	NOUN
dpc-4022	56	6	issues	issue	NOUN
dpc-4022	56	7	,	,	PUNCT
dpc-4022	56	8	the	the	DET
dpc-4022	56	9	braf	braf	NOUN
dpc-4022	56	10	mutation	mutation	NOUN
dpc-4022	56	11	analyses	analysis	NOUN
dpc-4022	56	12	could	could	AUX
dpc-4022	56	13	be	be	AUX
dpc-4022	56	14	performed	perform	VERB
dpc-4022	56	15	in	in	ADP
dpc-4022	56	16	only	only	ADV
dpc-4022	56	17	53	53	NUM
dpc-4022	56	18	patients	patient	NOUN
dpc-4022	56	19	.	.	PUNCT
dpc-4022	57	1	the	the	DET
dpc-4022	57	2	data	datum	NOUN
dpc-4022	57	3	revealed	reveal	VERB
dpc-4022	57	4	wild	wild	ADJ
dpc-4022	57	5	type	type	NOUN
dpc-4022	57	6	in	in	ADP
dpc-4022	57	7	54.7	54.7	NUM
dpc-4022	57	8	%	%	NOUN
dpc-4022	57	9	and	and	CCONJ
dpc-4022	57	10	mutant	mutant	ADJ
dpc-4022	57	11	type	type	NOUN
dpc-4022	57	12	in	in	ADP
dpc-4022	57	13	45.3	45.3	NUM
dpc-4022	57	14	%	%	NOUN
dpc-4022	57	15	.	.	PUNCT
dpc-4022	58	1	lymph	lymph	NOUN
dpc-4022	58	2	nodes	node	NOUN
dpc-4022	58	3	were	be	AUX
dpc-4022	58	4	involved	involve	VERB
dpc-4022	58	5	in	in	ADP
dpc-4022	58	6	50	50	NUM
dpc-4022	58	7	of	of	ADP
dpc-4022	58	8	147	147	NUM
dpc-4022	58	9	patients	patient	NOUN
dpc-4022	58	10	with	with	ADP
dpc-4022	58	11	pcm	pcm	NOUN
dpc-4022	58	12	(	(	PUNCT
dpc-4022	58	13	34	34	NUM
dpc-4022	58	14	%	%	NOUN
dpc-4022	58	15	)	)	PUNCT
dpc-4022	58	16	.	.	PUNCT
dpc-4022	59	1	the	the	DET
dpc-4022	59	2	lymph	lymph	NOUN
dpc-4022	59	3	node	node	PROPN
dpc-4022	59	4	involvement	involvement	NOUN
dpc-4022	59	5	conclusions	conclusion	NOUN
dpc-4022	59	6	:	:	PUNCT
dpc-4022	59	7	relatively	relatively	ADV
dpc-4022	59	8	younger	young	ADJ
dpc-4022	59	9	age	age	NOUN
dpc-4022	59	10	at	at	ADP
dpc-4022	59	11	melanoma	melanoma	ADJ
dpc-4022	59	12	diagnosis	diagnosis	NOUN
dpc-4022	59	13	,	,	PUNCT
dpc-4022	59	14	frequent	frequent	ADJ
dpc-4022	59	15	presence	presence	NOUN
dpc-4022	59	16	of	of	ADP
dpc-4022	59	17	thick	thick	ADJ
dpc-4022	59	18	(	(	PUNCT
dpc-4022	59	19	>	>	SYM
dpc-4022	59	20	4	4	NUM
dpc-4022	59	21	mm	mm	NOUN
dpc-4022	59	22	)	)	PUNCT
dpc-4022	59	23	tumor	tumor	NOUN
dpc-4022	59	24	,	,	PUNCT
dpc-4022	59	25	and	and	CCONJ
dpc-4022	59	26	frequent	frequent	ADJ
dpc-4022	59	27	acral	acral	ADJ
dpc-4022	59	28	lentiginous	lentiginous	ADJ
dpc-4022	59	29	subtype	subtype	NOUN
dpc-4022	59	30	are	be	AUX
dpc-4022	59	31	the	the	DET
dpc-4022	59	32	most	most	ADV
dpc-4022	59	33	remarkable	remarkable	ADJ
dpc-4022	59	34	features	feature	NOUN
dpc-4022	59	35	that	that	PRON
dpc-4022	59	36	suggest	suggest	VERB
dpc-4022	59	37	the	the	DET
dpc-4022	59	38	low	low	ADJ
dpc-4022	59	39	awareness	awareness	NOUN
dpc-4022	59	40	and	and	CCONJ
dpc-4022	59	41	knowledge	knowledge	NOUN
dpc-4022	59	42	of	of	ADP
dpc-4022	59	43	melanoma	melanoma	NOUN
dpc-4022	59	44	in	in	ADP
dpc-4022	59	45	our	our	PRON
dpc-4022	59	46	population	population	NOUN
dpc-4022	59	47	.	.	PUNCT
dpc-4022	60	1	original	original	ADJ
dpc-4022	60	2	article	article	NOUN
dpc-4022	60	3	|	|	ADV
dpc-4022	60	4	dermatol	dermatol	ADJ
dpc-4022	60	5	pract	pract	NOUN
dpc-4022	60	6	concept	concept	NOUN
dpc-4022	60	7	.	.	PUNCT
dpc-4022	61	1	2024;14(3):e2024135	2024;14(3):e2024135	NUM
dpc-4022	61	2	3	3	NUM
dpc-4022	61	3	significantly	significantly	ADV
dpc-4022	61	4	correlated	correlate	VERB
dpc-4022	61	5	with	with	ADP
dpc-4022	61	6	tumor	tumor	NOUN
dpc-4022	61	7	ulceration	ulceration	NOUN
dpc-4022	61	8	status	status	NOUN
dpc-4022	61	9	,	,	PUNCT
dpc-4022	61	10	presence	presence	NOUN
dpc-4022	61	11	of	of	ADP
dpc-4022	61	12	metastasis	metastasis	NOUN
dpc-4022	61	13	,	,	PUNCT
dpc-4022	61	14	histopathological	histopathological	ADJ
dpc-4022	61	15	subtype	subtype	NOUN
dpc-4022	61	16	,	,	PUNCT
dpc-4022	61	17	and	and	CCONJ
dpc-4022	61	18	age	age	NOUN
dpc-4022	61	19	at	at	ADP
dpc-4022	61	20	diagnosis	diagnosis	NOUN
dpc-4022	61	21	(	(	PUNCT
dpc-4022	61	22	all	all	DET
dpc-4022	61	23	p	p	X
dpc-4022	61	24	<	<	X
dpc-4022	61	25	0.05	0.05	NUM
dpc-4022	61	26	)	)	PUNCT
dpc-4022	61	27	(	(	PUNCT
dpc-4022	61	28	table	table	NOUN
dpc-4022	61	29	4	4	NUM
dpc-4022	61	30	)	)	PUNCT
dpc-4022	61	31	.	.	PUNCT
dpc-4022	62	1	compared	compare	VERB
dpc-4022	62	2	with	with	ADP
dpc-4022	62	3	patients	patient	NOUN
dpc-4022	62	4	with	with	ADP
dpc-4022	62	5	smm	smm	NOUN
dpc-4022	62	6	,	,	PUNCT
dpc-4022	62	7	patients	patient	NOUN
dpc-4022	62	8	with	with	ADP
dpc-4022	62	9	alm	alm	NOUN
dpc-4022	62	10	and	and	CCONJ
dpc-4022	62	11	patients	patient	NOUN
dpc-4022	62	12	with	with	ADP
dpc-4022	62	13	nm	nm	NOUN
dpc-4022	62	14	had	have	VERB
dpc-4022	62	15	more	more	ADJ
dpc-4022	62	16	lymph	lymph	NOUN
dpc-4022	62	17	node	node	NOUN
dpc-4022	62	18	involvement	involvement	NOUN
dpc-4022	62	19	(	(	PUNCT
dpc-4022	62	20	60	60	NUM
dpc-4022	62	21	%	%	NOUN
dpc-4022	62	22	,	,	PUNCT
dpc-4022	62	23	p	p	X
dpc-4022	62	24	=	=	PUNCT
dpc-4022	62	25	0.002	0.002	NUM
dpc-4022	62	26	and	and	CCONJ
dpc-4022	62	27	42.6	42.6	NUM
dpc-4022	62	28	%	%	NOUN
dpc-4022	62	29	,	,	PUNCT
dpc-4022	62	30	p	p	X
dpc-4022	62	31	<	<	X
dpc-4022	62	32	0.001	0.001	NUM
dpc-4022	62	33	,	,	PUNCT
dpc-4022	62	34	respectively	respectively	ADV
dpc-4022	62	35	)	)	PUNCT
dpc-4022	62	36	.	.	PUNCT
dpc-4022	63	1	the	the	DET
dpc-4022	63	2	patients	patient	NOUN
dpc-4022	63	3	over	over	ADP
dpc-4022	63	4	45	45	NUM
dpc-4022	63	5	years	year	NOUN
dpc-4022	63	6	had	have	VERB
dpc-4022	63	7	more	more	ADJ
dpc-4022	63	8	lymph	lymph	NOUN
dpc-4022	63	9	node	node	ADJ
dpc-4022	63	10	involvement	involvement	NOUN
dpc-4022	63	11	than	than	ADP
dpc-4022	63	12	younger	young	ADJ
dpc-4022	63	13	ones	one	NOUN
dpc-4022	63	14	(	(	PUNCT
dpc-4022	63	15	p	p	X
dpc-4022	63	16	=	=	NOUN
dpc-4022	63	17	0.015	0.015	NUM
dpc-4022	63	18	)	)	PUNCT
dpc-4022	63	19	,	,	PUNCT
dpc-4022	63	20	whereas	whereas	SCONJ
dpc-4022	63	21	it	it	PRON
dpc-4022	63	22	did	do	AUX
dpc-4022	63	23	not	not	PART
dpc-4022	63	24	differ	differ	VERB
dpc-4022	63	25	for	for	ADP
dpc-4022	63	26	both	both	DET
dpc-4022	63	27	genders	gender	NOUN
dpc-4022	63	28	and	and	CCONJ
dpc-4022	63	29	localizations	localization	NOUN
dpc-4022	63	30	of	of	ADP
dpc-4022	63	31	tumors	tumor	NOUN
dpc-4022	63	32	(	(	PUNCT
dpc-4022	63	33	p	p	X
dpc-4022	63	34	>	>	X
dpc-4022	63	35	0.05	0.05	NUM
dpc-4022	63	36	)	)	PUNCT
dpc-4022	63	37	.	.	PUNCT
dpc-4022	64	1	of	of	ADP
dpc-4022	64	2	all	all	DET
dpc-4022	64	3	pcm	pcm	NOUN
dpc-4022	64	4	patients	patient	NOUN
dpc-4022	64	5	for	for	ADP
dpc-4022	64	6	whom	whom	PRON
dpc-4022	64	7	staging	staging	NOUN
dpc-4022	64	8	information	information	NOUN
dpc-4022	64	9	was	be	AUX
dpc-4022	64	10	available	available	ADJ
dpc-4022	64	11	,	,	PUNCT
dpc-4022	64	12	30	30	NUM
dpc-4022	64	13	(	(	PUNCT
dpc-4022	64	14	20.5	20.5	NUM
dpc-4022	64	15	%	%	NOUN
dpc-4022	64	16	)	)	PUNCT
dpc-4022	64	17	had	have	VERB
dpc-4022	64	18	distant	distant	ADJ
dpc-4022	64	19	metastases	metastasis	NOUN
dpc-4022	64	20	.	.	PUNCT
dpc-4022	65	1	within	within	ADP
dpc-4022	65	2	the	the	DET
dpc-4022	65	3	30	30	NUM
dpc-4022	65	4	(	(	PUNCT
dpc-4022	65	5	20.5	20.5	NUM
dpc-4022	65	6	%	%	NOUN
dpc-4022	65	7	)	)	PUNCT
dpc-4022	65	8	patients	patient	NOUN
dpc-4022	65	9	diagnosed	diagnose	VERB
dpc-4022	65	10	with	with	ADP
dpc-4022	65	11	stage	stage	NOUN
dpc-4022	65	12	iv	iv	NUM
dpc-4022	65	13	metastatic	metastatic	ADJ
dpc-4022	65	14	pcm	pcm	NOUN
dpc-4022	65	15	,	,	PUNCT
dpc-4022	65	16	metastatic	metastatic	ADJ
dpc-4022	65	17	organ	organ	NOUN
dpc-4022	65	18	data	datum	NOUN
dpc-4022	65	19	were	be	AUX
dpc-4022	65	20	available	available	ADJ
dpc-4022	65	21	for	for	ADP
dpc-4022	65	22	22	22	NUM
dpc-4022	65	23	individuals	individual	NOUN
dpc-4022	65	24	,	,	PUNCT
dpc-4022	65	25	revealing	reveal	VERB
dpc-4022	65	26	that	that	SCONJ
dpc-4022	65	27	eight	eight	NUM
dpc-4022	65	28	patients	patient	NOUN
dpc-4022	65	29	presented	present	VERB
dpc-4022	65	30	with	with	ADP
dpc-4022	65	31	multiple	multiple	ADJ
dpc-4022	65	32	organ	organ	NOUN
dpc-4022	65	33	metastases	metastasis	NOUN
dpc-4022	65	34	,	,	PUNCT
dpc-4022	65	35	while	while	SCONJ
dpc-4022	65	36	14	14	NUM
dpc-4022	65	37	patients	patient	NOUN
dpc-4022	65	38	exhibited	exhibit	VERB
dpc-4022	65	39	single	single	ADJ
dpc-4022	65	40	organ	organ	NOUN
dpc-4022	65	41	involvement	involvement	NOUN
dpc-4022	65	42	(	(	PUNCT
dpc-4022	65	43	table	table	NOUN
dpc-4022	65	44	5	5	NUM
dpc-4022	65	45	)	)	PUNCT
dpc-4022	65	46	.	.	PUNCT
dpc-4022	66	1	the	the	DET
dpc-4022	66	2	overall	overall	ADJ
dpc-4022	66	3	survival	survival	NOUN
dpc-4022	66	4	data	datum	NOUN
dpc-4022	66	5	of	of	ADP
dpc-4022	66	6	178	178	NUM
dpc-4022	66	7	patients	patient	NOUN
dpc-4022	66	8	with	with	ADP
dpc-4022	66	9	melanoma	melanoma	NOUN
dpc-4022	66	10	was	be	AUX
dpc-4022	66	11	evaluated	evaluate	VERB
dpc-4022	66	12	at	at	ADP
dpc-4022	66	13	the	the	DET
dpc-4022	66	14	time	time	NOUN
dpc-4022	66	15	of	of	ADP
dpc-4022	66	16	the	the	DET
dpc-4022	66	17	study	study	NOUN
dpc-4022	66	18	.	.	PUNCT
dpc-4022	67	1	according	accord	VERB
dpc-4022	67	2	to	to	ADP
dpc-4022	67	3	the	the	DET
dpc-4022	67	4	statistical	statistical	ADJ
dpc-4022	67	5	analysis	analysis	NOUN
dpc-4022	67	6	,	,	PUNCT
dpc-4022	67	7	the	the	DET
dpc-4022	67	8	median	median	ADJ
dpc-4022	67	9	follow	follow	VERB
dpc-4022	67	10	-	-	PUNCT
dpc-4022	67	11	up	up	NOUN
dpc-4022	67	12	period	period	NOUN
dpc-4022	67	13	was	be	AUX
dpc-4022	67	14	32.5	32.5	NUM
dpc-4022	67	15	months	month	NOUN
dpc-4022	67	16	(	(	PUNCT
dpc-4022	67	17	range	range	NOUN
dpc-4022	67	18	1	1	NUM
dpc-4022	67	19	-	-	SYM
dpc-4022	67	20	162	162	NUM
dpc-4022	67	21	months	month	NOUN
dpc-4022	67	22	)	)	PUNCT
dpc-4022	67	23	.	.	PUNCT
dpc-4022	68	1	during	during	ADP
dpc-4022	68	2	the	the	DET
dpc-4022	68	3	follow	follow	NOUN
dpc-4022	68	4	-	-	PUNCT
dpc-4022	68	5	up	up	NOUN
dpc-4022	68	6	,	,	PUNCT
dpc-4022	68	7	41	41	NUM
dpc-4022	68	8	patients	patient	NOUN
dpc-4022	68	9	have	have	AUX
dpc-4022	68	10	died	die	VERB
dpc-4022	68	11	.	.	PUNCT
dpc-4022	69	1	the	the	DET
dpc-4022	69	2	estimate	estimate	NOUN
dpc-4022	69	3	of	of	ADP
dpc-4022	69	4	the	the	DET
dpc-4022	69	5	mean	mean	ADJ
dpc-4022	69	6	overall	overall	ADJ
dpc-4022	69	7	survival	survival	NOUN
dpc-4022	69	8	time	time	NOUN
dpc-4022	69	9	was	be	AUX
dpc-4022	69	10	50	50	NUM
dpc-4022	69	11	months	month	NOUN
dpc-4022	69	12	(	(	PUNCT
dpc-4022	69	13	95	95	NUM
dpc-4022	69	14	%	%	NOUN
dpc-4022	69	15	confidence	confidence	NOUN
dpc-4022	69	16	interval	interval	NOUN
dpc-4022	69	17	:	:	PUNCT
dpc-4022	69	18	46.6	46.6	NUM
dpc-4022	69	19	–	–	PUNCT
dpc-4022	69	20	52.5	52.5	NUM
dpc-4022	69	21	)	)	PUNCT
dpc-4022	69	22	.	.	PUNCT
dpc-4022	70	1	for	for	ADP
dpc-4022	70	2	pcm	pcm	NOUN
dpc-4022	70	3	patients	patient	NOUN
dpc-4022	70	4	,	,	PUNCT
dpc-4022	70	5	27	27	NUM
dpc-4022	70	6	patients	patient	NOUN
dpc-4022	70	7	have	have	AUX
dpc-4022	70	8	died	die	VERB
dpc-4022	70	9	during	during	ADP
dpc-4022	70	10	the	the	DET
dpc-4022	70	11	follow	follow	NOUN
dpc-4022	70	12	-	-	PUNCT
dpc-4022	70	13	up	up	NOUN
dpc-4022	70	14	time	time	NOUN
dpc-4022	70	15	.	.	PUNCT
dpc-4022	71	1	the	the	DET
dpc-4022	71	2	estimate	estimate	NOUN
dpc-4022	71	3	of	of	ADP
dpc-4022	71	4	the	the	DET
dpc-4022	71	5	mean	mean	ADJ
dpc-4022	71	6	overall	overall	ADJ
dpc-4022	71	7	survival	survival	NOUN
dpc-4022	71	8	time	time	NOUN
dpc-4022	71	9	was	be	AUX
dpc-4022	71	10	53	53	NUM
dpc-4022	71	11	months	month	NOUN
dpc-4022	71	12	(	(	PUNCT
dpc-4022	71	13	95	95	NUM
dpc-4022	71	14	%	%	NOUN
dpc-4022	71	15	confidence	confidence	NOUN
dpc-4022	71	16	interval	interval	NOUN
dpc-4022	71	17	:	:	PUNCT
dpc-4022	71	18	50	50	NUM
dpc-4022	71	19	–	–	PUNCT
dpc-4022	71	20	55	55	NUM
dpc-4022	71	21	)	)	PUNCT
dpc-4022	71	22	.	.	PUNCT
dpc-4022	72	1	for	for	ADP
dpc-4022	72	2	all	all	DET
dpc-4022	72	3	pcm	pcm	ADJ
dpc-4022	72	4	patients	patient	NOUN
dpc-4022	72	5	,	,	PUNCT
dpc-4022	72	6	the	the	DET
dpc-4022	72	7	5	5	NUM
dpc-4022	72	8	-	-	PUNCT
dpc-4022	72	9	year	year	NOUN
dpc-4022	72	10	survival	survival	NOUN
dpc-4022	72	11	rate	rate	NOUN
dpc-4022	72	12	of	of	ADP
dpc-4022	72	13	t1	t1	PROPN
dpc-4022	72	14	was	be	AUX
dpc-4022	72	15	significantly	significantly	ADV
dpc-4022	72	16	higher	high	ADJ
dpc-4022	72	17	than	than	ADP
dpc-4022	72	18	t2	t2	NOUN
dpc-4022	72	19	,	,	PUNCT
dpc-4022	72	20	t3	t3	PROPN
dpc-4022	72	21	,	,	PUNCT
dpc-4022	72	22	and	and	CCONJ
dpc-4022	72	23	t4	t4	PROPN
dpc-4022	72	24	(	(	PUNCT
dpc-4022	72	25	p	p	X
dpc-4022	72	26	=	=	NOUN
dpc-4022	72	27	0.016	0.016	NUM
dpc-4022	72	28	)	)	PUNCT
dpc-4022	72	29	(	(	PUNCT
dpc-4022	72	30	figure	figure	NOUN
dpc-4022	72	31	1a	1a	NOUN
dpc-4022	72	32	)	)	PUNCT
dpc-4022	72	33	.	.	PUNCT
dpc-4022	73	1	the	the	DET
dpc-4022	73	2	5	5	NUM
dpc-4022	73	3	-	-	PUNCT
dpc-4022	73	4	year	year	NOUN
dpc-4022	73	5	survival	survival	NOUN
dpc-4022	73	6	rate	rate	NOUN
dpc-4022	73	7	was	be	AUX
dpc-4022	73	8	highest	high	ADJ
dpc-4022	73	9	in	in	ADP
dpc-4022	73	10	t1	t1	PROPN
dpc-4022	73	11	patients	patient	NOUN
dpc-4022	73	12	(	(	PUNCT
dpc-4022	73	13	100	100	NUM
dpc-4022	73	14	%	%	NOUN
dpc-4022	73	15	)	)	PUNCT
dpc-4022	73	16	,	,	PUNCT
dpc-4022	73	17	87	87	NUM
dpc-4022	73	18	%	%	NOUN
dpc-4022	73	19	in	in	ADP
dpc-4022	73	20	t2	t2	NOUN
dpc-4022	73	21	,	,	PUNCT
dpc-4022	73	22	77.1	77.1	NUM
dpc-4022	73	23	%	%	NOUN
dpc-4022	73	24	in	in	ADP
dpc-4022	73	25	t3	t3	PROPN
dpc-4022	73	26	,	,	PUNCT
dpc-4022	73	27	and	and	CCONJ
dpc-4022	73	28	76.0	76.0	NUM
dpc-4022	73	29	%	%	NOUN
dpc-4022	73	30	in	in	ADP
dpc-4022	73	31	t4	t4	PROPN
dpc-4022	73	32	patients	patient	NOUN
dpc-4022	73	33	,	,	PUNCT
dpc-4022	73	34	respectively	respectively	ADV
dpc-4022	73	35	.	.	PUNCT
dpc-4022	74	1	the	the	DET
dpc-4022	74	2	results	result	NOUN
dpc-4022	74	3	of	of	ADP
dpc-4022	74	4	the	the	DET
dpc-4022	74	5	log	log	NOUN
dpc-4022	74	6	-	-	PUNCT
dpc-4022	74	7	rank	rank	NOUN
dpc-4022	74	8	test	test	NOUN
dpc-4022	74	9	regarding	regard	VERB
dpc-4022	74	10	death	death	NOUN
dpc-4022	74	11	for	for	ADP
dpc-4022	74	12	each	each	DET
dpc-4022	74	13	breslow	breslow	ADJ
dpc-4022	74	14	thickness	thickness	NOUN
dpc-4022	74	15	stage	stage	NOUN
dpc-4022	74	16	showed	show	VERB
dpc-4022	74	17	that	that	SCONJ
dpc-4022	74	18	the	the	DET
dpc-4022	74	19	survival	survival	NOUN
dpc-4022	74	20	rate	rate	NOUN
dpc-4022	74	21	of	of	ADP
dpc-4022	74	22	t1	t1	PROPN
dpc-4022	74	23	was	be	AUX
dpc-4022	74	24	the	the	DET
dpc-4022	74	25	highest	high	ADJ
dpc-4022	74	26	compared	compare	VERB
dpc-4022	74	27	to	to	ADP
dpc-4022	74	28	patients	patient	NOUN
dpc-4022	74	29	in	in	ADP
dpc-4022	74	30	other	other	ADJ
dpc-4022	74	31	stages	stage	NOUN
dpc-4022	74	32	(	(	PUNCT
dpc-4022	74	33	p	p	X
dpc-4022	74	34	=	=	NOUN
dpc-4022	74	35	0.016	0.016	NUM
dpc-4022	74	36	)	)	PUNCT
dpc-4022	74	37	.	.	PUNCT
dpc-4022	75	1	when	when	SCONJ
dpc-4022	75	2	the	the	DET
dpc-4022	75	3	5	5	NUM
dpc-4022	75	4	-	-	PUNCT
dpc-4022	75	5	year	year	NOUN
dpc-4022	75	6	survival	survival	NOUN
dpc-4022	75	7	is	be	AUX
dpc-4022	75	8	analyzed	analyze	VERB
dpc-4022	75	9	based	base	VERB
dpc-4022	75	10	on	on	ADP
dpc-4022	75	11	the	the	DET
dpc-4022	75	12	stage	stage	NOUN
dpc-4022	75	13	determined	determine	VERB
dpc-4022	75	14	by	by	ADP
dpc-4022	75	15	ajcc	ajcc	NOUN
dpc-4022	75	16	8th	8th	ADJ
dpc-4022	75	17	for	for	ADP
dpc-4022	75	18	all	all	DET
dpc-4022	75	19	pcm	pcm	ADJ
dpc-4022	75	20	patients	patient	NOUN
dpc-4022	75	21	,	,	PUNCT
dpc-4022	75	22	the	the	DET
dpc-4022	75	23	survival	survival	NOUN
dpc-4022	75	24	rate	rate	NOUN
dpc-4022	75	25	of	of	ADP
dpc-4022	75	26	stage	stage	NOUN
dpc-4022	75	27	iv	iv	NUM
dpc-4022	75	28	patients	patient	NOUN
dpc-4022	75	29	was	be	AUX
dpc-4022	75	30	the	the	DET
dpc-4022	75	31	lowest	low	ADJ
dpc-4022	75	32	compared	compare	VERB
dpc-4022	75	33	to	to	ADP
dpc-4022	75	34	patients	patient	NOUN
dpc-4022	75	35	in	in	ADP
dpc-4022	75	36	other	other	ADJ
dpc-4022	75	37	melanoma	melanoma	NOUN
dpc-4022	75	38	stages	stage	NOUN
dpc-4022	75	39	(	(	PUNCT
dpc-4022	75	40	p	p	X
dpc-4022	75	41	<	<	X
dpc-4022	75	42	0.001	0.001	NUM
dpc-4022	75	43	)	)	PUNCT
dpc-4022	75	44	.	.	PUNCT
dpc-4022	76	1	the	the	DET
dpc-4022	76	2	estimate	estimate	NOUN
dpc-4022	76	3	of	of	ADP
dpc-4022	76	4	the	the	DET
dpc-4022	76	5	mean	mean	ADJ
dpc-4022	76	6	overall	overall	ADJ
dpc-4022	76	7	survival	survival	NOUN
dpc-4022	76	8	time	time	NOUN
dpc-4022	76	9	for	for	ADP
dpc-4022	76	10	stage	stage	NOUN
dpc-4022	76	11	iv	iv	NUM
dpc-4022	76	12	was	be	AUX
dpc-4022	76	13	32.8	32.8	NUM
dpc-4022	76	14	months	month	NOUN
dpc-4022	76	15	(	(	PUNCT
dpc-4022	76	16	95	95	NUM
dpc-4022	76	17	%	%	NOUN
dpc-4022	76	18	confidence	confidence	NOUN
dpc-4022	76	19	interval	interval	NOUN
dpc-4022	76	20	:	:	PUNCT
dpc-4022	76	21	32.8	32.8	NUM
dpc-4022	76	22	–	–	PUNCT
dpc-4022	76	23	48.1	48.1	NUM
dpc-4022	76	24	)	)	PUNCT
dpc-4022	76	25	.	.	PUNCT
dpc-4022	77	1	in	in	ADP
dpc-4022	77	2	the	the	DET
dpc-4022	77	3	context	context	NOUN
dpc-4022	77	4	of	of	ADP
dpc-4022	77	5	the	the	DET
dpc-4022	77	6	5	5	NUM
dpc-4022	77	7	-	-	PUNCT
dpc-4022	77	8	year	year	NOUN
dpc-4022	77	9	survival	survival	NOUN
dpc-4022	77	10	analysis	analysis	NOUN
dpc-4022	77	11	concerning	concern	VERB
dpc-4022	77	12	factors	factor	NOUN
dpc-4022	77	13	influencing	influence	VERB
dpc-4022	77	14	overall	overall	ADJ
dpc-4022	77	15	survival	survival	NOUN
dpc-4022	77	16	in	in	ADP
dpc-4022	77	17	melanoma	melanoma	NOUN
dpc-4022	77	18	,	,	PUNCT
dpc-4022	77	19	a	a	DET
dpc-4022	77	20	significant	significant	ADJ
dpc-4022	77	21	relationship	relationship	NOUN
dpc-4022	77	22	was	be	AUX
dpc-4022	77	23	observed	observe	VERB
dpc-4022	77	24	with	with	ADP
dpc-4022	77	25	ulceration	ulceration	NOUN
dpc-4022	77	26	(	(	PUNCT
dpc-4022	77	27	p	p	X
dpc-4022	77	28	<	<	X
dpc-4022	77	29	0.001	0.001	NUM
dpc-4022	77	30	)	)	PUNCT
dpc-4022	77	31	,	,	PUNCT
dpc-4022	77	32	breslow	breslow	ADJ
dpc-4022	77	33	thickness	thickness	NOUN
dpc-4022	77	34	(	(	PUNCT
dpc-4022	77	35	p	p	X
dpc-4022	77	36	=	=	NOUN
dpc-4022	77	37	0.016	0.016	NUM
dpc-4022	77	38	)	)	PUNCT
dpc-4022	77	39	,	,	PUNCT
dpc-4022	77	40	ajcc	ajcc	PROPN
dpc-4022	77	41	8th	8th	ADJ
dpc-4022	77	42	stage	stage	NOUN
dpc-4022	77	43	(	(	PUNCT
dpc-4022	77	44	p	p	X
dpc-4022	77	45	<	<	X
dpc-4022	77	46	0.001	0.001	NUM
dpc-4022	77	47	)	)	PUNCT
dpc-4022	77	48	,	,	PUNCT
dpc-4022	77	49	and	and	CCONJ
dpc-4022	77	50	age	age	NOUN
dpc-4022	77	51	(	(	PUNCT
dpc-4022	77	52	p	p	X
dpc-4022	77	53	=	=	NOUN
dpc-4022	77	54	0.008	0.008	NUM
dpc-4022	77	55	)	)	PUNCT
dpc-4022	77	56	.	.	PUNCT
dpc-4022	78	1	however	however	ADV
dpc-4022	78	2	,	,	PUNCT
dpc-4022	78	3	there	there	PRON
dpc-4022	78	4	was	be	VERB
dpc-4022	78	5	no	no	DET
dpc-4022	78	6	significant	significant	ADJ
dpc-4022	78	7	relationship	relationship	NOUN
dpc-4022	78	8	detected	detect	VERB
dpc-4022	78	9	concerning	concern	VERB
dpc-4022	78	10	gender	gender	NOUN
dpc-4022	78	11	(	(	PUNCT
dpc-4022	78	12	p	p	NOUN
dpc-4022	78	13	=	=	NOUN
dpc-4022	78	14	0.374	0.374	NUM
dpc-4022	78	15	)	)	PUNCT
dpc-4022	78	16	and	and	CCONJ
dpc-4022	78	17	localization	localization	NOUN
dpc-4022	78	18	(	(	PUNCT
dpc-4022	78	19	p	p	X
dpc-4022	78	20	=	=	NOUN
dpc-4022	78	21	0.540	0.540	NUM
dpc-4022	78	22	)	)	PUNCT
dpc-4022	78	23	(	(	PUNCT
dpc-4022	78	24	figure	figure	NOUN
dpc-4022	78	25	1	1	NUM
dpc-4022	78	26	,	,	PUNCT
dpc-4022	78	27	a	a	DET
dpc-4022	78	28	-	-	PUNCT
dpc-4022	78	29	f	f	NOUN
dpc-4022	78	30	)	)	PUNCT
dpc-4022	78	31	.	.	PUNCT
dpc-4022	79	1	conclusions	conclusion	NOUN
dpc-4022	79	2	our	our	PRON
dpc-4022	79	3	findings	finding	NOUN
dpc-4022	79	4	,	,	PUNCT
dpc-4022	79	5	indicating	indicate	VERB
dpc-4022	79	6	a	a	DET
dpc-4022	79	7	mean	mean	ADJ
dpc-4022	79	8	age	age	NOUN
dpc-4022	79	9	of	of	ADP
dpc-4022	79	10	melanoma	melanoma	ADJ
dpc-4022	79	11	diagnosis	diagnosis	NOUN
dpc-4022	79	12	at	at	ADP
dpc-4022	79	13	54.7	54.7	NUM
dpc-4022	79	14	years	year	NOUN
dpc-4022	79	15	,	,	PUNCT
dpc-4022	79	16	align	align	VERB
dpc-4022	79	17	closely	closely	ADV
dpc-4022	79	18	with	with	ADP
dpc-4022	79	19	prior	prior	ADJ
dpc-4022	79	20	research	research	NOUN
dpc-4022	79	21	conducted	conduct	VERB
dpc-4022	79	22	in	in	ADP
dpc-4022	79	23	turkey	turkey	NOUN
dpc-4022	80	1	[	[	X
dpc-4022	80	2	2	2	NUM
dpc-4022	80	3	-	-	SYM
dpc-4022	80	4	5	5	NUM
dpc-4022	80	5	]	]	PUNCT
dpc-4022	80	6	,	,	PUNCT
dpc-4022	80	7	which	which	PRON
dpc-4022	80	8	is	be	AUX
dpc-4022	80	9	younger	young	ADJ
dpc-4022	80	10	than	than	ADP
dpc-4022	80	11	the	the	DET
dpc-4022	80	12	most	most	ADV
dpc-4022	80	13	recent	recent	ADJ
dpc-4022	80	14	data	datum	NOUN
dpc-4022	80	15	of	of	ADP
dpc-4022	80	16	the	the	DET
dpc-4022	80	17	american	american	PROPN
dpc-4022	80	18	cancer	cancer	NOUN
dpc-4022	80	19	society	society	PROPN
dpc-4022	80	20	reporting	report	VERB
dpc-4022	80	21	the	the	DET
dpc-4022	80	22	average	average	ADJ
dpc-4022	80	23	age	age	NOUN
dpc-4022	80	24	of	of	ADP
dpc-4022	80	25	diagnosis	diagnosis	NOUN
dpc-4022	80	26	for	for	ADP
dpc-4022	80	27	melanoma	melanoma	NOUN
dpc-4022	80	28	as	as	ADP
dpc-4022	80	29	65	65	NUM
dpc-4022	80	30	years	year	NOUN
dpc-4022	81	1	[	[	X
dpc-4022	81	2	6	6	NUM
dpc-4022	81	3	]	]	PUNCT
dpc-4022	81	4	.	.	PUNCT
dpc-4022	82	1	notably	notably	ADV
dpc-4022	82	2	,	,	PUNCT
dpc-4022	82	3	the	the	DET
dpc-4022	82	4	mean	mean	ADJ
dpc-4022	82	5	age	age	NOUN
dpc-4022	82	6	of	of	ADP
dpc-4022	82	7	melanoma	melanoma	ADJ
dpc-4022	82	8	diagnosis	diagnosis	NOUN
dpc-4022	82	9	in	in	ADP
dpc-4022	82	10	turkey	turkey	NOUN
dpc-4022	82	11	is	be	AUX
dpc-4022	82	12	younger	young	ADJ
dpc-4022	82	13	than	than	ADP
dpc-4022	82	14	in	in	ADP
dpc-4022	82	15	the	the	DET
dpc-4022	82	16	table	table	NOUN
dpc-4022	82	17	1	1	NUM
dpc-4022	82	18	.	.	PUNCT
dpc-4022	82	19	patient	patient	ADJ
dpc-4022	82	20	and	and	CCONJ
dpc-4022	82	21	tumor	tumor	NOUN
dpc-4022	82	22	characteristics	characteristic	NOUN
dpc-4022	82	23	of	of	ADP
dpc-4022	82	24	primary	primary	ADJ
dpc-4022	82	25	cutaneous	cutaneous	ADJ
dpc-4022	82	26	melanoma	melanoma	NOUN
dpc-4022	82	27	patients	patient	NOUN
dpc-4022	82	28	.	.	PUNCT
dpc-4022	83	1	features	feature	VERB
dpc-4022	83	2	n	n	PROPN
dpc-4022	83	3	(	(	PUNCT
dpc-4022	83	4	%	%	INTJ
dpc-4022	83	5	)	)	PUNCT
dpc-4022	83	6	histopathological	histopathological	ADJ
dpc-4022	83	7	subtype	subtype	NOUN
dpc-4022	83	8	(	(	PUNCT
dpc-4022	83	9	n	n	NOUN
dpc-4022	83	10	=	=	SYM
dpc-4022	83	11	152	152	NUM
dpc-4022	83	12	)	)	PUNCT
dpc-4022	83	13	ssm	ssm	NOUN
dpc-4022	83	14	59	59	NUM
dpc-4022	83	15	38.8	38.8	NUM
dpc-4022	83	16	nm	nm	NOUN
dpc-4022	83	17	51	51	NUM
dpc-4022	83	18	33.6	33.6	NUM
dpc-4022	83	19	alm	alm	NOUN
dpc-4022	83	20	26	26	NUM
dpc-4022	83	21	17.1	17.1	NUM
dpc-4022	83	22	lmm	lmm	PROPN
dpc-4022	83	23	8	8	NUM
dpc-4022	83	24	5.3	5.3	NUM
dpc-4022	83	25	others	other	NOUN
dpc-4022	83	26	8	8	NUM
dpc-4022	83	27	5.3	5.3	NUM
dpc-4022	83	28	age	age	NOUN
dpc-4022	83	29	(	(	PUNCT
dpc-4022	83	30	n	n	NOUN
dpc-4022	83	31	=	=	SYM
dpc-4022	83	32	155	155	NUM
dpc-4022	83	33	)	)	PUNCT
dpc-4022	83	34	,	,	PUNCT
dpc-4022	83	35	years	year	NOUN
dpc-4022	83	36	<	<	X
dpc-4022	83	37	18	18	NUM
dpc-4022	83	38	1	1	NUM
dpc-4022	83	39	0.6	0.6	NUM
dpc-4022	83	40	18	18	NUM
dpc-4022	83	41	-	-	SYM
dpc-4022	83	42	30	30	NUM
dpc-4022	83	43	23	23	NUM
dpc-4022	83	44	14.8	14.8	NUM
dpc-4022	83	45	31	31	NUM
dpc-4022	83	46	-	-	SYM
dpc-4022	83	47	45	45	NUM
dpc-4022	83	48	32	32	NUM
dpc-4022	83	49	20.6	20.6	NUM
dpc-4022	83	50	46	46	NUM
dpc-4022	83	51	-	-	SYM
dpc-4022	83	52	65	65	NUM
dpc-4022	83	53	49	49	NUM
dpc-4022	83	54	31.6	31.6	NUM
dpc-4022	83	55	>	>	SYM
dpc-4022	83	56	65	65	NUM
dpc-4022	83	57	50	50	NUM
dpc-4022	83	58	32.3	32.3	NUM
dpc-4022	83	59	gender	gender	NOUN
dpc-4022	83	60	(	(	PUNCT
dpc-4022	83	61	n	n	NOUN
dpc-4022	83	62	=	=	SYM
dpc-4022	83	63	158	158	NUM
dpc-4022	83	64	)	)	PUNCT
dpc-4022	83	65	male	male	NOUN
dpc-4022	83	66	81	81	NUM
dpc-4022	83	67	51.3	51.3	NUM
dpc-4022	83	68	female	female	NOUN
dpc-4022	83	69	77	77	NUM
dpc-4022	83	70	48.7	48.7	NUM
dpc-4022	83	71	breslow	breslow	NOUN
dpc-4022	83	72	thickness	thickness	NOUN
dpc-4022	83	73	(	(	PUNCT
dpc-4022	83	74	n	n	NOUN
dpc-4022	83	75	=	=	SYM
dpc-4022	83	76	137	137	NUM
dpc-4022	83	77	)	)	PUNCT
dpc-4022	83	78	t1	t1	NOUN
dpc-4022	83	79	(	(	PUNCT
dpc-4022	83	80	≤	≤	NOUN
dpc-4022	83	81	 	 	SPACE
dpc-4022	83	82	1	1	NUM
dpc-4022	83	83	mm	mm	NOUN
dpc-4022	83	84	)	)	PUNCT
dpc-4022	83	85	37	37	NUM
dpc-4022	83	86	27.0	27.0	NUM
dpc-4022	83	87	t2	t2	NOUN
dpc-4022	83	88	(	(	PUNCT
dpc-4022	83	89	1.1	1.1	NUM
dpc-4022	83	90	-	-	SYM
dpc-4022	83	91	2	2	NUM
dpc-4022	83	92	mm	mm	NOUN
dpc-4022	83	93	)	)	PUNCT
dpc-4022	83	94	23	23	NUM
dpc-4022	83	95	16.8	16.8	NUM
dpc-4022	83	96	t3	t3	NOUN
dpc-4022	83	97	(	(	PUNCT
dpc-4022	83	98	2.1	2.1	NUM
dpc-4022	83	99	-	-	SYM
dpc-4022	83	100	4	4	NUM
dpc-4022	83	101	mm	mm	NOUN
dpc-4022	83	102	)	)	PUNCT
dpc-4022	83	103	35	35	NUM
dpc-4022	83	104	25.5	25.5	NUM
dpc-4022	83	105	t4	t4	PROPN
dpc-4022	83	106	(	(	PUNCT
dpc-4022	83	107	>	>	SYM
dpc-4022	83	108	4	4	NUM
dpc-4022	83	109	mm	mm	NOUN
dpc-4022	83	110	)	)	PUNCT
dpc-4022	83	111	42	42	NUM
dpc-4022	83	112	30.7	30.7	NUM
dpc-4022	83	113	ulceration	ulceration	NOUN
dpc-4022	83	114	(	(	PUNCT
dpc-4022	83	115	n	n	NOUN
dpc-4022	83	116	=	=	SYM
dpc-4022	83	117	92	92	NUM
dpc-4022	83	118	)	)	PUNCT
dpc-4022	83	119	present	present	VERB
dpc-4022	83	120	51	51	NUM
dpc-4022	83	121	55.4	55.4	NUM
dpc-4022	83	122	absent	absent	ADJ
dpc-4022	83	123	41	41	NUM
dpc-4022	83	124	44.6	44.6	NUM
dpc-4022	83	125	lymph	lymph	NOUN
dpc-4022	83	126	node	node	NOUN
dpc-4022	83	127	involvement	involvement	NOUN
dpc-4022	83	128	(	(	PUNCT
dpc-4022	83	129	n	n	NOUN
dpc-4022	83	130	=	=	SYM
dpc-4022	83	131	147	147	NUM
dpc-4022	83	132	)	)	PUNCT
dpc-4022	83	133	n0	n0	NOUN
dpc-4022	83	134	97	97	NUM
dpc-4022	83	135	66.0	66.0	NUM
dpc-4022	83	136	n1	n1	NOUN
dpc-4022	83	137	23	23	NUM
dpc-4022	83	138	15.6	15.6	NUM
dpc-4022	83	139	n2	n2	NOUN
dpc-4022	83	140	4	4	NUM
dpc-4022	83	141	2.7	2.7	NUM
dpc-4022	83	142	n3	n3	VERB
dpc-4022	83	143	23	23	NUM
dpc-4022	83	144	15.6	15.6	NUM
dpc-4022	83	145	metastasis	metastasis	NOUN
dpc-4022	83	146	(	(	PUNCT
dpc-4022	83	147	n	n	NOUN
dpc-4022	83	148	=	=	SYM
dpc-4022	83	149	151	151	NUM
dpc-4022	83	150	)	)	PUNCT
dpc-4022	83	151	m0	m0	NOUN
dpc-4022	83	152	121	121	NUM
dpc-4022	83	153	80.1	80.1	NUM
dpc-4022	83	154	m1	m1	NOUN
dpc-4022	83	155	30	30	NUM
dpc-4022	83	156	19.9	19.9	NUM
dpc-4022	83	157	braf	braf	NOUN
dpc-4022	83	158	mutation	mutation	NOUN
dpc-4022	83	159	(	(	PUNCT
dpc-4022	83	160	n	n	NOUN
dpc-4022	83	161	=	=	SYM
dpc-4022	83	162	53	53	NUM
dpc-4022	83	163	)	)	PUNCT
dpc-4022	83	164	wild	wild	ADJ
dpc-4022	83	165	type	type	NOUN
dpc-4022	83	166	29	29	NUM
dpc-4022	83	167	54.7	54.7	NUM
dpc-4022	83	168	mutant	mutant	NOUN
dpc-4022	83	169	type	type	NOUN
dpc-4022	83	170	24	24	NUM
dpc-4022	83	171	45.3	45.3	NUM
dpc-4022	83	172	overall	overall	ADJ
dpc-4022	83	173	survival	survival	NOUN
dpc-4022	83	174	(	(	PUNCT
dpc-4022	83	175	n	n	NOUN
dpc-4022	83	176	=	=	SYM
dpc-4022	83	177	158	158	NUM
dpc-4022	83	178	)	)	PUNCT
dpc-4022	83	179	alive	alive	ADJ
dpc-4022	83	180	131	131	NUM
dpc-4022	83	181	82.9	82.9	NUM
dpc-4022	83	182	dead	dead	ADJ
dpc-4022	83	183	27	27	NUM
dpc-4022	83	184	17.1	17.1	NUM
dpc-4022	83	185	stage	stage	NOUN
dpc-4022	83	186	(	(	PUNCT
dpc-4022	83	187	n	n	NOUN
dpc-4022	83	188	=	=	SYM
dpc-4022	83	189	146	146	NUM
dpc-4022	83	190	)	)	PUNCT
dpc-4022	83	191	i	i	PRON
dpc-4022	83	192	48	48	NUM
dpc-4022	83	193	32.9	32.9	NUM
dpc-4022	83	194	ii	ii	NUM
dpc-4022	83	195	42	42	NUM
dpc-4022	83	196	28.8	28.8	NUM
dpc-4022	83	197	iii	iii	NUM
dpc-4022	83	198	26	26	NUM
dpc-4022	83	199	17.8	17.8	NUM
dpc-4022	83	200	iv	iv	NUM
dpc-4022	83	201	30	30	NUM
dpc-4022	83	202	20.5	20.5	NUM
dpc-4022	83	203	sentinel	sentinel	NOUN
dpc-4022	83	204	lymph	lymph	NOUN
dpc-4022	83	205	node	node	NOUN
dpc-4022	83	206	involvement	involvement	NOUN
dpc-4022	83	207	(	(	PUNCT
dpc-4022	83	208	n	n	NOUN
dpc-4022	83	209	=	=	SYM
dpc-4022	83	210	55	55	NUM
dpc-4022	83	211	)	)	PUNCT
dpc-4022	83	212	negative	negative	ADJ
dpc-4022	83	213	34	34	NUM
dpc-4022	83	214	61.8	61.8	NUM
dpc-4022	83	215	positive	positive	ADJ
dpc-4022	83	216	21	21	NUM
dpc-4022	83	217	38.2	38.2	NUM
dpc-4022	83	218	alm	alm	NOUN
dpc-4022	83	219	=	=	SYM
dpc-4022	83	220	acral	acral	ADJ
dpc-4022	83	221	lentiginous	lentiginous	ADJ
dpc-4022	83	222	melanoma	melanoma	NOUN
dpc-4022	83	223	;	;	PUNCT
dpc-4022	83	224	lmm	lmm	PROPN
dpc-4022	83	225	=	=	SYM
dpc-4022	83	226	lentigo	lentigo	ADJ
dpc-4022	83	227	malignant	malignant	ADJ
dpc-4022	83	228	melanoma	melanoma	NOUN
dpc-4022	83	229	;	;	PUNCT
dpc-4022	83	230	nm	nm	ADJ
dpc-4022	83	231	=	=	PUNCT
dpc-4022	83	232	nodular	nodular	ADJ
dpc-4022	83	233	melanoma	melanoma	NOUN
dpc-4022	83	234	;	;	PUNCT
dpc-4022	83	235	ssm	ssm	PROPN
dpc-4022	83	236	=	=	PROPN
dpc-4022	83	237	superficial	superficial	ADJ
dpc-4022	83	238	spreading	spread	VERB
dpc-4022	83	239	melanoma	melanoma	NOUN
dpc-4022	83	240	.	.	PUNCT
dpc-4022	84	1	4	4	NUM
dpc-4022	84	2	original	original	ADJ
dpc-4022	84	3	article	article	NOUN
dpc-4022	84	4	|	|	ADV
dpc-4022	84	5	dermatol	dermatol	ADJ
dpc-4022	84	6	pract	pract	NOUN
dpc-4022	84	7	concept	concept	NOUN
dpc-4022	84	8	.	.	PUNCT
dpc-4022	85	1	2024;14(3):e2024135	2024;14(3):e2024135	NUM
dpc-4022	85	2	of	of	ADP
dpc-4022	85	3	cutaneous	cutaneous	ADJ
dpc-4022	85	4	and	and	CCONJ
dpc-4022	85	5	non	non	ADJ
dpc-4022	85	6	-	-	ADJ
dpc-4022	85	7	cutaneous	cutaneous	ADJ
dpc-4022	85	8	melanoma	melanoma	NOUN
dpc-4022	85	9	patients	patient	NOUN
dpc-4022	85	10	and	and	CCONJ
dpc-4022	85	11	distribution	distribution	NOUN
dpc-4022	85	12	of	of	ADP
dpc-4022	85	13	histopathological	histopathological	ADJ
dpc-4022	85	14	subtypes	subtype	NOUN
dpc-4022	85	15	of	of	ADP
dpc-4022	85	16	pcm	pcm	NOUN
dpc-4022	85	17	our	our	PRON
dpc-4022	85	18	findings	finding	NOUN
dpc-4022	85	19	are	be	AUX
dpc-4022	85	20	compatible	compatible	ADJ
dpc-4022	85	21	with	with	ADP
dpc-4022	85	22	the	the	DET
dpc-4022	85	23	results	result	NOUN
dpc-4022	85	24	of	of	ADP
dpc-4022	85	25	related	related	ADJ
dpc-4022	85	26	literature	literature	NOUN
dpc-4022	85	27	[	[	X
dpc-4022	85	28	14	14	NUM
dpc-4022	85	29	]	]	PUNCT
dpc-4022	85	30	,	,	PUNCT
dpc-4022	85	31	the	the	DET
dpc-4022	85	32	alm	alm	NOUN
dpc-4022	85	33	subtype	subtype	NOUN
dpc-4022	85	34	remarkably	remarkably	ADV
dpc-4022	85	35	emerged	emerge	VERB
dpc-4022	85	36	as	as	ADP
dpc-4022	85	37	the	the	DET
dpc-4022	85	38	third	third	ADJ
dpc-4022	85	39	most	most	ADV
dpc-4022	85	40	prevalent	prevalent	ADJ
dpc-4022	85	41	subtype	subtype	NOUN
dpc-4022	85	42	within	within	ADP
dpc-4022	85	43	our	our	PRON
dpc-4022	85	44	study	study	NOUN
dpc-4022	85	45	population	population	NOUN
dpc-4022	85	46	(	(	PUNCT
dpc-4022	85	47	17.1	17.1	NUM
dpc-4022	85	48	%	%	NOUN
dpc-4022	85	49	)	)	PUNCT
dpc-4022	85	50	.	.	PUNCT
dpc-4022	86	1	according	accord	VERB
dpc-4022	86	2	to	to	ADP
dpc-4022	86	3	population	population	NOUN
dpc-4022	86	4	-	-	PUNCT
dpc-4022	86	5	based	base	VERB
dpc-4022	86	6	data	datum	NOUN
dpc-4022	86	7	,	,	PUNCT
dpc-4022	86	8	alm	alm	NOUN
dpc-4022	86	9	accounts	account	VERB
dpc-4022	86	10	for	for	ADP
dpc-4022	86	11	approximately	approximately	ADV
dpc-4022	86	12	5	5	NUM
dpc-4022	86	13	%	%	NOUN
dpc-4022	86	14	of	of	ADP
dpc-4022	86	15	melanoma	melanoma	NOUN
dpc-4022	86	16	cases	case	NOUN
dpc-4022	86	17	among	among	ADP
dpc-4022	86	18	the	the	DET
dpc-4022	86	19	four	four	NUM
dpc-4022	86	20	major	major	ADJ
dpc-4022	86	21	histologic	histologic	ADJ
dpc-4022	86	22	subtypes	subtype	NOUN
dpc-4022	86	23	of	of	ADP
dpc-4022	86	24	pcm	pcm	NOUN
dpc-4022	86	25	in	in	ADP
dpc-4022	86	26	the	the	DET
dpc-4022	86	27	usa	usa	PROPN
dpc-4022	86	28	[	[	X
dpc-4022	86	29	14	14	NUM
dpc-4022	86	30	]	]	PUNCT
dpc-4022	86	31	.	.	PUNCT
dpc-4022	87	1	in	in	ADP
dpc-4022	87	2	contrast	contrast	NOUN
dpc-4022	87	3	,	,	PUNCT
dpc-4022	87	4	it	it	PRON
dpc-4022	87	5	appears	appear	VERB
dpc-4022	87	6	to	to	PART
dpc-4022	87	7	be	be	AUX
dpc-4022	87	8	relatively	relatively	ADV
dpc-4022	87	9	more	more	ADV
dpc-4022	87	10	common	common	ADJ
dpc-4022	87	11	among	among	ADP
dpc-4022	87	12	african	african	ADJ
dpc-4022	87	13	americans	americans	PROPN
dpc-4022	87	14	,	,	PUNCT
dpc-4022	87	15	constituting	constitute	VERB
dpc-4022	87	16	approximately	approximately	ADV
dpc-4022	87	17	36	36	NUM
dpc-4022	87	18	%	%	NOUN
dpc-4022	87	19	of	of	ADP
dpc-4022	87	20	melanoma	melanoma	NOUN
dpc-4022	87	21	cases	case	NOUN
dpc-4022	87	22	[	[	X
dpc-4022	87	23	15	15	NUM
dpc-4022	87	24	]	]	PUNCT
dpc-4022	87	25	.	.	PUNCT
dpc-4022	88	1	the	the	DET
dpc-4022	88	2	striking	striking	ADJ
dpc-4022	88	3	frequency	frequency	NOUN
dpc-4022	88	4	of	of	ADP
dpc-4022	88	5	alm	alm	NOUN
dpc-4022	88	6	in	in	ADP
dpc-4022	88	7	our	our	PRON
dpc-4022	88	8	cohort	cohort	NOUN
dpc-4022	88	9	patients	patient	NOUN
dpc-4022	88	10	may	may	AUX
dpc-4022	88	11	be	be	AUX
dpc-4022	88	12	related	relate	VERB
dpc-4022	88	13	to	to	ADP
dpc-4022	88	14	the	the	DET
dpc-4022	88	15	data	datum	NOUN
dpc-4022	88	16	of	of	ADP
dpc-4022	88	17	a	a	DET
dpc-4022	88	18	referral	referral	ADJ
dpc-4022	88	19	hospital	hospital	NOUN
dpc-4022	88	20	serving	serve	VERB
dpc-4022	88	21	with	with	ADP
dpc-4022	88	22	an	an	DET
dpc-4022	88	23	experienced	experienced	ADJ
dpc-4022	88	24	multidisciplinary	multidisciplinary	ADJ
dpc-4022	88	25	approach	approach	NOUN
dpc-4022	88	26	to	to	ADP
dpc-4022	88	27	a	a	DET
dpc-4022	88	28	considerable	considerable	ADJ
dpc-4022	88	29	number	number	NOUN
dpc-4022	88	30	of	of	ADP
dpc-4022	88	31	patients	patient	NOUN
dpc-4022	88	32	applying	apply	VERB
dpc-4022	88	33	from	from	ADP
dpc-4022	88	34	various	various	ADJ
dpc-4022	88	35	regions	region	NOUN
dpc-4022	88	36	of	of	ADP
dpc-4022	88	37	our	our	PRON
dpc-4022	88	38	country	country	NOUN
dpc-4022	88	39	.	.	PUNCT
dpc-4022	89	1	nevertheless	nevertheless	ADV
dpc-4022	89	2	,	,	PUNCT
dpc-4022	89	3	further	further	ADJ
dpc-4022	89	4	investigations	investigation	NOUN
dpc-4022	89	5	are	be	AUX
dpc-4022	89	6	needed	need	VERB
dpc-4022	89	7	usa	usa	PROPN
dpc-4022	89	8	and	and	CCONJ
dpc-4022	89	9	england	england	PROPN
dpc-4022	90	1	[	[	X
dpc-4022	90	2	7,8	7,8	NUM
dpc-4022	90	3	]	]	PUNCT
dpc-4022	90	4	.	.	PUNCT
dpc-4022	91	1	intense	intense	ADJ
dpc-4022	91	2	sun	sun	NOUN
dpc-4022	91	3	exposure	exposure	NOUN
dpc-4022	91	4	starting	start	VERB
dpc-4022	91	5	from	from	ADP
dpc-4022	91	6	an	an	DET
dpc-4022	91	7	early	early	ADJ
dpc-4022	91	8	age	age	NOUN
dpc-4022	91	9	and	and	CCONJ
dpc-4022	91	10	low	low	ADJ
dpc-4022	91	11	awareness	awareness	NOUN
dpc-4022	91	12	of	of	ADP
dpc-4022	91	13	uv	uv	NOUN
dpc-4022	91	14	protection	protection	NOUN
dpc-4022	91	15	may	may	AUX
dpc-4022	91	16	be	be	AUX
dpc-4022	91	17	the	the	DET
dpc-4022	91	18	main	main	ADJ
dpc-4022	91	19	reasons	reason	NOUN
dpc-4022	91	20	for	for	ADP
dpc-4022	91	21	younger	young	ADJ
dpc-4022	91	22	melanoma	melanoma	NOUN
dpc-4022	91	23	diagnoses	diagnosis	NOUN
dpc-4022	91	24	in	in	ADP
dpc-4022	91	25	our	our	PRON
dpc-4022	91	26	country	country	NOUN
dpc-4022	91	27	.	.	PUNCT
dpc-4022	92	1	the	the	DET
dpc-4022	92	2	incidence	incidence	NOUN
dpc-4022	92	3	studies	study	NOUN
dpc-4022	92	4	conducted	conduct	VERB
dpc-4022	92	5	in	in	ADP
dpc-4022	92	6	different	different	ADJ
dpc-4022	92	7	countries	country	NOUN
dpc-4022	92	8	revealed	reveal	VERB
dpc-4022	92	9	different	different	ADJ
dpc-4022	92	10	male	male	ADJ
dpc-4022	92	11	/	/	SYM
dpc-4022	92	12	female	female	ADJ
dpc-4022	92	13	ratios	ratio	NOUN
dpc-4022	92	14	.	.	PUNCT
dpc-4022	93	1	while	while	SCONJ
dpc-4022	93	2	most	most	ADJ
dpc-4022	93	3	western	western	ADJ
dpc-4022	93	4	and	and	CCONJ
dpc-4022	93	5	northern	northern	ADJ
dpc-4022	93	6	european	european	ADJ
dpc-4022	93	7	countries	country	NOUN
dpc-4022	93	8	report	report	VERB
dpc-4022	93	9	higher	high	ADJ
dpc-4022	93	10	incidence	incidence	NOUN
dpc-4022	93	11	rates	rate	NOUN
dpc-4022	93	12	in	in	ADP
dpc-4022	93	13	women	woman	NOUN
dpc-4022	93	14	than	than	ADP
dpc-4022	93	15	in	in	ADP
dpc-4022	93	16	men	man	NOUN
dpc-4022	93	17	[	[	X
dpc-4022	93	18	9	9	NUM
dpc-4022	93	19	]	]	PUNCT
dpc-4022	93	20	,	,	PUNCT
dpc-4022	93	21	most	most	ADJ
dpc-4022	93	22	eastern	eastern	ADJ
dpc-4022	93	23	,	,	PUNCT
dpc-4022	93	24	southern	southern	ADJ
dpc-4022	93	25	,	,	PUNCT
dpc-4022	93	26	and	and	CCONJ
dpc-4022	93	27	central	central	ADJ
dpc-4022	93	28	european	european	ADJ
dpc-4022	93	29	countries	country	NOUN
dpc-4022	93	30	have	have	AUX
dpc-4022	93	31	reported	report	VERB
dpc-4022	93	32	higher	high	ADJ
dpc-4022	93	33	incidences	incidence	NOUN
dpc-4022	93	34	of	of	ADP
dpc-4022	93	35	melanoma	melanoma	NOUN
dpc-4022	93	36	in	in	ADP
dpc-4022	93	37	men	man	NOUN
dpc-4022	93	38	[	[	X
dpc-4022	93	39	10	10	NUM
dpc-4022	93	40	]	]	PUNCT
dpc-4022	93	41	.	.	PUNCT
dpc-4022	94	1	however	however	ADV
dpc-4022	94	2	,	,	PUNCT
dpc-4022	94	3	our	our	PRON
dpc-4022	94	4	data	data	NOUN
dpc-4022	94	5	is	be	AUX
dpc-4022	94	6	similar	similar	ADJ
dpc-4022	94	7	to	to	ADP
dpc-4022	94	8	the	the	DET
dpc-4022	94	9	gender	gender	NOUN
dpc-4022	94	10	ratios	ratio	NOUN
dpc-4022	94	11	of	of	ADP
dpc-4022	94	12	melanoma	melanoma	NOUN
dpc-4022	94	13	patients	patient	NOUN
dpc-4022	94	14	diagnosed	diagnose	VERB
dpc-4022	94	15	in	in	ADP
dpc-4022	94	16	the	the	DET
dpc-4022	94	17	usa	usa	PROPN
dpc-4022	94	18	,	,	PUNCT
dpc-4022	94	19	eastern	eastern	PROPN
dpc-4022	94	20	europe	europe	PROPN
dpc-4022	94	21	,	,	PUNCT
dpc-4022	94	22	and	and	CCONJ
dpc-4022	94	23	australia	australia	PROPN
dpc-4022	95	1	[	[	X
dpc-4022	95	2	11	11	NUM
dpc-4022	95	3	]	]	PUNCT
dpc-4022	95	4	.	.	PUNCT
dpc-4022	96	1	in	in	ADP
dpc-4022	96	2	the	the	DET
dpc-4022	96	3	existing	exist	VERB
dpc-4022	96	4	literature	literature	NOUN
dpc-4022	96	5	,	,	PUNCT
dpc-4022	96	6	the	the	DET
dpc-4022	96	7	distribution	distribution	NOUN
dpc-4022	96	8	of	of	ADP
dpc-4022	96	9	melanoma	melanoma	NOUN
dpc-4022	96	10	is	be	AUX
dpc-4022	96	11	documented	document	VERB
dpc-4022	96	12	with	with	ADP
dpc-4022	96	13	approximately	approximately	ADV
dpc-4022	96	14	90	90	NUM
dpc-4022	96	15	-	-	SYM
dpc-4022	96	16	95	95	NUM
dpc-4022	96	17	%	%	NOUN
dpc-4022	96	18	cutaneous	cutaneous	ADJ
dpc-4022	96	19	,	,	PUNCT
dpc-4022	96	20	5	5	NUM
dpc-4022	96	21	%	%	NOUN
dpc-4022	96	22	in	in	ADP
dpc-4022	96	23	ocular	ocular	ADJ
dpc-4022	96	24	,	,	PUNCT
dpc-4022	96	25	3	3	NUM
dpc-4022	96	26	%	%	NOUN
dpc-4022	96	27	metastases	metastasis	NOUN
dpc-4022	96	28	from	from	ADP
dpc-4022	96	29	an	an	DET
dpc-4022	96	30	unknown	unknown	ADJ
dpc-4022	96	31	primary	primary	ADJ
dpc-4022	96	32	site	site	NOUN
dpc-4022	96	33	,	,	PUNCT
dpc-4022	96	34	and	and	CCONJ
dpc-4022	96	35	1	1	NUM
dpc-4022	96	36	%	%	NOUN
dpc-4022	96	37	in	in	ADP
dpc-4022	96	38	mucosal	mucosal	ADJ
dpc-4022	96	39	tissues	tissue	NOUN
dpc-4022	97	1	[	[	X
dpc-4022	97	2	12,13	12,13	NUM
dpc-4022	97	3	]	]	PUNCT
dpc-4022	97	4	.	.	PUNCT
dpc-4022	98	1	when	when	SCONJ
dpc-4022	98	2	compared	compare	VERB
dpc-4022	98	3	,	,	PUNCT
dpc-4022	98	4	percentages	percentage	NOUN
dpc-4022	98	5	table	table	VERB
dpc-4022	98	6	2	2	NUM
dpc-4022	98	7	.	.	PUNCT
dpc-4022	98	8	tumor	tumor	NOUN
dpc-4022	98	9	localization	localization	NOUN
dpc-4022	98	10	distribution	distribution	NOUN
dpc-4022	98	11	across	across	ADP
dpc-4022	98	12	gender	gender	NOUN
dpc-4022	98	13	groups	group	NOUN
dpc-4022	98	14	.	.	PUNCT
dpc-4022	99	1	parameters	parameter	NOUN
dpc-4022	99	2	involved	involve	VERB
dpc-4022	99	3	site	site	NOUN
dpc-4022	99	4	n	n	PROPN
dpc-4022	99	5	(	(	PUNCT
dpc-4022	99	6	%	%	INTJ
dpc-4022	99	7	)	)	PUNCT
dpc-4022	99	8	phead	phead	ADJ
dpc-4022	99	9	-	-	PUNCT
dpc-4022	99	10	neck	neck	NOUN
dpc-4022	99	11	trunk	trunk	NOUN
dpc-4022	99	12	upper	upper	ADJ
dpc-4022	99	13	extremity	extremity	NOUN
dpc-4022	99	14	lower	low	ADJ
dpc-4022	99	15	extremity	extremity	NOUN
dpc-4022	99	16	total	total	ADJ
dpc-4022	99	17	gender	gender	NOUN
dpc-4022	99	18	male	male	NOUN
dpc-4022	99	19	16	16	NUM
dpc-4022	99	20	(	(	PUNCT
dpc-4022	99	21	20.3	20.3	NUM
dpc-4022	99	22	)	)	SYM
dpc-4022	99	23	26	26	NUM
dpc-4022	99	24	(	(	PUNCT
dpc-4022	99	25	32.9	32.9	NUM
dpc-4022	99	26	)	)	PUNCT
dpc-4022	99	27	9	9	NUM
dpc-4022	99	28	(	(	PUNCT
dpc-4022	99	29	11.4	11.4	NUM
dpc-4022	99	30	)	)	SYM
dpc-4022	99	31	28	28	NUM
dpc-4022	99	32	(	(	PUNCT
dpc-4022	99	33	35.4	35.4	NUM
dpc-4022	99	34	)	)	PUNCT
dpc-4022	99	35	79	79	NUM
dpc-4022	99	36	(	(	PUNCT
dpc-4022	99	37	100	100	NUM
dpc-4022	99	38	)	)	PUNCT
dpc-4022	99	39	0.341	0.341	NUM
dpc-4022	99	40	female	female	ADJ
dpc-4022	99	41	12	12	NUM
dpc-4022	99	42	(	(	PUNCT
dpc-4022	99	43	17.1	17.1	NUM
dpc-4022	99	44	)	)	PUNCT
dpc-4022	99	45	17	17	NUM
dpc-4022	99	46	(	(	PUNCT
dpc-4022	99	47	24.3	24.3	NUM
dpc-4022	99	48	)	)	PUNCT
dpc-4022	99	49	14	14	NUM
dpc-4022	99	50	(	(	PUNCT
dpc-4022	99	51	20.0	20.0	NUM
dpc-4022	99	52	)	)	PUNCT
dpc-4022	99	53	27	27	NUM
dpc-4022	99	54	(	(	PUNCT
dpc-4022	99	55	38.6	38.6	NUM
dpc-4022	99	56	)	)	SYM
dpc-4022	99	57	70	70	NUM
dpc-4022	99	58	(	(	PUNCT
dpc-4022	99	59	100	100	NUM
dpc-4022	99	60	)	)	PUNCT
dpc-4022	99	61	total	total	NOUN
dpc-4022	99	62	28	28	NUM
dpc-4022	99	63	(	(	PUNCT
dpc-4022	99	64	18.8	18.8	NUM
dpc-4022	99	65	)	)	PUNCT
dpc-4022	99	66	43	43	NUM
dpc-4022	99	67	(	(	PUNCT
dpc-4022	99	68	28.9	28.9	NUM
dpc-4022	99	69	)	)	PUNCT
dpc-4022	99	70	23	23	NUM
dpc-4022	99	71	(	(	PUNCT
dpc-4022	99	72	15.4	15.4	NUM
dpc-4022	99	73	)	)	PUNCT
dpc-4022	99	74	55	55	NUM
dpc-4022	99	75	(	(	PUNCT
dpc-4022	99	76	36.9	36.9	NUM
dpc-4022	99	77	)	)	PUNCT
dpc-4022	99	78	149	149	NUM
dpc-4022	99	79	(	(	PUNCT
dpc-4022	99	80	100	100	NUM
dpc-4022	99	81	)	)	PUNCT
dpc-4022	99	82	table	table	NOUN
dpc-4022	99	83	3	3	NUM
dpc-4022	99	84	.	.	PUNCT
dpc-4022	99	85	breslow	breslow	ADJ
dpc-4022	99	86	thickness	thickness	NOUN
dpc-4022	99	87	distribution	distribution	NOUN
dpc-4022	99	88	across	across	ADP
dpc-4022	99	89	gender	gender	NOUN
dpc-4022	99	90	,	,	PUNCT
dpc-4022	99	91	histopathological	histopathological	ADJ
dpc-4022	99	92	subtype	subtype	NOUN
dpc-4022	99	93	of	of	ADP
dpc-4022	99	94	primary	primary	ADJ
dpc-4022	99	95	cutaneous	cutaneous	ADJ
dpc-4022	99	96	melanoma	melanoma	NOUN
dpc-4022	99	97	,	,	PUNCT
dpc-4022	99	98	lymph	lymph	NOUN
dpc-4022	99	99	node	node	NOUN
dpc-4022	99	100	involvement	involvement	NOUN
dpc-4022	99	101	,	,	PUNCT
dpc-4022	99	102	ulceration	ulceration	NOUN
dpc-4022	99	103	,	,	PUNCT
dpc-4022	99	104	5	5	NUM
dpc-4022	99	105	-	-	PUNCT
dpc-4022	99	106	year	year	NOUN
dpc-4022	99	107	overall	overall	ADJ
dpc-4022	99	108	survival	survival	NOUN
dpc-4022	99	109	,	,	PUNCT
dpc-4022	99	110	and	and	CCONJ
dpc-4022	99	111	tumor	tumor	NOUN
dpc-4022	99	112	localization	localization	NOUN
dpc-4022	99	113	.	.	PUNCT
dpc-4022	100	1	parameters	parameter	NOUN
dpc-4022	100	2	≤1	≤1	PROPN
dpc-4022	100	3	mm	mm	INTJ
dpc-4022	100	4	n	n	CCONJ
dpc-4022	100	5	(	(	PUNCT
dpc-4022	100	6	%	%	INTJ
dpc-4022	100	7	)	)	PUNCT
dpc-4022	100	8	1.1	1.1	NUM
dpc-4022	100	9	-	-	SYM
dpc-4022	100	10	2	2	NUM
dpc-4022	100	11	mm	mm	NOUN
dpc-4022	100	12	n	n	PROPN
dpc-4022	100	13	(	(	PUNCT
dpc-4022	100	14	%	%	INTJ
dpc-4022	100	15	)	)	PUNCT
dpc-4022	100	16	2.1	2.1	NUM
dpc-4022	100	17	-	-	SYM
dpc-4022	100	18	4	4	NUM
dpc-4022	100	19	mm	mm	NOUN
dpc-4022	100	20	n	n	PROPN
dpc-4022	100	21	(	(	PUNCT
dpc-4022	100	22	%	%	INTJ
dpc-4022	100	23	)	)	PUNCT
dpc-4022	100	24	>	>	PUNCT
dpc-4022	100	25	4	4	NUM
dpc-4022	100	26	mm	mm	NOUN
dpc-4022	100	27	n	n	PROPN
dpc-4022	100	28	(	(	PUNCT
dpc-4022	100	29	%	%	INTJ
dpc-4022	100	30	)	)	PUNCT
dpc-4022	101	1	p	p	NOUN
dpc-4022	101	2	gender	gender	NOUN
dpc-4022	101	3	male	male	NOUN
dpc-4022	101	4	14	14	NUM
dpc-4022	101	5	(	(	PUNCT
dpc-4022	101	6	41.2	41.2	NUM
dpc-4022	101	7	)	)	PUNCT
dpc-4022	101	8	11	11	NUM
dpc-4022	101	9	(	(	PUNCT
dpc-4022	101	10	44.0	44.0	NUM
dpc-4022	101	11	)	)	PUNCT
dpc-4022	101	12	25	25	NUM
dpc-4022	101	13	(	(	PUNCT
dpc-4022	101	14	64.1	64.1	NUM
dpc-4022	101	15	)	)	PUNCT
dpc-4022	101	16	21	21	NUM
dpc-4022	101	17	(	(	PUNCT
dpc-4022	101	18	55.3	55.3	NUM
dpc-4022	101	19	)	)	PUNCT
dpc-4022	101	20	0.196	0.196	NUM
dpc-4022	101	21	female	female	ADJ
dpc-4022	101	22	20	20	NUM
dpc-4022	101	23	(	(	PUNCT
dpc-4022	101	24	58.8	58.8	NUM
dpc-4022	101	25	)	)	PUNCT
dpc-4022	101	26	14	14	NUM
dpc-4022	101	27	(	(	PUNCT
dpc-4022	101	28	56.0	56.0	NUM
dpc-4022	101	29	)	)	PUNCT
dpc-4022	101	30	14	14	NUM
dpc-4022	101	31	(	(	PUNCT
dpc-4022	101	32	35.9	35.9	NUM
dpc-4022	101	33	)	)	PUNCT
dpc-4022	101	34	17	17	NUM
dpc-4022	101	35	(	(	PUNCT
dpc-4022	101	36	44.7	44.7	NUM
dpc-4022	101	37	)	)	PUNCT
dpc-4022	101	38	histopathological	histopathological	ADJ
dpc-4022	101	39	subtype	subtype	NOUN
dpc-4022	101	40	ssm	ssm	NOUN
dpc-4022	101	41	25	25	NUM
dpc-4022	101	42	(	(	PUNCT
dpc-4022	101	43	46.3	46.3	NUM
dpc-4022	101	44	)	)	SYM
dpc-4022	101	45	14	14	NUM
dpc-4022	101	46	(	(	PUNCT
dpc-4022	101	47	25.9	25.9	NUM
dpc-4022	101	48	)	)	PUNCT
dpc-4022	101	49	11	11	NUM
dpc-4022	101	50	(	(	PUNCT
dpc-4022	101	51	20.4	20.4	NUM
dpc-4022	101	52	)	)	SYM
dpc-4022	101	53	4	4	NUM
dpc-4022	101	54	(	(	PUNCT
dpc-4022	101	55	7.4	7.4	NUM
dpc-4022	101	56	)	)	PUNCT
dpc-4022	101	57	<	<	X
dpc-4022	101	58	0.001	0.001	NUM
dpc-4022	101	59	nm	nm	PRON
dpc-4022	101	60	1	1	NUM
dpc-4022	101	61	(	(	PUNCT
dpc-4022	101	62	2.1	2.1	NUM
dpc-4022	101	63	)	)	SYM
dpc-4022	101	64	2	2	NUM
dpc-4022	101	65	(	(	PUNCT
dpc-4022	101	66	4.3	4.3	NUM
dpc-4022	101	67	)	)	PUNCT
dpc-4022	101	68	22	22	NUM
dpc-4022	101	69	(	(	PUNCT
dpc-4022	101	70	46.8	46.8	NUM
dpc-4022	101	71	)	)	PUNCT
dpc-4022	101	72	22	22	NUM
dpc-4022	101	73	(	(	PUNCT
dpc-4022	101	74	46.8	46.8	NUM
dpc-4022	101	75	)	)	PUNCT
dpc-4022	101	76	alm	alm	NOUN
dpc-4022	101	77	5	5	NUM
dpc-4022	101	78	(	(	PUNCT
dpc-4022	101	79	26.3	26.3	NUM
dpc-4022	101	80	)	)	PUNCT
dpc-4022	101	81	6	6	NUM
dpc-4022	101	82	(	(	PUNCT
dpc-4022	101	83	31.6	31.6	NUM
dpc-4022	101	84	)	)	PUNCT
dpc-4022	101	85	2	2	NUM
dpc-4022	101	86	(	(	PUNCT
dpc-4022	101	87	10.5	10.5	NUM
dpc-4022	101	88	)	)	PUNCT
dpc-4022	101	89	6	6	NUM
dpc-4022	101	90	(	(	PUNCT
dpc-4022	101	91	31.6	31.6	NUM
dpc-4022	101	92	)	)	PUNCT
dpc-4022	101	93	lmm	lmm	PROPN
dpc-4022	101	94	1	1	NUM
dpc-4022	101	95	(	(	PUNCT
dpc-4022	101	96	16.7	16.7	NUM
dpc-4022	101	97	)	)	SYM
dpc-4022	101	98	1	1	NUM
dpc-4022	101	99	(	(	PUNCT
dpc-4022	101	100	16.7	16.7	NUM
dpc-4022	101	101	)	)	SYM
dpc-4022	101	102	2	2	NUM
dpc-4022	101	103	(	(	PUNCT
dpc-4022	101	104	33.3	33.3	NUM
dpc-4022	101	105	)	)	SYM
dpc-4022	101	106	2	2	NUM
dpc-4022	101	107	(	(	PUNCT
dpc-4022	101	108	33.3	33.3	NUM
dpc-4022	101	109	)	)	PUNCT
dpc-4022	101	110	othersa	othersa	NOUN
dpc-4022	101	111	2	2	NUM
dpc-4022	101	112	(	(	PUNCT
dpc-4022	101	113	28.6	28.6	NUM
dpc-4022	101	114	)	)	SYM
dpc-4022	101	115	1	1	NUM
dpc-4022	101	116	(	(	PUNCT
dpc-4022	101	117	14.3	14.3	NUM
dpc-4022	101	118	)	)	PUNCT
dpc-4022	101	119	2	2	NUM
dpc-4022	101	120	(	(	PUNCT
dpc-4022	101	121	28.6	28.6	NUM
dpc-4022	101	122	)	)	SYM
dpc-4022	101	123	2	2	NUM
dpc-4022	101	124	(	(	PUNCT
dpc-4022	101	125	28.6	28.6	NUM
dpc-4022	101	126	)	)	PUNCT
dpc-4022	101	127	lymph	lymph	NOUN
dpc-4022	101	128	node	node	NOUN
dpc-4022	101	129	involvement	involvement	NOUN
dpc-4022	101	130	(	(	PUNCT
dpc-4022	101	131	-	-	SYM
dpc-4022	101	132	)	)	SYM
dpc-4022	101	133	32	32	NUM
dpc-4022	101	134	(	(	PUNCT
dpc-4022	101	135	97.0	97.0	NUM
dpc-4022	101	136	)	)	PUNCT
dpc-4022	101	137	21	21	NUM
dpc-4022	101	138	(	(	PUNCT
dpc-4022	101	139	84.0	84.0	NUM
dpc-4022	101	140	)	)	PUNCT
dpc-4022	101	141	21	21	NUM
dpc-4022	101	142	(	(	PUNCT
dpc-4022	101	143	56.8	56.8	NUM
dpc-4022	101	144	)	)	PUNCT
dpc-4022	101	145	18	18	NUM
dpc-4022	101	146	(	(	PUNCT
dpc-4022	101	147	48.6	48.6	NUM
dpc-4022	101	148	)	)	PUNCT
dpc-4022	101	149	<	<	X
dpc-4022	101	150	0.001	0.001	NUM
dpc-4022	101	151	(	(	PUNCT
dpc-4022	101	152	+	+	NOUN
dpc-4022	101	153	)	)	PUNCT
dpc-4022	101	154	1	1	NUM
dpc-4022	101	155	(	(	PUNCT
dpc-4022	101	156	3.0	3.0	NUM
dpc-4022	101	157	)	)	PUNCT
dpc-4022	101	158	4	4	NUM
dpc-4022	101	159	(	(	PUNCT
dpc-4022	101	160	16.0	16.0	NUM
dpc-4022	101	161	)	)	PUNCT
dpc-4022	101	162	16	16	NUM
dpc-4022	101	163	(	(	PUNCT
dpc-4022	101	164	43.2	43.2	NUM
dpc-4022	101	165	)	)	PUNCT
dpc-4022	101	166	19	19	NUM
dpc-4022	101	167	(	(	PUNCT
dpc-4022	101	168	51.4	51.4	NUM
dpc-4022	101	169	)	)	PUNCT
dpc-4022	101	170	ulceration	ulceration	NOUN
dpc-4022	101	171	(	(	PUNCT
dpc-4022	101	172	+	+	NOUN
dpc-4022	101	173	)	)	PUNCT
dpc-4022	101	174	0	0	NUM
dpc-4022	102	1	(	(	PUNCT
dpc-4022	102	2	0	0	NUM
dpc-4022	102	3	)	)	PUNCT
dpc-4022	102	4	7	7	NUM
dpc-4022	102	5	(	(	PUNCT
dpc-4022	102	6	46.7	46.7	NUM
dpc-4022	102	7	)	)	PUNCT
dpc-4022	102	8	14	14	NUM
dpc-4022	102	9	(	(	PUNCT
dpc-4022	102	10	53.8	53.8	NUM
dpc-4022	102	11	)	)	PUNCT
dpc-4022	102	12	18	18	NUM
dpc-4022	102	13	(	(	PUNCT
dpc-4022	102	14	64.3	64.3	NUM
dpc-4022	102	15	)	)	PUNCT
dpc-4022	102	16	<	<	X
dpc-4022	102	17	0.001	0.001	NUM
dpc-4022	102	18	(	(	PUNCT
dpc-4022	102	19	-	-	PUNCT
dpc-4022	102	20	)	)	SYM
dpc-4022	102	21	21	21	NUM
dpc-4022	102	22	(	(	PUNCT
dpc-4022	102	23	100	100	NUM
dpc-4022	102	24	)	)	PUNCT
dpc-4022	102	25	8	8	NUM
dpc-4022	102	26	(	(	PUNCT
dpc-4022	102	27	53.3	53.3	NUM
dpc-4022	102	28	)	)	PUNCT
dpc-4022	102	29	12	12	NUM
dpc-4022	102	30	(	(	PUNCT
dpc-4022	102	31	46.2	46.2	NUM
dpc-4022	102	32	)	)	PUNCT
dpc-4022	102	33	10	10	NUM
dpc-4022	102	34	(	(	PUNCT
dpc-4022	102	35	35.7	35.7	NUM
dpc-4022	102	36	)	)	PUNCT
dpc-4022	102	37	overall	overall	ADJ
dpc-4022	102	38	survival	survival	NOUN
dpc-4022	102	39	died	die	VERB
dpc-4022	102	40	0	0	NUM
dpc-4022	102	41	(	(	PUNCT
dpc-4022	102	42	0	0	NUM
dpc-4022	102	43	)	)	PUNCT
dpc-4022	102	44	3	3	NUM
dpc-4022	102	45	(	(	PUNCT
dpc-4022	102	46	13.0	13.0	NUM
dpc-4022	102	47	)	)	PUNCT
dpc-4022	102	48	10	10	NUM
dpc-4022	102	49	(	(	PUNCT
dpc-4022	102	50	27	27	NUM
dpc-4022	102	51	)	)	PUNCT
dpc-4022	102	52	10	10	NUM
dpc-4022	102	53	(	(	PUNCT
dpc-4022	102	54	23.8	23.8	NUM
dpc-4022	102	55	)	)	PUNCT
dpc-4022	102	56	0.014	0.014	NUM
dpc-4022	102	57	alive	alive	ADJ
dpc-4022	102	58	37	37	NUM
dpc-4022	102	59	(	(	PUNCT
dpc-4022	102	60	100	100	NUM
dpc-4022	102	61	)	)	PUNCT
dpc-4022	102	62	20	20	NUM
dpc-4022	102	63	(	(	PUNCT
dpc-4022	102	64	87.0	87.0	NUM
dpc-4022	102	65	)	)	PUNCT
dpc-4022	102	66	27	27	NUM
dpc-4022	102	67	(	(	PUNCT
dpc-4022	102	68	73	73	NUM
dpc-4022	102	69	)	)	PUNCT
dpc-4022	102	70	32	32	NUM
dpc-4022	102	71	(	(	PUNCT
dpc-4022	102	72	76.2	76.2	NUM
dpc-4022	102	73	)	)	PUNCT
dpc-4022	102	74	localization	localization	NOUN
dpc-4022	102	75	head	head	NOUN
dpc-4022	102	76	-	-	PUNCT
dpc-4022	102	77	neck	neck	NOUN
dpc-4022	102	78	4	4	NUM
dpc-4022	102	79	(	(	PUNCT
dpc-4022	102	80	13.3	13.3	NUM
dpc-4022	102	81	)	)	SYM
dpc-4022	102	82	2	2	NUM
dpc-4022	102	83	(	(	PUNCT
dpc-4022	102	84	8.0	8.0	NUM
dpc-4022	102	85	)	)	PUNCT
dpc-4022	102	86	7	7	NUM
dpc-4022	102	87	(	(	PUNCT
dpc-4022	102	88	18.9	18.9	NUM
dpc-4022	102	89	)	)	PUNCT
dpc-4022	102	90	11	11	NUM
dpc-4022	102	91	(	(	PUNCT
dpc-4022	102	92	29.7	29.7	NUM
dpc-4022	102	93	)	)	PUNCT
dpc-4022	102	94	0.194	0.194	NUM
dpc-4022	102	95	trunk	trunk	NOUN
dpc-4022	102	96	12	12	NUM
dpc-4022	102	97	(	(	PUNCT
dpc-4022	102	98	40.0	40.0	NUM
dpc-4022	102	99	)	)	PUNCT
dpc-4022	102	100	9	9	NUM
dpc-4022	102	101	(	(	PUNCT
dpc-4022	102	102	36.0	36.0	NUM
dpc-4022	102	103	)	)	PUNCT
dpc-4022	102	104	13	13	NUM
dpc-4022	102	105	(	(	PUNCT
dpc-4022	102	106	35.1	35.1	NUM
dpc-4022	102	107	)	)	SYM
dpc-4022	102	108	5	5	NUM
dpc-4022	102	109	(	(	PUNCT
dpc-4022	102	110	13.5	13.5	NUM
dpc-4022	102	111	)	)	PUNCT
dpc-4022	102	112	upper	upper	ADJ
dpc-4022	102	113	extremity	extremity	NOUN
dpc-4022	102	114	4	4	NUM
dpc-4022	102	115	(	(	PUNCT
dpc-4022	102	116	13.3	13.3	NUM
dpc-4022	102	117	)	)	PUNCT
dpc-4022	102	118	5	5	NUM
dpc-4022	102	119	(	(	PUNCT
dpc-4022	102	120	20.0	20.0	NUM
dpc-4022	102	121	)	)	PUNCT
dpc-4022	102	122	7	7	NUM
dpc-4022	102	123	(	(	PUNCT
dpc-4022	102	124	18.9	18.9	NUM
dpc-4022	102	125	)	)	PUNCT
dpc-4022	102	126	5	5	NUM
dpc-4022	102	127	(	(	PUNCT
dpc-4022	102	128	13.5	13.5	NUM
dpc-4022	102	129	)	)	PUNCT
dpc-4022	102	130	lower	low	ADJ
dpc-4022	102	131	extremity	extremity	NOUN
dpc-4022	102	132	10	10	NUM
dpc-4022	102	133	(	(	PUNCT
dpc-4022	102	134	33.3	33.3	NUM
dpc-4022	102	135	)	)	PUNCT
dpc-4022	102	136	9	9	NUM
dpc-4022	102	137	(	(	PUNCT
dpc-4022	102	138	36.0	36.0	NUM
dpc-4022	102	139	)	)	PUNCT
dpc-4022	102	140	10	10	NUM
dpc-4022	102	141	(	(	PUNCT
dpc-4022	102	142	27.0	27.0	NUM
dpc-4022	102	143	)	)	PUNCT
dpc-4022	102	144	16	16	NUM
dpc-4022	102	145	(	(	PUNCT
dpc-4022	102	146	43.2	43.2	NUM
dpc-4022	102	147	)	)	PUNCT
dpc-4022	102	148	arare	arare	NOUN
dpc-4022	102	149	subtypes	subtype	NOUN
dpc-4022	102	150	(	(	PUNCT
dpc-4022	102	151	amelanotic	amelanotic	ADJ
dpc-4022	102	152	,	,	PUNCT
dpc-4022	102	153	animal	animal	NOUN
dpc-4022	102	154	type	type	NOUN
dpc-4022	102	155	,	,	PUNCT
dpc-4022	102	156	desmoplastic	desmoplastic	ADJ
dpc-4022	102	157	)	)	PUNCT
dpc-4022	102	158	alm	alm	NOUN
dpc-4022	102	159	=	=	SYM
dpc-4022	102	160	acral	acral	ADJ
dpc-4022	102	161	lentiginous	lentiginous	ADJ
dpc-4022	102	162	melanoma	melanoma	NOUN
dpc-4022	102	163	;	;	PUNCT
dpc-4022	102	164	lmm	lmm	PROPN
dpc-4022	102	165	=	=	SYM
dpc-4022	102	166	lentigo	lentigo	ADJ
dpc-4022	102	167	malignant	malignant	ADJ
dpc-4022	102	168	melanoma	melanoma	NOUN
dpc-4022	102	169	;	;	PUNCT
dpc-4022	102	170	nm	nm	ADJ
dpc-4022	102	171	=	=	PUNCT
dpc-4022	102	172	nodular	nodular	ADJ
dpc-4022	102	173	melanoma	melanoma	NOUN
dpc-4022	102	174	;	;	PUNCT
dpc-4022	102	175	ssm	ssm	PROPN
dpc-4022	102	176	=	=	PROPN
dpc-4022	102	177	superficial	superficial	ADJ
dpc-4022	102	178	spreading	spread	VERB
dpc-4022	102	179	melanoma	melanoma	NOUN
dpc-4022	102	180	.	.	PUNCT
dpc-4022	103	1	original	original	ADJ
dpc-4022	103	2	article	article	NOUN
dpc-4022	103	3	|	|	ADV
dpc-4022	103	4	dermatol	dermatol	ADJ
dpc-4022	103	5	pract	pract	NOUN
dpc-4022	103	6	concept	concept	NOUN
dpc-4022	103	7	.	.	PUNCT
dpc-4022	104	1	2024;14(3):e2024135	2024;14(3):e2024135	NUM
dpc-4022	104	2	5	5	NUM
dpc-4022	104	3	to	to	PART
dpc-4022	104	4	explain	explain	VERB
dpc-4022	104	5	the	the	DET
dpc-4022	104	6	reasons	reason	NOUN
dpc-4022	104	7	for	for	ADP
dpc-4022	104	8	the	the	DET
dpc-4022	104	9	high	high	ADJ
dpc-4022	104	10	frequency	frequency	NOUN
dpc-4022	104	11	of	of	ADP
dpc-4022	104	12	alm	alm	NOUN
dpc-4022	104	13	patients	patient	NOUN
dpc-4022	104	14	,	,	PUNCT
dpc-4022	104	15	including	include	VERB
dpc-4022	104	16	detailed	detail	VERB
dpc-4022	104	17	clinical	clinical	ADJ
dpc-4022	104	18	characteristics	characteristic	NOUN
dpc-4022	104	19	and	and	CCONJ
dpc-4022	104	20	risk	risk	NOUN
dpc-4022	104	21	factors	factor	NOUN
dpc-4022	104	22	.	.	PUNCT
dpc-4022	105	1	in	in	ADP
dpc-4022	105	2	our	our	PRON
dpc-4022	105	3	analysis	analysis	NOUN
dpc-4022	105	4	,	,	PUNCT
dpc-4022	105	5	lower	low	ADJ
dpc-4022	105	6	extremities	extremity	NOUN
dpc-4022	105	7	predominated	predominate	VERB
dpc-4022	105	8	as	as	ADP
dpc-4022	105	9	the	the	DET
dpc-4022	105	10	most	most	ADV
dpc-4022	105	11	common	common	ADJ
dpc-4022	105	12	site	site	NOUN
dpc-4022	105	13	,	,	PUNCT
dpc-4022	105	14	followed	follow	VERB
dpc-4022	105	15	by	by	ADP
dpc-4022	105	16	the	the	DET
dpc-4022	105	17	trunk	trunk	NOUN
dpc-4022	105	18	in	in	ADP
dpc-4022	105	19	both	both	DET
dpc-4022	105	20	genders	gender	NOUN
dpc-4022	105	21	,	,	PUNCT
dpc-4022	105	22	diverging	diverge	VERB
dpc-4022	105	23	from	from	ADP
dpc-4022	105	24	reports	report	NOUN
dpc-4022	105	25	indicating	indicate	VERB
dpc-4022	105	26	a	a	DET
dpc-4022	105	27	primary	primary	ADJ
dpc-4022	105	28	involvement	involvement	NOUN
dpc-4022	105	29	of	of	ADP
dpc-4022	105	30	the	the	DET
dpc-4022	105	31	trunk	trunk	NOUN
dpc-4022	105	32	in	in	ADP
dpc-4022	105	33	males	male	NOUN
dpc-4022	105	34	and	and	CCONJ
dpc-4022	105	35	lower	low	ADJ
dpc-4022	105	36	extremities	extremity	NOUN
dpc-4022	105	37	in	in	ADP
dpc-4022	105	38	females	female	NOUN
dpc-4022	105	39	[	[	X
dpc-4022	105	40	16	16	NUM
dpc-4022	105	41	]	]	PUNCT
dpc-4022	105	42	.	.	PUNCT
dpc-4022	106	1	we	we	PRON
dpc-4022	106	2	observed	observe	VERB
dpc-4022	106	3	that	that	SCONJ
dpc-4022	106	4	our	our	PRON
dpc-4022	106	5	patients	patient	NOUN
dpc-4022	106	6	’	'	PUNCT
dpc-4022	106	7	tumors	tumor	NOUN
dpc-4022	106	8	were	be	AUX
dpc-4022	106	9	mainly	mainly	ADV
dpc-4022	106	10	thicker	thick	ADJ
dpc-4022	106	11	than	than	ADP
dpc-4022	106	12	4	4	NUM
dpc-4022	106	13	mm	mm	NOUN
dpc-4022	106	14	in	in	ADP
dpc-4022	106	15	contrast	contrast	NOUN
dpc-4022	106	16	to	to	ADP
dpc-4022	106	17	studies	study	NOUN
dpc-4022	106	18	conducted	conduct	VERB
dpc-4022	106	19	in	in	ADP
dpc-4022	106	20	western	western	ADJ
dpc-4022	106	21	countries	country	NOUN
dpc-4022	106	22	;	;	PUNCT
dpc-4022	106	23	most	most	ADJ
dpc-4022	106	24	of	of	ADP
dpc-4022	106	25	their	their	PRON
dpc-4022	106	26	patients	patient	NOUN
dpc-4022	106	27	were	be	AUX
dpc-4022	106	28	diagnosed	diagnose	VERB
dpc-4022	106	29	at	at	ADP
dpc-4022	106	30	an	an	DET
dpc-4022	106	31	early	early	ADJ
dpc-4022	106	32	stage	stage	NOUN
dpc-4022	106	33	[	[	X
dpc-4022	106	34	17	17	NUM
dpc-4022	106	35	]	]	PUNCT
dpc-4022	106	36	.	.	PUNCT
dpc-4022	107	1	male	male	ADJ
dpc-4022	107	2	gender	gender	NOUN
dpc-4022	107	3	is	be	AUX
dpc-4022	107	4	a	a	DET
dpc-4022	107	5	poor	poor	ADJ
dpc-4022	107	6	prognostic	prognostic	ADJ
dpc-4022	107	7	criterion	criterion	NOUN
dpc-4022	107	8	for	for	ADP
dpc-4022	107	9	breslow	breslow	ADJ
dpc-4022	107	10	thickness	thickness	NOUN
dpc-4022	107	11	[	[	X
dpc-4022	107	12	18	18	NUM
dpc-4022	107	13	]	]	PUNCT
dpc-4022	107	14	.	.	PUNCT
dpc-4022	108	1	as	as	SCONJ
dpc-4022	108	2	the	the	DET
dpc-4022	108	3	tumor	tumor	NOUN
dpc-4022	108	4	thickness	thickness	NOUN
dpc-4022	108	5	increases	increase	VERB
dpc-4022	108	6	in	in	ADP
dpc-4022	108	7	pcm	pcm	ADJ
dpc-4022	108	8	,	,	PUNCT
dpc-4022	108	9	malignant	malignant	ADJ
dpc-4022	108	10	cells	cell	NOUN
dpc-4022	108	11	are	be	AUX
dpc-4022	108	12	more	more	ADV
dpc-4022	108	13	likely	likely	ADJ
dpc-4022	108	14	to	to	PART
dpc-4022	108	15	spread	spread	VERB
dpc-4022	108	16	to	to	ADP
dpc-4022	108	17	regional	regional	ADJ
dpc-4022	108	18	lymph	lymph	NOUN
dpc-4022	108	19	nodes	node	NOUN
dpc-4022	108	20	by	by	ADP
dpc-4022	108	21	lymphatic	lymphatic	ADJ
dpc-4022	108	22	invasion	invasion	NOUN
dpc-4022	108	23	.	.	PUNCT
dpc-4022	109	1	the	the	DET
dpc-4022	109	2	analysis	analysis	NOUN
dpc-4022	109	3	of	of	ADP
dpc-4022	109	4	our	our	PRON
dpc-4022	109	5	study	study	NOUN
dpc-4022	109	6	data	datum	NOUN
dpc-4022	109	7	also	also	ADV
dpc-4022	109	8	pointed	point	VERB
dpc-4022	109	9	out	out	ADP
dpc-4022	109	10	the	the	DET
dpc-4022	109	11	correlation	correlation	NOUN
dpc-4022	109	12	between	between	ADP
dpc-4022	109	13	tumor	tumor	NOUN
dpc-4022	109	14	thickness	thickness	NOUN
dpc-4022	109	15	table	table	NOUN
dpc-4022	109	16	4	4	NUM
dpc-4022	109	17	.	.	PUNCT
dpc-4022	110	1	lymph	lymph	NOUN
dpc-4022	110	2	node	node	PROPN
dpc-4022	110	3	involvement	involvement	NOUN
dpc-4022	110	4	according	accord	VERB
dpc-4022	110	5	to	to	ADP
dpc-4022	110	6	subtype	subtype	NOUN
dpc-4022	110	7	,	,	PUNCT
dpc-4022	110	8	ulceration	ulceration	NOUN
dpc-4022	110	9	,	,	PUNCT
dpc-4022	110	10	age	age	NOUN
dpc-4022	110	11	,	,	PUNCT
dpc-4022	110	12	metastasis	metastasis	NOUN
dpc-4022	110	13	status	status	NOUN
dpc-4022	110	14	,	,	PUNCT
dpc-4022	110	15	localization	localization	NOUN
dpc-4022	110	16	and	and	CCONJ
dpc-4022	110	17	gender	gender	NOUN
dpc-4022	110	18	.	.	PUNCT
dpc-4022	111	1	lymph	lymph	NOUN
dpc-4022	111	2	node	node	PROPN
dpc-4022	111	3	involvement	involvement	NOUN
dpc-4022	111	4	subtype	subtype	NOUN
dpc-4022	111	5	ln	ln	ADJ
dpc-4022	111	6	(	(	PUNCT
dpc-4022	111	7	-	-	SYM
dpc-4022	111	8	)	)	PUNCT
dpc-4022	111	9	ln	ln	NOUN
dpc-4022	111	10	(	(	PUNCT
dpc-4022	111	11	+	+	NOUN
dpc-4022	111	12	)	)	PUNCT
dpc-4022	111	13	total	total	ADJ
dpc-4022	111	14	pn	pn	PROPN
dpc-4022	111	15	(	(	PUNCT
dpc-4022	111	16	%	%	NOUN
dpc-4022	111	17	)	)	PUNCT
dpc-4022	111	18	n	n	CCONJ
dpc-4022	111	19	(	(	PUNCT
dpc-4022	111	20	%	%	NOUN
dpc-4022	111	21	)	)	PUNCT
dpc-4022	111	22	n	n	CCONJ
dpc-4022	111	23	(	(	PUNCT
dpc-4022	111	24	%	%	INTJ
dpc-4022	111	25	)	)	PUNCT
dpc-4022	111	26	smm	smm	X
dpc-4022	111	27	49	49	NUM
dpc-4022	111	28	(	(	PUNCT
dpc-4022	111	29	86.0	86.0	NUM
dpc-4022	111	30	)	)	PUNCT
dpc-4022	111	31	8	8	NUM
dpc-4022	111	32	(	(	PUNCT
dpc-4022	111	33	14.0	14.0	NUM
dpc-4022	111	34	)	)	PUNCT
dpc-4022	111	35	57	57	NUM
dpc-4022	111	36	(	(	PUNCT
dpc-4022	111	37	100	100	NUM
dpc-4022	111	38	)	)	PUNCT
dpc-4022	111	39	<	<	X
dpc-4022	111	40	0.001	0.001	NUM
dpc-4022	111	41	nm	nm	PRON
dpc-4022	111	42	27	27	NUM
dpc-4022	111	43	(	(	PUNCT
dpc-4022	111	44	57.4	57.4	NUM
dpc-4022	111	45	)	)	PUNCT
dpc-4022	111	46	20	20	NUM
dpc-4022	111	47	(	(	PUNCT
dpc-4022	111	48	42.6	42.6	NUM
dpc-4022	111	49	)	)	PUNCT
dpc-4022	111	50	47	47	NUM
dpc-4022	111	51	(	(	PUNCT
dpc-4022	111	52	100.0	100.0	NUM
dpc-4022	111	53	)	)	PUNCT
dpc-4022	111	54	alm	alm	NOUN
dpc-4022	111	55	10	10	NUM
dpc-4022	111	56	(	(	PUNCT
dpc-4022	111	57	40.0	40.0	NUM
dpc-4022	111	58	)	)	SYM
dpc-4022	111	59	15	15	NUM
dpc-4022	111	60	(	(	PUNCT
dpc-4022	111	61	60.0	60.0	NUM
dpc-4022	111	62	)	)	PUNCT
dpc-4022	111	63	25	25	NUM
dpc-4022	111	64	(	(	PUNCT
dpc-4022	111	65	100.0	100.0	NUM
dpc-4022	111	66	)	)	PUNCT
dpc-4022	111	67	lmm	lmm	PROPN
dpc-4022	111	68	3	3	NUM
dpc-4022	111	69	(	(	PUNCT
dpc-4022	111	70	42.9	42.9	NUM
dpc-4022	111	71	)	)	PUNCT
dpc-4022	111	72	4	4	NUM
dpc-4022	111	73	(	(	PUNCT
dpc-4022	111	74	57.1	57.1	NUM
dpc-4022	111	75	)	)	PUNCT
dpc-4022	111	76	7	7	NUM
dpc-4022	111	77	(	(	PUNCT
dpc-4022	111	78	100.0	100.0	NUM
dpc-4022	111	79	)	)	PUNCT
dpc-4022	111	80	rare	rare	ADJ
dpc-4022	111	81	subtypea	subtypea	NOUN
dpc-4022	111	82	5	5	NUM
dpc-4022	111	83	(	(	PUNCT
dpc-4022	111	84	55.6	55.6	NUM
dpc-4022	111	85	)	)	PUNCT
dpc-4022	111	86	4	4	NUM
dpc-4022	111	87	(	(	PUNCT
dpc-4022	111	88	44.4	44.4	NUM
dpc-4022	111	89	)	)	PUNCT
dpc-4022	111	90	9	9	NUM
dpc-4022	111	91	(	(	PUNCT
dpc-4022	111	92	100.0	100.0	NUM
dpc-4022	111	93	)	)	PUNCT
dpc-4022	111	94	ulceration	ulceration	NOUN
dpc-4022	111	95	present	present	ADJ
dpc-4022	111	96	41	41	NUM
dpc-4022	111	97	(	(	PUNCT
dpc-4022	111	98	80.4	80.4	NUM
dpc-4022	111	99	)	)	SYM
dpc-4022	111	100	1	1	NUM
dpc-4022	111	101	(	(	PUNCT
dpc-4022	111	102	19.6	19.6	NUM
dpc-4022	111	103	)	)	PUNCT
dpc-4022	111	104	51	51	NUM
dpc-4022	111	105	(	(	PUNCT
dpc-4022	111	106	100.0	100.0	NUM
dpc-4022	111	107	)	)	PUNCT
dpc-4022	111	108	<	<	X
dpc-4022	111	109	0.001	0.001	NUM
dpc-4022	111	110	absent	absent	ADJ
dpc-4022	111	111	23	23	NUM
dpc-4022	111	112	(	(	PUNCT
dpc-4022	111	113	52.3	52.3	NUM
dpc-4022	111	114	)	)	PUNCT
dpc-4022	111	115	21	21	NUM
dpc-4022	111	116	(	(	PUNCT
dpc-4022	111	117	47.7	47.7	NUM
dpc-4022	111	118	)	)	PUNCT
dpc-4022	111	119	44	44	NUM
dpc-4022	111	120	(	(	PUNCT
dpc-4022	111	121	100.0	100.0	NUM
dpc-4022	111	122	)	)	PUNCT
dpc-4022	111	123	age	age	NOUN
dpc-4022	111	124	group	group	NOUN
dpc-4022	111	125	18	18	NUM
dpc-4022	111	126	-	-	SYM
dpc-4022	111	127	30	30	NUM
dpc-4022	111	128	19	19	NUM
dpc-4022	111	129	(	(	PUNCT
dpc-4022	111	130	86.4	86.4	NUM
dpc-4022	111	131	)	)	PUNCT
dpc-4022	111	132	3	3	NUM
dpc-4022	111	133	(	(	PUNCT
dpc-4022	111	134	13.6	13.6	NUM
dpc-4022	111	135	)	)	PUNCT
dpc-4022	111	136	22	22	NUM
dpc-4022	111	137	(	(	PUNCT
dpc-4022	111	138	10	10	NUM
dpc-4022	111	139	)	)	PUNCT
dpc-4022	111	140	0.015	0.015	NUM
dpc-4022	111	141	31	31	NUM
dpc-4022	111	142	-	-	SYM
dpc-4022	111	143	45	45	NUM
dpc-4022	111	144	24	24	NUM
dpc-4022	111	145	(	(	PUNCT
dpc-4022	111	146	70.6	70.6	NUM
dpc-4022	111	147	)	)	PUNCT
dpc-4022	111	148	10	10	NUM
dpc-4022	111	149	(	(	PUNCT
dpc-4022	111	150	29.4	29.4	NUM
dpc-4022	111	151	)	)	PUNCT
dpc-4022	111	152	34	34	NUM
dpc-4022	111	153	(	(	PUNCT
dpc-4022	111	154	100	100	NUM
dpc-4022	111	155	)	)	PUNCT
dpc-4022	111	156	46	46	NUM
dpc-4022	111	157	-	-	SYM
dpc-4022	111	158	65	65	NUM
dpc-4022	111	159	28	28	NUM
dpc-4022	111	160	(	(	PUNCT
dpc-4022	111	161	52.8	52.8	NUM
dpc-4022	111	162	)	)	PUNCT
dpc-4022	111	163	25	25	NUM
dpc-4022	111	164	(	(	PUNCT
dpc-4022	111	165	47.2	47.2	NUM
dpc-4022	111	166	)	)	PUNCT
dpc-4022	111	167	53	53	NUM
dpc-4022	111	168	(	(	PUNCT
dpc-4022	111	169	100	100	NUM
dpc-4022	111	170	)	)	PUNCT
dpc-4022	111	171	>	>	PUNCT
dpc-4022	111	172	65	65	NUM
dpc-4022	111	173	27	27	NUM
dpc-4022	111	174	(	(	PUNCT
dpc-4022	111	175	51.9	51.9	NUM
dpc-4022	111	176	)	)	PUNCT
dpc-4022	111	177	25	25	NUM
dpc-4022	111	178	(	(	PUNCT
dpc-4022	111	179	48.1	48.1	NUM
dpc-4022	111	180	)	)	PUNCT
dpc-4022	111	181	52	52	NUM
dpc-4022	111	182	(	(	PUNCT
dpc-4022	111	183	100	100	NUM
dpc-4022	111	184	)	)	PUNCT
dpc-4022	111	185	metastasis	metastasis	NOUN
dpc-4022	111	186	status	status	NOUN
dpc-4022	111	187	present	present	ADJ
dpc-4022	111	188	97	97	NUM
dpc-4022	111	189	(	(	PUNCT
dpc-4022	111	190	78.2	78.2	NUM
dpc-4022	111	191	)	)	PUNCT
dpc-4022	111	192	27	27	NUM
dpc-4022	111	193	(	(	PUNCT
dpc-4022	111	194	21.8	21.8	NUM
dpc-4022	111	195	)	)	SYM
dpc-4022	111	196	124	124	NUM
dpc-4022	111	197	(	(	PUNCT
dpc-4022	111	198	100	100	NUM
dpc-4022	111	199	)	)	PUNCT
dpc-4022	112	1	<	<	X
dpc-4022	112	2	0.001	0.001	NUM
dpc-4022	112	3	absent	absent	ADJ
dpc-4022	112	4	2	2	NUM
dpc-4022	112	5	(	(	PUNCT
dpc-4022	112	6	5.4	5.4	NUM
dpc-4022	112	7	)	)	PUNCT
dpc-4022	112	8	35	35	NUM
dpc-4022	112	9	(	(	PUNCT
dpc-4022	112	10	94.6	94.6	NUM
dpc-4022	112	11	)	)	PUNCT
dpc-4022	112	12	37	37	NUM
dpc-4022	112	13	(	(	PUNCT
dpc-4022	112	14	100	100	NUM
dpc-4022	112	15	)	)	PUNCT
dpc-4022	112	16	localization	localization	NOUN
dpc-4022	112	17	head	head	NOUN
dpc-4022	112	18	-	-	PUNCT
dpc-4022	112	19	neck	neck	NOUN
dpc-4022	112	20	18	18	NUM
dpc-4022	112	21	(	(	PUNCT
dpc-4022	112	22	64.3	64.3	NUM
dpc-4022	112	23	)	)	PUNCT
dpc-4022	112	24	10	10	NUM
dpc-4022	112	25	(	(	PUNCT
dpc-4022	112	26	35.7	35.7	NUM
dpc-4022	112	27	)	)	SYM
dpc-4022	112	28	28	28	NUM
dpc-4022	112	29	(	(	PUNCT
dpc-4022	112	30	100	100	NUM
dpc-4022	112	31	)	)	PUNCT
dpc-4022	112	32	0.491	0.491	NUM
dpc-4022	112	33	trunk	trunk	NOUN
dpc-4022	112	34	31	31	NUM
dpc-4022	112	35	(	(	PUNCT
dpc-4022	112	36	73.8	73.8	NUM
dpc-4022	112	37	)	)	PUNCT
dpc-4022	112	38	11	11	NUM
dpc-4022	112	39	(	(	PUNCT
dpc-4022	112	40	26.2	26.2	NUM
dpc-4022	112	41	)	)	PUNCT
dpc-4022	112	42	42	42	NUM
dpc-4022	112	43	(	(	PUNCT
dpc-4022	112	44	100	100	NUM
dpc-4022	112	45	)	)	PUNCT
dpc-4022	112	46	upper	upper	ADJ
dpc-4022	112	47	extremities	extremity	NOUN
dpc-4022	112	48	1	1	NUM
dpc-4022	112	49	3(59.1	3(59.1	NUM
dpc-4022	112	50	)	)	PUNCT
dpc-4022	112	51	9	9	NUM
dpc-4022	112	52	(	(	PUNCT
dpc-4022	112	53	40.9	40.9	NUM
dpc-4022	112	54	)	)	PUNCT
dpc-4022	112	55	22	22	NUM
dpc-4022	112	56	(	(	PUNCT
dpc-4022	112	57	100	100	NUM
dpc-4022	112	58	)	)	PUNCT
dpc-4022	112	59	lower	low	ADJ
dpc-4022	112	60	extremities	extremity	NOUN
dpc-4022	112	61	31	31	NUM
dpc-4022	112	62	(	(	PUNCT
dpc-4022	112	63	59.6	59.6	NUM
dpc-4022	112	64	)	)	SYM
dpc-4022	112	65	21	21	NUM
dpc-4022	112	66	(	(	PUNCT
dpc-4022	112	67	40.4	40.4	NUM
dpc-4022	112	68	)	)	PUNCT
dpc-4022	112	69	52	52	NUM
dpc-4022	112	70	(	(	PUNCT
dpc-4022	112	71	100	100	NUM
dpc-4022	112	72	)	)	PUNCT
dpc-4022	112	73	gender	gender	NOUN
dpc-4022	112	74	male	male	NOUN
dpc-4022	112	75	4	4	NUM
dpc-4022	112	76	(	(	PUNCT
dpc-4022	112	77	57.0	57.0	NUM
dpc-4022	112	78	)	)	PUNCT
dpc-4022	112	79	37	37	NUM
dpc-4022	112	80	(	(	PUNCT
dpc-4022	112	81	43.0	43.0	NUM
dpc-4022	112	82	)	)	PUNCT
dpc-4022	112	83	86	86	NUM
dpc-4022	112	84	(	(	PUNCT
dpc-4022	112	85	100	100	NUM
dpc-4022	112	86	)	)	PUNCT
dpc-4022	112	87	0.251	0.251	NUM
dpc-4022	112	88	female	female	ADJ
dpc-4022	112	89	50	50	NUM
dpc-4022	112	90	(	(	PUNCT
dpc-4022	112	91	65.8	65.8	NUM
dpc-4022	112	92	)	)	PUNCT
dpc-4022	112	93	26	26	NUM
dpc-4022	112	94	(	(	PUNCT
dpc-4022	112	95	34.2	34.2	NUM
dpc-4022	112	96	)	)	PUNCT
dpc-4022	112	97	76	76	NUM
dpc-4022	112	98	(	(	PUNCT
dpc-4022	112	99	100	100	NUM
dpc-4022	112	100	)	)	PUNCT
dpc-4022	112	101	arare	arare	NOUN
dpc-4022	112	102	subtypes	subtype	NOUN
dpc-4022	112	103	(	(	PUNCT
dpc-4022	112	104	amelanotic	amelanotic	ADJ
dpc-4022	112	105	,	,	PUNCT
dpc-4022	112	106	animal	animal	NOUN
dpc-4022	112	107	type	type	NOUN
dpc-4022	112	108	,	,	PUNCT
dpc-4022	112	109	desmoplastic	desmoplastic	ADJ
dpc-4022	112	110	)	)	PUNCT
dpc-4022	112	111	alm	alm	NOUN
dpc-4022	112	112	=	=	SYM
dpc-4022	112	113	acral	acral	ADJ
dpc-4022	112	114	lentiginous	lentiginous	ADJ
dpc-4022	112	115	melanoma	melanoma	NOUN
dpc-4022	112	116	;	;	PUNCT
dpc-4022	112	117	lmm	lmm	PROPN
dpc-4022	112	118	=	=	SYM
dpc-4022	112	119	lentigo	lentigo	ADJ
dpc-4022	112	120	malignant	malignant	ADJ
dpc-4022	112	121	melanoma	melanoma	NOUN
dpc-4022	112	122	;	;	PUNCT
dpc-4022	112	123	ln	ln	ADJ
dpc-4022	112	124	=	=	PUNCT
dpc-4022	112	125	lymph	lymph	NOUN
dpc-4022	112	126	node	node	NOUN
dpc-4022	112	127	;	;	PUNCT
dpc-4022	113	1	nm	nm	ADJ
dpc-4022	113	2	=	=	PUNCT
dpc-4022	113	3	nodular	nodular	ADJ
dpc-4022	113	4	melanoma	melanoma	NOUN
dpc-4022	113	5	;	;	PUNCT
dpc-4022	113	6	ssm	ssm	PROPN
dpc-4022	113	7	=	=	PROPN
dpc-4022	113	8	superficial	superficial	ADJ
dpc-4022	113	9	spreading	spread	VERB
dpc-4022	113	10	melanoma	melanoma	NOUN
dpc-4022	113	11	.	.	PUNCT
dpc-4022	114	1	table	table	NOUN
dpc-4022	114	2	5	5	NUM
dpc-4022	114	3	.	.	PUNCT
dpc-4022	115	1	metastatic	metastatic	ADJ
dpc-4022	115	2	sites	site	NOUN
dpc-4022	115	3	of	of	ADP
dpc-4022	115	4	stage	stage	NOUN
dpc-4022	115	5	iv	iv	NUM
dpc-4022	115	6	patients	patient	NOUN
dpc-4022	115	7	with	with	ADP
dpc-4022	115	8	primary	primary	ADJ
dpc-4022	115	9	cutaneous	cutaneous	ADJ
dpc-4022	115	10	melanoma	melanoma	NOUN
dpc-4022	115	11	.	.	PUNCT
dpc-4022	116	1	metastatic	metastatic	ADJ
dpc-4022	116	2	site	site	NOUN
dpc-4022	116	3	n	n	CCONJ
dpc-4022	116	4	%	%	NOUN
dpc-4022	116	5	lung	lung	NOUN
dpc-4022	116	6	10	10	NUM
dpc-4022	116	7	45	45	NUM
dpc-4022	116	8	brain	brain	NOUN
dpc-4022	116	9	9	9	NUM
dpc-4022	116	10	40	40	NUM
dpc-4022	116	11	liver	liver	NOUN
dpc-4022	116	12	5	5	NUM
dpc-4022	116	13	23	23	NUM
dpc-4022	116	14	bone	bone	NOUN
dpc-4022	116	15	7	7	NUM
dpc-4022	116	16	32	32	NUM
dpc-4022	116	17	single	single	ADJ
dpc-4022	116	18	organ	organ	NOUN
dpc-4022	116	19	/	/	SYM
dpc-4022	116	20	tissue	tissue	NOUN
dpc-4022	116	21	involved	involve	VERB
dpc-4022	116	22	14	14	NUM
dpc-4022	116	23	64	64	NUM
dpc-4022	116	24	lung	lung	NOUN
dpc-4022	116	25	7	7	NUM
dpc-4022	116	26	32	32	NUM
dpc-4022	116	27	brain	brain	NOUN
dpc-4022	116	28	4	4	NUM
dpc-4022	116	29	18	18	NUM
dpc-4022	116	30	liver	liver	NOUN
dpc-4022	116	31	2	2	NUM
dpc-4022	116	32	9	9	NUM
dpc-4022	116	33	bone	bone	NOUN
dpc-4022	116	34	1	1	NUM
dpc-4022	116	35	4	4	NUM
dpc-4022	116	36	multiple	multiple	ADJ
dpc-4022	116	37	organ	organ	NOUN
dpc-4022	116	38	/	/	SYM
dpc-4022	116	39	tissue	tissue	NOUN
dpc-4022	116	40	involvement	involvement	NOUN
dpc-4022	116	41	8	8	NUM
dpc-4022	116	42	36	36	NUM
dpc-4022	116	43	6	6	NUM
dpc-4022	116	44	original	original	ADJ
dpc-4022	116	45	article	article	NOUN
dpc-4022	116	46	|	|	ADV
dpc-4022	116	47	dermatol	dermatol	ADJ
dpc-4022	116	48	pract	pract	NOUN
dpc-4022	116	49	concept	concept	NOUN
dpc-4022	116	50	.	.	PUNCT
dpc-4022	117	1	2024;14(3):e2024135	2024;14(3):e2024135	NUM
dpc-4022	117	2	is	be	AUX
dpc-4022	117	3	the	the	DET
dpc-4022	117	4	small	small	ADJ
dpc-4022	117	5	number	number	NOUN
dpc-4022	117	6	of	of	ADP
dpc-4022	117	7	patients	patient	NOUN
dpc-4022	117	8	having	have	VERB
dpc-4022	117	9	braf	braf	NOUN
dpc-4022	117	10	mutation	mutation	NOUN
dpc-4022	117	11	analysis	analysis	NOUN
dpc-4022	117	12	.	.	PUNCT
dpc-4022	118	1	although	although	SCONJ
dpc-4022	118	2	limited	limited	ADJ
dpc-4022	118	3	data	datum	NOUN
dpc-4022	118	4	was	be	AUX
dpc-4022	118	5	available	available	ADJ
dpc-4022	118	6	,	,	PUNCT
dpc-4022	118	7	mutant	mutant	ADJ
dpc-4022	118	8	braf	braf	NOUN
dpc-4022	118	9	was	be	AUX
dpc-4022	118	10	positive	positive	ADJ
dpc-4022	118	11	in	in	ADP
dpc-4022	118	12	45.3	45.3	NUM
dpc-4022	118	13	%	%	NOUN
dpc-4022	118	14	of	of	ADP
dpc-4022	118	15	53	53	NUM
dpc-4022	118	16	patients	patient	NOUN
dpc-4022	118	17	in	in	ADP
dpc-4022	118	18	our	our	PRON
dpc-4022	118	19	study	study	NOUN
dpc-4022	118	20	population	population	NOUN
dpc-4022	118	21	.	.	PUNCT
dpc-4022	119	1	of	of	ADP
dpc-4022	119	2	our	our	PRON
dpc-4022	119	3	study	study	NOUN
dpc-4022	119	4	patients	patient	NOUN
dpc-4022	119	5	,	,	PUNCT
dpc-4022	119	6	32.9	32.9	NUM
dpc-4022	119	7	%	%	NOUN
dpc-4022	119	8	had	have	VERB
dpc-4022	119	9	stage	stage	NOUN
dpc-4022	119	10	i	i	PRON
dpc-4022	119	11	,	,	PUNCT
dpc-4022	119	12	28.8	28.8	NUM
dpc-4022	119	13	%	%	NOUN
dpc-4022	119	14	had	have	VERB
dpc-4022	119	15	stage	stage	NOUN
dpc-4022	119	16	ii	ii	PROPN
dpc-4022	119	17	,	,	PUNCT
dpc-4022	119	18	17.8	17.8	NUM
dpc-4022	119	19	%	%	NOUN
dpc-4022	119	20	stage	stage	NOUN
dpc-4022	119	21	iii	iii	NOUN
dpc-4022	119	22	,	,	PUNCT
dpc-4022	119	23	and	and	CCONJ
dpc-4022	119	24	20.5	20.5	NUM
dpc-4022	119	25	%	%	NOUN
dpc-4022	119	26	had	have	VERB
dpc-4022	119	27	stage	stage	NOUN
dpc-4022	119	28	iv	iv	X
dpc-4022	119	29	pcm	pcm	NOUN
dpc-4022	119	30	.	.	PUNCT
dpc-4022	120	1	in	in	ADP
dpc-4022	120	2	contrast	contrast	NOUN
dpc-4022	120	3	,	,	PUNCT
dpc-4022	120	4	patients	patient	NOUN
dpc-4022	120	5	in	in	ADP
dpc-4022	120	6	stage	stage	NOUN
dpc-4022	120	7	iv	iv	NUM
dpc-4022	120	8	were	be	AUX
dpc-4022	120	9	reported	report	VERB
dpc-4022	120	10	to	to	PART
dpc-4022	120	11	be	be	AUX
dpc-4022	120	12	higher	high	ADJ
dpc-4022	120	13	at	at	ADP
dpc-4022	120	14	25	25	NUM
dpc-4022	120	15	%	%	NOUN
dpc-4022	120	16	to	to	ADP
dpc-4022	120	17	48.7	48.7	NUM
dpc-4022	120	18	%	%	NOUN
dpc-4022	120	19	in	in	ADP
dpc-4022	120	20	different	different	ADJ
dpc-4022	120	21	patient	patient	ADJ
dpc-4022	120	22	study	study	NOUN
dpc-4022	120	23	groups	group	NOUN
dpc-4022	120	24	[	[	X
dpc-4022	120	25	9	9	NUM
dpc-4022	120	26	]	]	PUNCT
dpc-4022	120	27	.	.	PUNCT
dpc-4022	121	1	the	the	DET
dpc-4022	121	2	distribution	distribution	NOUN
dpc-4022	121	3	of	of	ADP
dpc-4022	121	4	melanoma	melanoma	NOUN
dpc-4022	121	5	patients	patient	NOUN
dpc-4022	121	6	data	datum	NOUN
dpc-4022	121	7	in	in	ADP
dpc-4022	121	8	turkish	turkish	ADJ
dpc-4022	121	9	studies	study	NOUN
dpc-4022	121	10	is	be	AUX
dpc-4022	121	11	complex	complex	ADJ
dpc-4022	121	12	,	,	PUNCT
dpc-4022	121	13	reflecting	reflect	VERB
dpc-4022	121	14	diverse	diverse	ADJ
dpc-4022	121	15	data	datum	NOUN
dpc-4022	121	16	sources	source	NOUN
dpc-4022	121	17	encompassing	encompass	VERB
dpc-4022	121	18	multiple	multiple	ADJ
dpc-4022	121	19	medical	medical	ADJ
dpc-4022	121	20	departments	department	NOUN
dpc-4022	121	21	such	such	ADJ
dpc-4022	121	22	as	as	ADP
dpc-4022	121	23	oncology	oncology	NOUN
dpc-4022	121	24	,	,	PUNCT
dpc-4022	121	25	dermatology	dermatology	NOUN
dpc-4022	121	26	,	,	PUNCT
dpc-4022	121	27	and	and	CCONJ
dpc-4022	121	28	plastic	plastic	ADJ
dpc-4022	121	29	surgery	surgery	NOUN
dpc-4022	121	30	.	.	PUNCT
dpc-4022	122	1	our	our	PRON
dpc-4022	122	2	data	datum	NOUN
dpc-4022	122	3	align	align	VERB
dpc-4022	122	4	with	with	ADP
dpc-4022	122	5	findings	finding	NOUN
dpc-4022	122	6	from	from	ADP
dpc-4022	122	7	specialized	specialized	ADJ
dpc-4022	122	8	and	and	CCONJ
dpc-4022	122	9	regional	regional	ADJ
dpc-4022	122	10	lymph	lymph	NOUN
dpc-4022	122	11	node	node	NOUN
dpc-4022	122	12	involvement	involvement	NOUN
dpc-4022	122	13	and	and	CCONJ
dpc-4022	122	14	ulceration	ulceration	NOUN
dpc-4022	122	15	.	.	PUNCT
dpc-4022	123	1	as	as	SCONJ
dpc-4022	123	2	expected	expect	VERB
dpc-4022	123	3	,	,	PUNCT
dpc-4022	123	4	in	in	ADP
dpc-4022	123	5	our	our	PRON
dpc-4022	123	6	study	study	NOUN
dpc-4022	123	7	,	,	PUNCT
dpc-4022	123	8	locoregional	locoregional	ADJ
dpc-4022	123	9	spread	spread	NOUN
dpc-4022	123	10	was	be	AUX
dpc-4022	123	11	higher	high	ADJ
dpc-4022	123	12	in	in	ADP
dpc-4022	123	13	ulcerated	ulcerated	ADJ
dpc-4022	123	14	than	than	ADP
dpc-4022	123	15	non	non	ADJ
dpc-4022	123	16	-	-	ADJ
dpc-4022	123	17	ulcered	ulcered	ADJ
dpc-4022	123	18	tumors	tumor	NOUN
dpc-4022	123	19	.	.	PUNCT
dpc-4022	124	1	the	the	DET
dpc-4022	124	2	most	most	ADV
dpc-4022	124	3	common	common	ADJ
dpc-4022	124	4	histopathological	histopathological	ADJ
dpc-4022	124	5	subtype	subtype	NOUN
dpc-4022	124	6	to	to	PART
dpc-4022	124	7	be	be	AUX
dpc-4022	124	8	associated	associate	VERB
dpc-4022	124	9	with	with	ADP
dpc-4022	124	10	lymph	lymph	NOUN
dpc-4022	124	11	node	node	NOUN
dpc-4022	124	12	involvement	involvement	NOUN
dpc-4022	124	13	is	be	AUX
dpc-4022	124	14	alm	alm	NOUN
dpc-4022	125	1	[	[	X
dpc-4022	125	2	19	19	NUM
dpc-4022	125	3	]	]	PUNCT
dpc-4022	125	4	.	.	PUNCT
dpc-4022	126	1	similarly	similarly	ADV
dpc-4022	126	2	,	,	PUNCT
dpc-4022	126	3	in	in	ADP
dpc-4022	126	4	our	our	PRON
dpc-4022	126	5	study	study	NOUN
dpc-4022	126	6	group	group	NOUN
dpc-4022	126	7	,	,	PUNCT
dpc-4022	126	8	patients	patient	NOUN
dpc-4022	126	9	with	with	ADP
dpc-4022	126	10	alm	alm	NOUN
dpc-4022	126	11	and	and	CCONJ
dpc-4022	126	12	lmm	lmm	PROPN
dpc-4022	126	13	had	have	VERB
dpc-4022	126	14	more	more	ADV
dpc-4022	126	15	common	common	ADJ
dpc-4022	126	16	lymph	lymph	NOUN
dpc-4022	126	17	node	node	NOUN
dpc-4022	126	18	involvement	involvement	NOUN
dpc-4022	126	19	than	than	ADP
dpc-4022	126	20	patients	patient	NOUN
dpc-4022	126	21	with	with	ADP
dpc-4022	126	22	ssm	ssm	PROPN
dpc-4022	126	23	and	and	CCONJ
dpc-4022	126	24	nm	nm	PROPN
dpc-4022	126	25	.	.	PUNCT
dpc-4022	127	1	detection	detection	NOUN
dpc-4022	127	2	of	of	ADP
dpc-4022	127	3	braf	braf	NOUN
dpc-4022	127	4	mutation	mutation	NOUN
dpc-4022	127	5	in	in	ADP
dpc-4022	127	6	melanoma	melanoma	NOUN
dpc-4022	127	7	patients	patient	NOUN
dpc-4022	127	8	gives	give	VERB
dpc-4022	127	9	them	they	PRON
dpc-4022	127	10	a	a	DET
dpc-4022	127	11	chance	chance	NOUN
dpc-4022	127	12	for	for	ADP
dpc-4022	127	13	targeted	target	VERB
dpc-4022	127	14	immunotherapy	immunotherapy	NOUN
dpc-4022	127	15	[	[	X
dpc-4022	127	16	20	20	NUM
dpc-4022	127	17	]	]	PUNCT
dpc-4022	127	18	.	.	PUNCT
dpc-4022	128	1	helen	helen	PROPN
dpc-4022	128	2	davies	davies	PROPN
dpc-4022	128	3	et	et	PROPN
dpc-4022	128	4	al	al	PROPN
dpc-4022	129	1	[	[	X
dpc-4022	129	2	21	21	NUM
dpc-4022	129	3	]	]	PUNCT
dpc-4022	129	4	reported	report	VERB
dpc-4022	129	5	a	a	DET
dpc-4022	129	6	50	50	NUM
dpc-4022	129	7	%	%	NOUN
dpc-4022	129	8	and	and	CCONJ
dpc-4022	129	9	60	60	NUM
dpc-4022	129	10	%	%	NOUN
dpc-4022	129	11	mutation	mutation	NOUN
dpc-4022	129	12	rate	rate	NOUN
dpc-4022	129	13	in	in	ADP
dpc-4022	129	14	all	all	DET
dpc-4022	129	15	human	human	ADJ
dpc-4022	129	16	cancers	cancer	NOUN
dpc-4022	129	17	and	and	CCONJ
dpc-4022	129	18	66	66	NUM
dpc-4022	129	19	%	%	NOUN
dpc-4022	129	20	in	in	ADP
dpc-4022	129	21	melanoma	melanoma	NOUN
dpc-4022	129	22	.	.	PUNCT
dpc-4022	130	1	one	one	NUM
dpc-4022	130	2	of	of	ADP
dpc-4022	130	3	the	the	DET
dpc-4022	130	4	limitations	limitation	NOUN
dpc-4022	130	5	of	of	ADP
dpc-4022	130	6	our	our	PRON
dpc-4022	130	7	study	study	NOUN
dpc-4022	130	8	1,0	1,0	NUM
dpc-4022	130	9	0,8	0,8	NUM
dpc-4022	130	10	0,6	0,6	NUM
dpc-4022	130	11	0,4	0,4	NUM
dpc-4022	130	12	0,2	0,2	NUM
dpc-4022	130	13	0,0	0,0	NOUN
dpc-4022	130	14	,	,	PUNCT
dpc-4022	130	15	00	00	PUNCT
dpc-4022	130	16	10,00	10,00	PROPN
dpc-4022	130	17	20,00	20,00	PROPN
dpc-4022	130	18	30,00	30,00	NUM
dpc-4022	130	19	time	time	NOUN
dpc-4022	130	20	survival	survival	NOUN
dpc-4022	130	21	functions	function	NOUN
dpc-4022	130	22	c	c	AUX
dpc-4022	130	23	um	um	INTJ
dpc-4022	130	24	s	s	VERB
dpc-4022	130	25	ur	ur	INTJ
dpc-4022	130	26	vl	vl	PROPN
dpc-4022	130	27	va	va	PROPN
dpc-4022	130	28	l	l	PROPN
dpc-4022	130	29	40,00	40,00	PROPN
dpc-4022	130	30	50,00	50,00	NUM
dpc-4022	130	31	60,00	60,00	NUM
dpc-4022	130	32	t	t	NOUN
dpc-4022	130	33	1	1	NUM
dpc-4022	130	34	2	2	NUM
dpc-4022	130	35	3	3	NUM
dpc-4022	130	36	4	4	NUM
dpc-4022	130	37	1	1	NUM
dpc-4022	130	38	-	-	PUNCT
dpc-4022	130	39	censored	censor	VERB
dpc-4022	130	40	2	2	NUM
dpc-4022	130	41	-	-	PUNCT
dpc-4022	130	42	censored	censor	VERB
dpc-4022	130	43	3	3	NUM
dpc-4022	130	44	-	-	PUNCT
dpc-4022	130	45	censored	censor	VERB
dpc-4022	130	46	4	4	NUM
dpc-4022	130	47	-	-	PUNCT
dpc-4022	130	48	censored	censor	VERB
dpc-4022	130	49	1,0	1,0	NUM
dpc-4022	130	50	0,8	0,8	NUM
dpc-4022	130	51	0,6	0,6	NUM
dpc-4022	130	52	0,4	0,4	NUM
dpc-4022	130	53	0,2	0,2	NUM
dpc-4022	130	54	0,0	0,0	NOUN
dpc-4022	130	55	,	,	PUNCT
dpc-4022	130	56	00	00	PUNCT
dpc-4022	130	57	10,00	10,00	PROPN
dpc-4022	130	58	20,00	20,00	PROPN
dpc-4022	130	59	30,00	30,00	NUM
dpc-4022	130	60	time	time	NOUN
dpc-4022	130	61	survival	survival	NOUN
dpc-4022	130	62	functions	function	NOUN
dpc-4022	130	63	c	c	VERB
dpc-4022	130	64	um	um	INTJ
dpc-4022	130	65	s	s	VERB
dpc-4022	130	66	ur	ur	INTJ
dpc-4022	130	67	vl	vl	PROPN
dpc-4022	130	68	va	va	PROPN
dpc-4022	130	69	l	l	PROPN
dpc-4022	130	70	40,00	40,00	PROPN
dpc-4022	130	71	50,00	50,00	NUM
dpc-4022	130	72	60,00	60,00	NUM
dpc-4022	130	73	localization	localization	NOUN
dpc-4022	130	74	1	1	NUM
dpc-4022	130	75	2	2	NUM
dpc-4022	130	76	3	3	NUM
dpc-4022	131	1	4	4	NUM
dpc-4022	131	2	1	1	NUM
dpc-4022	131	3	-	-	PUNCT
dpc-4022	131	4	censored	censor	VERB
dpc-4022	131	5	2	2	NUM
dpc-4022	131	6	-	-	PUNCT
dpc-4022	131	7	censored	censor	VERB
dpc-4022	131	8	3	3	NUM
dpc-4022	131	9	-	-	PUNCT
dpc-4022	131	10	censored	censor	VERB
dpc-4022	131	11	4	4	NUM
dpc-4022	131	12	-	-	PUNCT
dpc-4022	131	13	censored	censor	VERB
dpc-4022	131	14	1,0	1,0	NUM
dpc-4022	131	15	0,8	0,8	NUM
dpc-4022	131	16	0,6	0,6	NUM
dpc-4022	131	17	0,4	0,4	NUM
dpc-4022	131	18	0,2	0,2	NUM
dpc-4022	131	19	0,0	0,0	NOUN
dpc-4022	131	20	,	,	PUNCT
dpc-4022	131	21	00	00	PUNCT
dpc-4022	131	22	10,00	10,00	PROPN
dpc-4022	131	23	20,00	20,00	PROPN
dpc-4022	131	24	30,00	30,00	NUM
dpc-4022	131	25	time	time	NOUN
dpc-4022	131	26	survival	survival	NOUN
dpc-4022	131	27	functions	function	NOUN
dpc-4022	131	28	c	c	VERB
dpc-4022	131	29	um	um	INTJ
dpc-4022	131	30	s	s	VERB
dpc-4022	131	31	ur	ur	INTJ
dpc-4022	131	32	vl	vl	PROPN
dpc-4022	131	33	va	va	PROPN
dpc-4022	131	34	l	l	PROPN
dpc-4022	131	35	40,00	40,00	PROPN
dpc-4022	131	36	50,00	50,00	NUM
dpc-4022	131	37	60,00	60,00	NUM
dpc-4022	131	38	stage	stage	NOUN
dpc-4022	131	39	1	1	NUM
dpc-4022	131	40	2	2	NUM
dpc-4022	131	41	3	3	NUM
dpc-4022	131	42	4	4	NUM
dpc-4022	131	43	1	1	NUM
dpc-4022	131	44	-	-	PUNCT
dpc-4022	131	45	censored	censor	VERB
dpc-4022	131	46	2	2	NUM
dpc-4022	131	47	-	-	PUNCT
dpc-4022	131	48	censored	censor	VERB
dpc-4022	131	49	3	3	NUM
dpc-4022	131	50	-	-	PUNCT
dpc-4022	131	51	censored	censor	VERB
dpc-4022	131	52	4	4	NUM
dpc-4022	131	53	-	-	PUNCT
dpc-4022	131	54	censored	censor	VERB
dpc-4022	131	55	1,0	1,0	NUM
dpc-4022	131	56	0,8	0,8	NUM
dpc-4022	131	57	0,6	0,6	NUM
dpc-4022	131	58	0,4	0,4	NUM
dpc-4022	131	59	0,2	0,2	NUM
dpc-4022	131	60	0,0	0,0	NOUN
dpc-4022	131	61	,	,	PUNCT
dpc-4022	131	62	00	00	PUNCT
dpc-4022	131	63	10,00	10,00	PROPN
dpc-4022	131	64	20,00	20,00	PROPN
dpc-4022	131	65	30,00	30,00	NUM
dpc-4022	131	66	time	time	NOUN
dpc-4022	131	67	survival	survival	NOUN
dpc-4022	131	68	functions	function	NOUN
dpc-4022	131	69	c	c	VERB
dpc-4022	131	70	um	um	INTJ
dpc-4022	131	71	s	s	VERB
dpc-4022	131	72	ur	ur	INTJ
dpc-4022	131	73	vl	vl	PROPN
dpc-4022	131	74	va	va	PROPN
dpc-4022	131	75	l	l	PROPN
dpc-4022	131	76	40,00	40,00	PROPN
dpc-4022	131	77	50,00	50,00	NUM
dpc-4022	131	78	60,00	60,00	NUM
dpc-4022	131	79	age	age	NOUN
dpc-4022	132	1	1,00	1,00	X
dpc-4022	132	2	2,00	2,00	PROPN
dpc-4022	132	3	3,00	3,00	NUM
dpc-4022	132	4	4,00	4,00	PROPN
dpc-4022	132	5	5,00	5,00	PROPN
dpc-4022	132	6	1,00	1,00	X
dpc-4022	132	7	-	-	ADJ
dpc-4022	132	8	censored	censor	VERB
dpc-4022	132	9	2,00	2,00	ADJ
dpc-4022	132	10	-	-	ADJ
dpc-4022	132	11	censored	censor	VERB
dpc-4022	132	12	3,00	3,00	ADV
dpc-4022	132	13	-	-	ADJ
dpc-4022	132	14	censored	censor	VERB
dpc-4022	132	15	4,00	4,00	ADJ
dpc-4022	132	16	-	-	PUNCT
dpc-4022	132	17	censored	censor	VERB
dpc-4022	132	18	5,00	5,00	ADJ
dpc-4022	132	19	-	-	ADJ
dpc-4022	132	20	censored	censor	VERB
dpc-4022	132	21	1,0	1,0	NUM
dpc-4022	132	22	0,8	0,8	NUM
dpc-4022	132	23	0,6	0,6	NUM
dpc-4022	132	24	0,4	0,4	NUM
dpc-4022	132	25	0,2	0,2	NUM
dpc-4022	132	26	0,0	0,0	NOUN
dpc-4022	132	27	,	,	PUNCT
dpc-4022	132	28	00	00	PUNCT
dpc-4022	132	29	10,00	10,00	PROPN
dpc-4022	132	30	20,00	20,00	PROPN
dpc-4022	132	31	30,00	30,00	NUM
dpc-4022	132	32	time	time	NOUN
dpc-4022	132	33	survival	survival	NOUN
dpc-4022	132	34	functions	function	NOUN
dpc-4022	132	35	c	c	VERB
dpc-4022	132	36	um	um	INTJ
dpc-4022	132	37	s	s	VERB
dpc-4022	132	38	ur	ur	INTJ
dpc-4022	132	39	vl	vl	PROPN
dpc-4022	132	40	va	va	PROPN
dpc-4022	132	41	l	l	PROPN
dpc-4022	132	42	40,00	40,00	PROPN
dpc-4022	132	43	50,00	50,00	NUM
dpc-4022	132	44	60,00	60,00	NUM
dpc-4022	132	45	ulceration	ulceration	NOUN
dpc-4022	132	46	0	0	NUM
dpc-4022	132	47	1	1	NUM
dpc-4022	132	48	0	0	NUM
dpc-4022	132	49	-	-	PUNCT
dpc-4022	132	50	censored	censor	VERB
dpc-4022	132	51	1	1	NUM
dpc-4022	132	52	-	-	PUNCT
dpc-4022	132	53	censored	censor	VERB
dpc-4022	132	54	1	1	NUM
dpc-4022	132	55	2	2	NUM
dpc-4022	132	56	1	1	NUM
dpc-4022	132	57	-	-	PUNCT
dpc-4022	132	58	censored	censor	VERB
dpc-4022	132	59	2	2	NUM
dpc-4022	132	60	-	-	PUNCT
dpc-4022	132	61	censored	censor	VERB
dpc-4022	132	62	1,0	1,0	NUM
dpc-4022	132	63	0,8	0,8	NUM
dpc-4022	132	64	0,6	0,6	NUM
dpc-4022	132	65	0,4	0,4	NUM
dpc-4022	132	66	0,2	0,2	NUM
dpc-4022	132	67	0,0	0,0	NOUN
dpc-4022	132	68	,	,	PUNCT
dpc-4022	132	69	00	00	PUNCT
dpc-4022	132	70	10,00	10,00	PROPN
dpc-4022	132	71	20,00	20,00	PROPN
dpc-4022	132	72	30,00	30,00	NUM
dpc-4022	132	73	time	time	NOUN
dpc-4022	132	74	survival	survival	NOUN
dpc-4022	132	75	functions	function	NOUN
dpc-4022	132	76	c	c	VERB
dpc-4022	132	77	um	um	INTJ
dpc-4022	132	78	s	s	VERB
dpc-4022	132	79	ur	ur	INTJ
dpc-4022	132	80	vl	vl	PROPN
dpc-4022	132	81	va	va	PROPN
dpc-4022	132	82	l	l	PROPN
dpc-4022	132	83	40,00	40,00	PROPN
dpc-4022	132	84	50,00	50,00	NUM
dpc-4022	132	85	60,00	60,00	NUM
dpc-4022	132	86	gender	gender	NOUN
dpc-4022	132	87	figure	figure	NOUN
dpc-4022	132	88	1	1	NUM
dpc-4022	132	89	.	.	PUNCT
dpc-4022	133	1	kaplan	kaplan	PROPN
dpc-4022	133	2	-	-	PUNCT
dpc-4022	133	3	meier	meier	PROPN
dpc-4022	133	4	survival	survival	NOUN
dpc-4022	133	5	plots	plot	NOUN
dpc-4022	133	6	of	of	ADP
dpc-4022	133	7	overall	overall	ADJ
dpc-4022	133	8	survival	survival	NOUN
dpc-4022	133	9	according	accord	VERB
dpc-4022	133	10	to	to	ADP
dpc-4022	133	11	:	:	PUNCT
dpc-4022	133	12	(	(	PUNCT
dpc-4022	133	13	a	a	X
dpc-4022	133	14	)	)	PUNCT
dpc-4022	133	15	breslow	breslow	ADJ
dpc-4022	133	16	thickness	thickness	NOUN
dpc-4022	133	17	(	(	PUNCT
dpc-4022	133	18	p	p	X
dpc-4022	133	19	=	=	PROPN
dpc-4022	133	20	0.016	0.016	NUM
dpc-4022	133	21	;	;	PUNCT
dpc-4022	133	22	log	log	PROPN
dpc-4022	133	23	rank	rank	PROPN
dpc-4022	133	24	test	test	NOUN
dpc-4022	133	25	)	)	PUNCT
dpc-4022	133	26	;	;	PUNCT
dpc-4022	133	27	(	(	PUNCT
dpc-4022	133	28	b	b	X
dpc-4022	133	29	)	)	PUNCT
dpc-4022	133	30	  	  	SPACE
dpc-4022	133	31	localization—1	localization—1	PROPN
dpc-4022	133	32	head	head	NOUN
dpc-4022	133	33	and	and	CCONJ
dpc-4022	133	34	neck	neck	NOUN
dpc-4022	133	35	,	,	PUNCT
dpc-4022	133	36	2	2	NUM
dpc-4022	133	37	trunk	trunk	NOUN
dpc-4022	133	38	,	,	PUNCT
dpc-4022	133	39	3	3	NUM
dpc-4022	133	40	upper	upper	ADJ
dpc-4022	133	41	extremities	extremity	NOUN
dpc-4022	133	42	,	,	PUNCT
dpc-4022	133	43	and	and	CCONJ
dpc-4022	133	44	4	4	NUM
dpc-4022	133	45	lower	low	ADJ
dpc-4022	133	46	extremities	extremity	NOUN
dpc-4022	133	47	(	(	PUNCT
dpc-4022	133	48	p	p	X
dpc-4022	133	49	=	=	NOUN
dpc-4022	133	50	0.540	0.540	NUM
dpc-4022	133	51	,	,	PUNCT
dpc-4022	133	52	log	log	VERB
dpc-4022	133	53	rank	rank	NOUN
dpc-4022	133	54	test	test	NOUN
dpc-4022	133	55	)	)	PUNCT
dpc-4022	133	56	;	;	PUNCT
dpc-4022	133	57	(	(	PUNCT
dpc-4022	133	58	c	c	X
dpc-4022	133	59	)	)	PUNCT
dpc-4022	133	60	ajcc	ajcc	PROPN
dpc-4022	133	61	8th	8th	ADJ
dpc-4022	133	62	stage	stage	NOUN
dpc-4022	133	63	(	(	PUNCT
dpc-4022	133	64	p	p	NOUN
dpc-4022	133	65	=	=	NOUN
dpc-4022	133	66	0.001	0.001	NUM
dpc-4022	133	67	,	,	PUNCT
dpc-4022	133	68	log	log	NOUN
dpc-4022	133	69	rank	rank	NOUN
dpc-4022	133	70	test	test	NOUN
dpc-4022	133	71	)	)	PUNCT
dpc-4022	133	72	;	;	PUNCT
dpc-4022	133	73	(	(	PUNCT
dpc-4022	133	74	d	d	X
dpc-4022	133	75	)	)	PUNCT
dpc-4022	133	76	age	age	NOUN
dpc-4022	133	77	group	group	NOUN
dpc-4022	133	78	:	:	PUNCT
dpc-4022	133	79	(	(	PUNCT
dpc-4022	133	80	group	group	NOUN
dpc-4022	133	81	1	1	NUM
dpc-4022	133	82	:	:	PUNCT
dpc-4022	133	83	<	<	X
dpc-4022	133	84	18	18	NUM
dpc-4022	133	85	,	,	PUNCT
dpc-4022	133	86	group	group	NOUN
dpc-4022	133	87	2	2	NUM
dpc-4022	133	88	:	:	SYM
dpc-4022	133	89	18	18	NUM
dpc-4022	133	90	-	-	SYM
dpc-4022	133	91	20	20	NUM
dpc-4022	133	92	,	,	PUNCT
dpc-4022	133	93	group	group	NOUN
dpc-4022	133	94	3	3	NUM
dpc-4022	133	95	:	:	SYM
dpc-4022	133	96	30	30	NUM
dpc-4022	133	97	-	-	SYM
dpc-4022	133	98	45	45	NUM
dpc-4022	133	99	,	,	PUNCT
dpc-4022	133	100	group	group	NOUN
dpc-4022	133	101	4	4	NUM
dpc-4022	133	102	:	:	SYM
dpc-4022	133	103	45	45	NUM
dpc-4022	133	104	-	-	SYM
dpc-4022	133	105	65	65	NUM
dpc-4022	133	106	,	,	PUNCT
dpc-4022	133	107	and	and	CCONJ
dpc-4022	133	108	group	group	NOUN
dpc-4022	133	109	5	5	NUM
dpc-4022	133	110	:	:	PUNCT
dpc-4022	133	111	>	>	X
dpc-4022	133	112	65	65	NUM
dpc-4022	133	113	)	)	PUNCT
dpc-4022	133	114	(	(	PUNCT
dpc-4022	133	115	p	p	X
dpc-4022	133	116	=	=	NOUN
dpc-4022	133	117	0.008	0.008	NUM
dpc-4022	133	118	,	,	PUNCT
dpc-4022	133	119	log	log	NOUN
dpc-4022	133	120	rank	rank	NOUN
dpc-4022	133	121	test	test	NOUN
dpc-4022	133	122	)	)	PUNCT
dpc-4022	133	123	;	;	PUNCT
dpc-4022	133	124	(	(	PUNCT
dpc-4022	133	125	e	e	NOUN
dpc-4022	133	126	)	)	PUNCT
dpc-4022	133	127	tumor	tumor	NOUN
dpc-4022	133	128	ulceration	ulceration	NOUN
dpc-4022	133	129	status	status	NOUN
dpc-4022	133	130	(	(	PUNCT
dpc-4022	133	131	1	1	NUM
dpc-4022	133	132	ulcerated	ulcerated	ADJ
dpc-4022	133	133	,	,	PUNCT
dpc-4022	133	134	0	0	NUM
dpc-4022	133	135	not	not	PART
dpc-4022	133	136	ulcerated	ulcerated	ADJ
dpc-4022	133	137	)	)	PUNCT
dpc-4022	133	138	(	(	PUNCT
dpc-4022	133	139	p	p	NOUN
dpc-4022	133	140	=	=	NOUN
dpc-4022	133	141	0.001	0.001	NUM
dpc-4022	133	142	,	,	PUNCT
dpc-4022	133	143	log	log	NOUN
dpc-4022	133	144	rank	rank	NOUN
dpc-4022	133	145	test	test	NOUN
dpc-4022	133	146	)	)	PUNCT
dpc-4022	133	147	;	;	PUNCT
dpc-4022	133	148	(	(	PUNCT
dpc-4022	133	149	f	f	X
dpc-4022	133	150	)	)	PUNCT
dpc-4022	133	151	gender—1	gender—1	ADJ
dpc-4022	133	152	male	male	NOUN
dpc-4022	133	153	,	,	PUNCT
dpc-4022	133	154	2	2	NUM
dpc-4022	133	155	female	female	NOUN
dpc-4022	133	156	(	(	PUNCT
dpc-4022	133	157	p	p	NOUN
dpc-4022	133	158	=	=	NOUN
dpc-4022	133	159	0.374	0.374	NUM
dpc-4022	133	160	,	,	PUNCT
dpc-4022	133	161	log	log	VERB
dpc-4022	133	162	rank	rank	NOUN
dpc-4022	133	163	test	test	NOUN
dpc-4022	133	164	)	)	PUNCT
dpc-4022	133	165	.	.	PUNCT
dpc-4022	134	1	original	original	ADJ
dpc-4022	134	2	article	article	NOUN
dpc-4022	134	3	|	|	ADV
dpc-4022	134	4	dermatol	dermatol	ADJ
dpc-4022	134	5	pract	pract	NOUN
dpc-4022	134	6	concept	concept	NOUN
dpc-4022	134	7	.	.	PUNCT
dpc-4022	135	1	2024;14(3):e2024135	2024;14(3):e2024135	NUM
dpc-4022	135	2	7	7	NUM
dpc-4022	135	3	3	3	NUM
dpc-4022	135	4	.	.	PUNCT
dpc-4022	136	1	celik	celik	AUX
dpc-4022	136	2	msski̇.	msski̇.	VERB
dpc-4022	136	3	retrospective	retrospective	ADJ
dpc-4022	136	4	evaluation	evaluation	NOUN
dpc-4022	136	5	of	of	ADP
dpc-4022	136	6	malignant	malignant	ADJ
dpc-4022	136	7	melanoma	melanoma	NOUN
dpc-4022	136	8	patients	patient	NOUN
dpc-4022	136	9	:	:	PUNCT
dpc-4022	136	10	a	a	DET
dpc-4022	136	11	single	single	ADJ
dpc-4022	136	12	-	-	PUNCT
dpc-4022	136	13	center	center	NOUN
dpc-4022	136	14	experience	experience	NOUN
dpc-4022	136	15	.	.	PUNCT
dpc-4022	137	1	family	family	NOUN
dpc-4022	137	2	practice	practice	NOUN
dpc-4022	137	3	and	and	CCONJ
dpc-4022	137	4	palliative	palliative	ADJ
dpc-4022	137	5	care	care	NOUN
dpc-4022	137	6	.	.	PUNCT
dpc-4022	138	1	2021	2021	NUM
dpc-4022	138	2	.	.	PUNCT
dpc-4022	139	1	4	4	NUM
dpc-4022	139	2	.	.	X
dpc-4022	139	3	gamsizkan	gamsizkan	PROPN
dpc-4022	139	4	m	m	PROPN
dpc-4022	139	5	,	,	PUNCT
dpc-4022	139	6	yilmaz	yilmaz	PROPN
dpc-4022	139	7	i	i	PRON
dpc-4022	139	8	,	,	PUNCT
dpc-4022	139	9	buyukbabani	buyukbabani	NOUN
dpc-4022	139	10	n	n	CCONJ
dpc-4022	139	11	,	,	PUNCT
dpc-4022	139	12	et	et	PROPN
dpc-4022	139	13	al	al	PROPN
dpc-4022	139	14	.	.	PUNCT
dpc-4022	140	1	a	a	DET
dpc-4022	140	2	retrospective	retrospective	ADJ
dpc-4022	140	3	multicenter	multicenter	ADJ
dpc-4022	140	4	evaluation	evaluation	NOUN
dpc-4022	140	5	of	of	ADP
dpc-4022	140	6	cutaneous	cutaneous	ADJ
dpc-4022	140	7	melanomas	melanomas	NOUN
dpc-4022	140	8	in	in	ADP
dpc-4022	140	9	turkey	turkey	PROPN
dpc-4022	140	10	.	.	PUNCT
dpc-4022	141	1	asian	asian	PROPN
dpc-4022	141	2	pac	pac	PROPN
dpc-4022	141	3	j	j	PROPN
dpc-4022	141	4	cancer	cancer	NOUN
dpc-4022	141	5	prev	prev	X
dpc-4022	141	6	.	.	PUNCT
dpc-4022	142	1	2014;15(23):10451	2014;15(23):10451	NUM
dpc-4022	142	2	-	-	SYM
dpc-4022	142	3	6	6	NUM
dpc-4022	142	4	.	.	PUNCT
dpc-4022	142	5	doi	doi	NOUN
dpc-4022	142	6	:	:	PUNCT
dpc-4022	142	7	10.7314	10.7314	NUM
dpc-4022	142	8	/	/	SYM
dpc-4022	142	9	apjcp	apjcp	ADJ
dpc-4022	142	10	.2014.15.23.10451	.2014.15.23.10451	PROPN
dpc-4022	142	11	.	.	PUNCT
dpc-4022	143	1	pmid	pmid	NOUN
dpc-4022	143	2	:	:	PUNCT
dpc-4022	143	3	25556491	25556491	NUM
dpc-4022	143	4	.	.	PUNCT
dpc-4022	144	1	5	5	X
dpc-4022	144	2	.	.	X
dpc-4022	144	3	can	can	AUX
dpc-4022	144	4	baykal	baykal	VERB
dpc-4022	144	5	bna	bna	PROPN
dpc-4022	144	6	,	,	PUNCT
dpc-4022	144	7	tugba	tugba	NOUN
dpc-4022	144	8	atci	atci	NOUN
dpc-4022	144	9	.	.	PUNCT
dpc-4022	145	1	is	be	AUX
dpc-4022	145	2	the	the	DET
dpc-4022	145	3	frequency	frequency	NOUN
dpc-4022	145	4	of	of	ADP
dpc-4022	145	5	primary	primary	ADJ
dpc-4022	145	6	cutaneous	cutaneous	ADJ
dpc-4022	145	7	melanoma	melanoma	NOUN
dpc-4022	145	8	increasing	increase	VERB
dpc-4022	145	9	in	in	ADP
dpc-4022	145	10	turkey	turkey	NOUN
dpc-4022	145	11	?	?	PUNCT
dpc-4022	146	1	an	an	DET
dpc-4022	146	2	evaluation	evaluation	NOUN
dpc-4022	146	3	of	of	ADP
dpc-4022	146	4	the	the	DET
dpc-4022	146	5	experiences	experience	NOUN
dpc-4022	146	6	of	of	ADP
dpc-4022	146	7	two	two	NUM
dpc-4022	146	8	dermatology	dermatology	NOUN
dpc-4022	146	9	centers	center	NOUN
dpc-4022	146	10	.	.	PUNCT
dpc-4022	147	1	journal	journal	NOUN
dpc-4022	147	2	of	of	ADP
dpc-4022	147	3	oncological	oncological	ADJ
dpc-4022	147	4	sciences	science	NOUN
dpc-4022	147	5	.	.	PUNCT
dpc-4022	148	1	2018;4(1):19	2018;4(1):19	NUM
dpc-4022	148	2	-	-	SYM
dpc-4022	148	3	23	23	NUM
dpc-4022	148	4	.	.	PUNCT
dpc-4022	149	1	6	6	NUM
dpc-4022	149	2	.	.	X
dpc-4022	149	3	society	society	PROPN
dpc-4022	149	4	ac	ac	PROPN
dpc-4022	149	5	.	.	PUNCT
dpc-4022	150	1	key	key	ADJ
dpc-4022	150	2	statistics	statistic	NOUN
dpc-4022	150	3	for	for	ADP
dpc-4022	150	4	melanoma	melanoma	NOUN
dpc-4022	150	5	skin	skin	NOUN
dpc-4022	150	6	cancer	cancer	NOUN
dpc-4022	150	7	2022	2022	NUM
dpc-4022	150	8	.	.	PUNCT
dpc-4022	151	1	available	available	ADJ
dpc-4022	151	2	from	from	ADP
dpc-4022	151	3	:	:	PUNCT
dpc-4022	151	4	https://www.cancer.org/cancer/melanoma-skin	https://www.cancer.org/cancer/melanoma-skin	PROPN
dpc-4022	151	5	cancer	cancer	NOUN
dpc-4022	151	6	/	/	SYM
dpc-4022	151	7	about	about	ADP
dpc-4022	151	8	/	/	SYM
dpc-4022	151	9	key	key	NOUN
dpc-4022	151	10	-	-	PUNCT
dpc-4022	151	11	statistics.html	statistics.html	NUM
dpc-4022	151	12	.	.	PUNCT
dpc-4022	152	1	accessed	access	VERB
dpc-4022	152	2	november	november	PROPN
dpc-4022	152	3	1st	1st	NOUN
dpc-4022	152	4	,	,	PUNCT
dpc-4022	152	5	2023	2023	NUM
dpc-4022	152	6	7	7	NUM
dpc-4022	152	7	.	.	PUNCT
dpc-4022	153	1	research	research	PROPN
dpc-4022	153	2	uc	uc	PROPN
dpc-4022	153	3	.	.	PROPN
dpc-4022	154	1	melanoma	melanoma	PROPN
dpc-4022	154	2	skin	skin	NOUN
dpc-4022	154	3	cancer	cancer	NOUN
dpc-4022	154	4	incidence	incidence	NOUN
dpc-4022	154	5	statistics	statistic	NOUN
dpc-4022	154	6	2018	2018	NUM
dpc-4022	154	7	accessed	access	VERB
dpc-4022	154	8	1st	1st	ADJ
dpc-4022	154	9	november	november	PROPN
dpc-4022	154	10	,	,	PUNCT
dpc-4022	154	11	2023	2023	NUM
dpc-4022	154	12	.	.	PUNCT
dpc-4022	155	1	available	available	ADJ
dpc-4022	155	2	from	from	ADP
dpc-4022	155	3	:	:	PUNCT
dpc-4022	155	4	https://www	https://www	PROPN
dpc-4022	155	5	.cancerresearchuk.org	.cancerresearchuk.org	PROPN
dpc-4022	155	6	/	/	SYM
dpc-4022	155	7	health	health	NOUN
dpc-4022	155	8	-	-	PUNCT
dpc-4022	155	9	professional	professional	ADJ
dpc-4022	155	10	/	/	SYM
dpc-4022	155	11	cancer	cancer	NOUN
dpc-4022	155	12	-	-	PUNCT
dpc-4022	155	13	statistics	statistic	NOUN
dpc-4022	155	14	/statistics	/statistic	NOUN
dpc-4022	155	15	-	-	PUNCT
dpc-4022	155	16	by	by	ADP
dpc-4022	155	17	-	-	PUNCT
dpc-4022	155	18	cancer	cancer	NOUN
dpc-4022	155	19	-	-	PUNCT
dpc-4022	155	20	type	type	NOUN
dpc-4022	155	21	/	/	SYM
dpc-4022	155	22	melanoma	melanoma	NOUN
dpc-4022	155	23	-	-	PUNCT
dpc-4022	155	24	skin	skin	NOUN
dpc-4022	155	25	-	-	PUNCT
dpc-4022	155	26	cancer	cancer	NOUN
dpc-4022	155	27	/	/	SYM
dpc-4022	155	28	incidence#ref-1	incidence#ref-1	PROPN
dpc-4022	155	29	.	.	PUNCT
dpc-4022	156	1	accessed	access	VERB
dpc-4022	156	2	november	november	PROPN
dpc-4022	156	3	1st	1st	NOUN
dpc-4022	156	4	,	,	PUNCT
dpc-4022	156	5	2023	2023	NUM
dpc-4022	156	6	8	8	NUM
dpc-4022	156	7	.	.	PUNCT
dpc-4022	157	1	paulson	paulson	PROPN
dpc-4022	157	2	kg	kg	PROPN
dpc-4022	157	3	,	,	PUNCT
dpc-4022	157	4	gupta	gupta	PROPN
dpc-4022	157	5	d	d	PROPN
dpc-4022	157	6	,	,	PUNCT
dpc-4022	157	7	kim	kim	PROPN
dpc-4022	157	8	ts	ts	PROPN
dpc-4022	157	9	,	,	PUNCT
dpc-4022	157	10	et	et	PROPN
dpc-4022	157	11	al	al	PROPN
dpc-4022	157	12	.	.	PUNCT
dpc-4022	157	13	age	age	NOUN
dpc-4022	157	14	-	-	PUNCT
dpc-4022	157	15	specific	specific	ADJ
dpc-4022	157	16	incidence	incidence	NOUN
dpc-4022	157	17	of	of	ADP
dpc-4022	157	18	melanoma	melanoma	NOUN
dpc-4022	157	19	in	in	ADP
dpc-4022	157	20	the	the	DET
dpc-4022	157	21	united	united	PROPN
dpc-4022	157	22	states	states	PROPN
dpc-4022	157	23	.	.	PUNCT
dpc-4022	158	1	jama	jama	PROPN
dpc-4022	158	2	dermatol	dermatol	NOUN
dpc-4022	158	3	.	.	PUNCT
dpc-4022	159	1	2020	2020	NUM
dpc-4022	159	2	;	;	PUNCT
dpc-4022	159	3	156(1):57	156(1):57	NUM
dpc-4022	159	4	-	-	SYM
dpc-4022	159	5	64	64	NUM
dpc-4022	159	6	.	.	PUNCT
dpc-4022	160	1	pmid	pmid	NOUN
dpc-4022	160	2	:	:	PUNCT
dpc-4022	160	3	 	 	SPACE
dpc-4022	160	4	31721989	31721989	NUM
dpc-4022	160	5	9	9	NUM
dpc-4022	160	6	.	.	PUNCT
dpc-4022	161	1	forsea	forsea	PROPN
dpc-4022	161	2	am	am	PROPN
dpc-4022	161	3	.	.	PUNCT
dpc-4022	162	1	melanoma	melanoma	NOUN
dpc-4022	162	2	epidemiology	epidemiology	NOUN
dpc-4022	162	3	and	and	CCONJ
dpc-4022	162	4	early	early	ADJ
dpc-4022	162	5	detection	detection	NOUN
dpc-4022	162	6	in	in	ADP
dpc-4022	162	7	europe	europe	PROPN
dpc-4022	162	8	:	:	PUNCT
dpc-4022	162	9	diversity	diversity	NOUN
dpc-4022	162	10	and	and	CCONJ
dpc-4022	162	11	disparities	disparity	NOUN
dpc-4022	162	12	.	.	PUNCT
dpc-4022	163	1	dermatol	dermatol	NOUN
dpc-4022	163	2	pract	pract	PROPN
dpc-4022	163	3	concept	concept	NOUN
dpc-4022	163	4	.	.	PUNCT
dpc-4022	164	1	2020;10(3):e2020033	2020;10(3):e2020033	NUM
dpc-4022	164	2	.	.	PUNCT
dpc-4022	165	1	pmid	pmid	NOUN
dpc-4022	165	2	:	:	PUNCT
dpc-4022	165	3	 	 	SPACE
dpc-4022	165	4	32642304	32642304	NUM
dpc-4022	165	5	10	10	NUM
dpc-4022	165	6	.	.	PUNCT
dpc-4022	166	1	olsen	olsen	PROPN
dpc-4022	166	2	cm	cm	PROPN
dpc-4022	166	3	,	,	PUNCT
dpc-4022	166	4	thompson	thompson	PROPN
dpc-4022	166	5	jf	jf	PROPN
dpc-4022	166	6	,	,	PUNCT
dpc-4022	166	7	pandeya	pandeya	PROPN
dpc-4022	166	8	n	n	PROPN
dpc-4022	166	9	,	,	PUNCT
dpc-4022	166	10	whiteman	whiteman	PROPN
dpc-4022	166	11	dc	dc	PROPN
dpc-4022	166	12	.	.	PUNCT
dpc-4022	166	13	evaluation	evaluation	NOUN
dpc-4022	166	14	of	of	ADP
dpc-4022	166	15	sex	sex	NOUN
dpc-4022	166	16	-	-	PUNCT
dpc-4022	166	17	specific	specific	ADJ
dpc-4022	166	18	incidence	incidence	NOUN
dpc-4022	166	19	of	of	ADP
dpc-4022	166	20	melanoma	melanoma	NOUN
dpc-4022	166	21	.	.	PUNCT
dpc-4022	167	1	jama	jama	PROPN
dpc-4022	167	2	dermatol	dermatol	NOUN
dpc-4022	167	3	.	.	PUNCT
dpc-4022	168	1	2020;156(5):553	2020;156(5):553	NOUN
dpc-4022	168	2	-	-	PUNCT
dpc-4022	168	3	60.pmid	60.pmid	NUM
dpc-4022	168	4	:	:	PUNCT
dpc-4022	168	5	32401272	32401272	NUM
dpc-4022	168	6	11	11	NUM
dpc-4022	168	7	.	.	PUNCT
dpc-4022	169	1	marks	marks	PROPN
dpc-4022	169	2	r.	r.	PROPN
dpc-4022	169	3	the	the	DET
dpc-4022	169	4	changing	change	VERB
dpc-4022	169	5	incidence	incidence	NOUN
dpc-4022	169	6	and	and	CCONJ
dpc-4022	169	7	mortality	mortality	NOUN
dpc-4022	169	8	of	of	ADP
dpc-4022	169	9	melanoma	melanoma	NOUN
dpc-4022	169	10	in	in	ADP
dpc-4022	169	11	australia	australia	PROPN
dpc-4022	169	12	.	.	PUNCT
dpc-4022	170	1	recent	recent	ADJ
dpc-4022	170	2	results	result	NOUN
dpc-4022	170	3	cancer	cancer	NOUN
dpc-4022	170	4	res	re	NOUN
dpc-4022	170	5	.	.	PUNCT
dpc-4022	171	1	2002;160:113	2002;160:113	NUM
dpc-4022	171	2	-	-	PUNCT
dpc-4022	171	3	21.pmid	21.pmid	NUM
dpc-4022	171	4	:	:	PUNCT
dpc-4022	171	5	12079205	12079205	NUM
dpc-4022	171	6	12	12	NUM
dpc-4022	171	7	.	.	PUNCT
dpc-4022	172	1	bolognia	bolognia	PROPN
dpc-4022	172	2	jl	jl	PROPN
dpc-4022	172	3	,	,	PUNCT
dpc-4022	172	4	schaffer	schaffer	PROPN
dpc-4022	172	5	jv	jv	PROPN
dpc-4022	172	6	.	.	PROPN
dpc-4022	172	7	dermatology	dermatology	NOUN
dpc-4022	172	8	.	.	PUNCT
dpc-4022	173	1	4th	4th	ADJ
dpc-4022	173	2	ed2018	ed2018	NOUN
dpc-4022	173	3	2008	2008	NUM
dpc-4022	173	4	-	-	SYM
dpc-4022	173	5	9	9	NUM
dpc-4022	173	6	p.	p.	NOUN
dpc-4022	173	7	13	13	NUM
dpc-4022	173	8	.	.	PUNCT
dpc-4022	174	1	del	del	PROPN
dpc-4022	174	2	fiore	fiore	NOUN
dpc-4022	174	3	p	p	X
dpc-4022	174	4	,	,	PUNCT
dpc-4022	174	5	rastrelli	rastrelli	PROPN
dpc-4022	174	6	m	m	PROPN
dpc-4022	174	7	,	,	PUNCT
dpc-4022	174	8	dall’olmo	dall’olmo	VERB
dpc-4022	174	9	l	l	NOUN
dpc-4022	174	10	,	,	PUNCT
dpc-4022	174	11	et	et	PROPN
dpc-4022	174	12	al	al	PROPN
dpc-4022	174	13	.	.	PUNCT
dpc-4022	175	1	melanoma	melanoma	PROPN
dpc-4022	175	2	of	of	ADP
dpc-4022	175	3	unknown	unknown	ADJ
dpc-4022	175	4	primary	primary	NOUN
dpc-4022	175	5	:	:	PUNCT
dpc-4022	175	6	evaluation	evaluation	NOUN
dpc-4022	175	7	of	of	ADP
dpc-4022	175	8	the	the	DET
dpc-4022	175	9	characteristics	characteristic	NOUN
dpc-4022	175	10	,	,	PUNCT
dpc-4022	175	11	treatment	treatment	NOUN
dpc-4022	175	12	strategies	strategy	NOUN
dpc-4022	175	13	,	,	PUNCT
dpc-4022	175	14	prognostic	prognostic	ADJ
dpc-4022	175	15	factors	factor	NOUN
dpc-4022	175	16	in	in	ADP
dpc-4022	175	17	a	a	DET
dpc-4022	175	18	monocentric	monocentric	ADJ
dpc-4022	175	19	retrospective	retrospective	ADJ
dpc-4022	175	20	study	study	NOUN
dpc-4022	175	21	.	.	PUNCT
dpc-4022	176	1	front	front	ADJ
dpc-4022	176	2	oncol	oncol	ADJ
dpc-4022	176	3	.	.	PUNCT
dpc-4022	177	1	2021;11:627527.pmid	2021;11:627527.pmid	NUM
dpc-4022	177	2	:	:	PUNCT
dpc-4022	177	3	33747946	33747946	NUM
dpc-4022	177	4	14	14	NUM
dpc-4022	177	5	.	.	PUNCT
dpc-4022	178	1	chang	chang	PROPN
dpc-4022	178	2	ae	ae	PROPN
dpc-4022	178	3	,	,	PUNCT
dpc-4022	178	4	karnell	karnell	PROPN
dpc-4022	178	5	lh	lh	PROPN
dpc-4022	178	6	,	,	PUNCT
dpc-4022	178	7	menck	menck	NOUN
dpc-4022	178	8	hr	hr	PROPN
dpc-4022	178	9	.	.	PUNCT
dpc-4022	179	1	the	the	DET
dpc-4022	179	2	national	national	PROPN
dpc-4022	179	3	cancer	cancer	PROPN
dpc-4022	179	4	data	data	PROPN
dpc-4022	179	5	base	base	PROPN
dpc-4022	179	6	report	report	NOUN
dpc-4022	179	7	on	on	ADP
dpc-4022	179	8	cutaneous	cutaneous	ADJ
dpc-4022	179	9	and	and	CCONJ
dpc-4022	179	10	noncutaneous	noncutaneous	ADJ
dpc-4022	179	11	melanoma	melanoma	NOUN
dpc-4022	179	12	:	:	PUNCT
dpc-4022	179	13	a	a	DET
dpc-4022	179	14	summary	summary	NOUN
dpc-4022	179	15	of	of	ADP
dpc-4022	179	16	84,836	84,836	NUM
dpc-4022	179	17	cases	case	NOUN
dpc-4022	179	18	from	from	ADP
dpc-4022	179	19	the	the	DET
dpc-4022	179	20	past	past	ADJ
dpc-4022	179	21	decade	decade	NOUN
dpc-4022	179	22	.	.	PUNCT
dpc-4022	180	1	the	the	DET
dpc-4022	180	2	american	american	PROPN
dpc-4022	180	3	college	college	PROPN
dpc-4022	180	4	of	of	ADP
dpc-4022	180	5	surgeons	surgeon	NOUN
dpc-4022	180	6	commission	commission	NOUN
dpc-4022	180	7	on	on	ADP
dpc-4022	180	8	cancer	cancer	NOUN
dpc-4022	180	9	and	and	CCONJ
dpc-4022	180	10	the	the	DET
dpc-4022	180	11	american	american	ADJ
dpc-4022	180	12	cancer	cancer	NOUN
dpc-4022	180	13	society	society	NOUN
dpc-4022	180	14	.	.	PUNCT
dpc-4022	181	1	cancer	cancer	NOUN
dpc-4022	181	2	.	.	PUNCT
dpc-4022	182	1	1998;83(8):1664	1998;83(8):1664	NUM
dpc-4022	182	2	-	-	SYM
dpc-4022	182	3	78.pmid	78.pmid	NUM
dpc-4022	182	4	:	:	PUNCT
dpc-4022	182	5	9781962	9781962	NUM
dpc-4022	182	6	15	15	NUM
dpc-4022	182	7	.	.	PUNCT
dpc-4022	183	1	bradford	bradford	PROPN
dpc-4022	183	2	pt	pt	PROPN
dpc-4022	183	3	,	,	PUNCT
dpc-4022	183	4	goldstein	goldstein	PROPN
dpc-4022	183	5	am	am	PROPN
dpc-4022	183	6	,	,	PUNCT
dpc-4022	183	7	mcmaster	mcmaster	PROPN
dpc-4022	183	8	ml	ml	PROPN
dpc-4022	183	9	,	,	PUNCT
dpc-4022	183	10	tucker	tucker	PROPN
dpc-4022	183	11	ma	ma	PROPN
dpc-4022	183	12	.	.	PROPN
dpc-4022	183	13	acral	acral	ADJ
dpc-4022	183	14	lentiginous	lentiginous	ADJ
dpc-4022	183	15	melanoma	melanoma	NOUN
dpc-4022	183	16	:	:	PUNCT
dpc-4022	183	17	incidence	incidence	NOUN
dpc-4022	183	18	and	and	CCONJ
dpc-4022	183	19	survival	survival	NOUN
dpc-4022	183	20	patterns	pattern	NOUN
dpc-4022	183	21	in	in	ADP
dpc-4022	183	22	the	the	DET
dpc-4022	183	23	united	united	PROPN
dpc-4022	183	24	states	states	PROPN
dpc-4022	183	25	,	,	PUNCT
dpc-4022	183	26	1986	1986	NUM
dpc-4022	183	27	-	-	SYM
dpc-4022	183	28	2005	2005	NUM
dpc-4022	183	29	.	.	PUNCT
dpc-4022	184	1	arch	arch	ADJ
dpc-4022	184	2	dermatol	dermatol	NOUN
dpc-4022	184	3	.	.	PUNCT
dpc-4022	185	1	2009;145(4):427	2009;145(4):427	NUM
dpc-4022	185	2	-	-	SYM
dpc-4022	185	3	34	34	NUM
dpc-4022	185	4	.	.	PUNCT
dpc-4022	186	1	pmid	pmid	NOUN
dpc-4022	186	2	:	:	PUNCT
dpc-4022	186	3	19380664	19380664	NUM
dpc-4022	186	4	16	16	NUM
dpc-4022	186	5	.	.	PUNCT
dpc-4022	186	6	stanienda	stanienda	NOUN
dpc-4022	186	7	-	-	PUNCT
dpc-4022	186	8	sokół	sokół	NOUN
dpc-4022	186	9	k	k	PROPN
dpc-4022	186	10	,	,	PUNCT
dpc-4022	186	11	salwowska	salwowska	ADJ
dpc-4022	186	12	n	n	CCONJ
dpc-4022	186	13	,	,	PUNCT
dpc-4022	186	14	sławińska	sławińska	NOUN
dpc-4022	186	15	m	m	PROPN
dpc-4022	186	16	,	,	PUNCT
dpc-4022	186	17	al	al	PROPN
dpc-4022	186	18	.	.	PROPN
dpc-4022	186	19	e.	e.	PROPN
dpc-4022	186	20	primary	primary	PROPN
dpc-4022	186	21	locations	location	NOUN
dpc-4022	186	22	of	of	ADP
dpc-4022	186	23	malignant	malignant	ADJ
dpc-4022	186	24	melanoma	melanoma	NOUN
dpc-4022	186	25	lesions	lesion	NOUN
dpc-4022	186	26	depending	depend	VERB
dpc-4022	186	27	on	on	ADP
dpc-4022	186	28	patients	patient	NOUN
dpc-4022	186	29	’	'	PUNCT
dpc-4022	186	30	gender	gender	NOUN
dpc-4022	186	31	and	and	CCONJ
dpc-4022	186	32	age	age	NOUN
dpc-4022	186	33	.	.	PUNCT
dpc-4022	187	1	asian	asian	PROPN
dpc-4022	187	2	pac	pac	PROPN
dpc-4022	187	3	j	j	PROPN
dpc-4022	187	4	cancer	cancer	NOUN
dpc-4022	187	5	prev	prev	X
dpc-4022	187	6	.	.	PUNCT
dpc-4022	188	1	2017;18(11):3081	2017;18(11):3081	NUM
dpc-4022	188	2	-	-	SYM
dpc-4022	188	3	6	6	NUM
dpc-4022	188	4	.	.	PUNCT
dpc-4022	189	1	pmid	pmid	NOUN
dpc-4022	189	2	:	:	PUNCT
dpc-4022	189	3	29172282	29172282	NUM
dpc-4022	189	4	17	17	NUM
dpc-4022	189	5	.	.	PUNCT
dpc-4022	190	1	kruijff	kruijff	PROPN
dpc-4022	190	2	s	s	PROPN
dpc-4022	190	3	,	,	PUNCT
dpc-4022	190	4	bastiaannet	bastiaannet	NOUN
dpc-4022	190	5	e	e	NOUN
dpc-4022	190	6	,	,	PUNCT
dpc-4022	190	7	francken	francken	PROPN
dpc-4022	190	8	ab	ab	PROPN
dpc-4022	190	9	,	,	PUNCT
dpc-4022	190	10	et	et	PROPN
dpc-4022	190	11	al	al	PROPN
dpc-4022	190	12	.	.	PUNCT
dpc-4022	191	1	breslow	breslow	ADJ
dpc-4022	191	2	thickness	thickness	NOUN
dpc-4022	191	3	in	in	ADP
dpc-4022	191	4	the	the	DET
dpc-4022	191	5	netherlands	netherlands	PROPN
dpc-4022	191	6	:	:	PUNCT
dpc-4022	191	7	a	a	DET
dpc-4022	191	8	population	population	NOUN
dpc-4022	191	9	-	-	PUNCT
dpc-4022	191	10	based	base	VERB
dpc-4022	191	11	study	study	NOUN
dpc-4022	191	12	of	of	ADP
dpc-4022	191	13	40	40	NUM
dpc-4022	191	14	880	880	NUM
dpc-4022	191	15	patients	patient	NOUN
dpc-4022	191	16	comparing	compare	VERB
dpc-4022	191	17	young	young	ADJ
dpc-4022	191	18	and	and	CCONJ
dpc-4022	191	19	elderly	elderly	ADJ
dpc-4022	191	20	patients	patient	NOUN
dpc-4022	191	21	.	.	PUNCT
dpc-4022	192	1	br	br	PROPN
dpc-4022	192	2	j	j	PROPN
dpc-4022	192	3	cancer	cancer	NOUN
dpc-4022	192	4	.	.	PUNCT
dpc-4022	193	1	2012;107(3	2012;107(3	NUM
dpc-4022	193	2	):	):	PUNCT
dpc-4022	194	1	570-4.pmid	570-4.pmid	NUM
dpc-4022	194	2	:	:	SYM
dpc-4022	194	3	22713665	22713665	NUM
dpc-4022	194	4	18	18	NUM
dpc-4022	194	5	.	.	PUNCT
dpc-4022	195	1	bellenghi	bellenghi	PROPN
dpc-4022	195	2	m	m	PROPN
dpc-4022	195	3	,	,	PUNCT
dpc-4022	195	4	puglisi	puglisi	VERB
dpc-4022	195	5	r	r	NOUN
dpc-4022	195	6	,	,	PUNCT
dpc-4022	195	7	pontecorvi	pontecorvi	VERB
dpc-4022	195	8	g	g	PROPN
dpc-4022	195	9	,	,	PUNCT
dpc-4022	196	1	al	al	PROPN
dpc-4022	196	2	.	.	PROPN
dpc-4022	196	3	e.	e.	PROPN
dpc-4022	196	4	sex	sex	PROPN
dpc-4022	196	5	and	and	CCONJ
dpc-4022	196	6	gender	gender	NOUN
dpc-4022	196	7	disparities	disparity	NOUN
dpc-4022	196	8	in	in	ADP
dpc-4022	196	9	melanoma	melanoma	NOUN
dpc-4022	196	10	.	.	PUNCT
dpc-4022	197	1	cancers	cancer	NOUN
dpc-4022	197	2	(	(	PUNCT
dpc-4022	197	3	basel	basel	PROPN
dpc-4022	197	4	)	)	PUNCT
dpc-4022	197	5	.	.	PUNCT
dpc-4022	198	1	2020;12(7	2020;12(7	NUM
dpc-4022	198	2	)	)	PUNCT
dpc-4022	198	3	.	.	PUNCT
dpc-4022	199	1	pmid	pmid	NOUN
dpc-4022	199	2	:	:	PUNCT
dpc-4022	199	3	32645881	32645881	NUM
dpc-4022	199	4	19	19	NUM
dpc-4022	199	5	.	.	PUNCT
dpc-4022	199	6	marek	marek	PROPN
dpc-4022	199	7	aj	aj	PROPN
dpc-4022	199	8	,	,	PUNCT
dpc-4022	199	9	ming	me	VERB
dpc-4022	199	10	me	i	PRON
dpc-4022	199	11	,	,	PUNCT
dpc-4022	199	12	bartlett	bartlett	PROPN
dpc-4022	199	13	ek	ek	PROPN
dpc-4022	199	14	,	,	PUNCT
dpc-4022	199	15	karakousis	karakousis	PROPN
dpc-4022	199	16	gc	gc	PROPN
dpc-4022	199	17	,	,	PUNCT
dpc-4022	199	18	chu	chu	PROPN
dpc-4022	199	19	ey	ey	PROPN
dpc-4022	199	20	.	.	PROPN
dpc-4022	199	21	acral	acral	ADJ
dpc-4022	199	22	lentiginous	lentiginous	ADJ
dpc-4022	199	23	histologic	histologic	ADJ
dpc-4022	199	24	subtype	subtype	NOUN
dpc-4022	199	25	and	and	CCONJ
dpc-4022	199	26	sentinel	sentinel	NOUN
dpc-4022	199	27	lymph	lymph	NOUN
dpc-4022	199	28	node	node	NOUN
dpc-4022	199	29	positivity	positivity	NOUN
dpc-4022	199	30	in	in	ADP
dpc-4022	199	31	thin	thin	ADJ
dpc-4022	199	32	melanoma	melanoma	NOUN
dpc-4022	199	33	.	.	PUNCT
dpc-4022	200	1	jama	jama	PROPN
dpc-4022	200	2	dermatol	dermatol	NOUN
dpc-4022	200	3	.	.	PUNCT
dpc-4022	201	1	2016;152(7):836	2016;152(7):836	NUM
dpc-4022	201	2	-	-	SYM
dpc-4022	201	3	7	7	NUM
dpc-4022	201	4	.	.	PUNCT
dpc-4022	202	1	pmid	pmid	NOUN
dpc-4022	202	2	:	:	PUNCT
dpc-4022	202	3	27096552	27096552	NUM
dpc-4022	202	4	referral	referral	ADJ
dpc-4022	202	5	hospitals	hospital	NOUN
dpc-4022	202	6	,	,	PUNCT
dpc-4022	202	7	particularly	particularly	ADV
dpc-4022	202	8	within	within	ADP
dpc-4022	202	9	oncology	oncology	NOUN
dpc-4022	202	10	and	and	CCONJ
dpc-4022	202	11	dermatology	dermatology	NOUN
dpc-4022	202	12	departments	department	NOUN
dpc-4022	202	13	[	[	X
dpc-4022	202	14	2	2	NUM
dpc-4022	202	15	-	-	SYM
dpc-4022	202	16	5	5	NUM
dpc-4022	202	17	]	]	PUNCT
dpc-4022	202	18	.	.	PUNCT
dpc-4022	203	1	based	base	VERB
dpc-4022	203	2	on	on	ADP
dpc-4022	203	3	melanoma	melanoma	NOUN
dpc-4022	203	4	patients	patient	NOUN
dpc-4022	203	5	diagnosed	diagnose	VERB
dpc-4022	203	6	in	in	ADP
dpc-4022	203	7	the	the	DET
dpc-4022	203	8	usa	usa	PROPN
dpc-4022	203	9	between	between	ADP
dpc-4022	203	10	2012	2012	NUM
dpc-4022	203	11	and	and	CCONJ
dpc-4022	203	12	2018	2018	NUM
dpc-4022	203	13	,	,	PUNCT
dpc-4022	203	14	according	accord	VERB
dpc-4022	203	15	to	to	ADP
dpc-4022	203	16	the	the	DET
dpc-4022	203	17	seer	seer	NOUN
dpc-4022	203	18	[	[	X
dpc-4022	203	19	surveillance	surveillance	NOUN
dpc-4022	203	20	,	,	PUNCT
dpc-4022	203	21	epidemiology	epidemiology	NOUN
dpc-4022	203	22	,	,	PUNCT
dpc-4022	203	23	and	and	CCONJ
dpc-4022	203	24	end	end	VERB
dpc-4022	203	25	results	result	NOUN
dpc-4022	203	26	]	]	PUNCT
dpc-4022	203	27	data	datum	NOUN
dpc-4022	203	28	of	of	ADP
dpc-4022	203	29	the	the	DET
dpc-4022	203	30	american	american	ADJ
dpc-4022	203	31	cancer	cancer	NOUN
dpc-4022	203	32	society	society	NOUN
dpc-4022	203	33	,	,	PUNCT
dpc-4022	203	34	the	the	DET
dpc-4022	203	35	5	5	NUM
dpc-4022	203	36	-	-	PUNCT
dpc-4022	203	37	year	year	NOUN
dpc-4022	203	38	relative	relative	ADJ
dpc-4022	203	39	survival	survival	NOUN
dpc-4022	203	40	rate	rate	NOUN
dpc-4022	203	41	in	in	ADP
dpc-4022	203	42	the	the	DET
dpc-4022	203	43	localized	localized	ADJ
dpc-4022	203	44	stage	stage	NOUN
dpc-4022	203	45	is	be	AUX
dpc-4022	203	46	99	99	NUM
dpc-4022	203	47	%	%	NOUN
dpc-4022	203	48	,	,	PUNCT
dpc-4022	203	49	71	71	NUM
dpc-4022	203	50	%	%	NOUN
dpc-4022	203	51	in	in	ADP
dpc-4022	203	52	the	the	DET
dpc-4022	203	53	regional	regional	ADJ
dpc-4022	203	54	,	,	PUNCT
dpc-4022	203	55	and	and	CCONJ
dpc-4022	203	56	32	32	NUM
dpc-4022	203	57	%	%	NOUN
dpc-4022	203	58	in	in	ADP
dpc-4022	203	59	the	the	DET
dpc-4022	203	60	distant	distant	ADJ
dpc-4022	203	61	stage	stage	NOUN
dpc-4022	203	62	,	,	PUNCT
dpc-4022	203	63	respectively	respectively	ADV
dpc-4022	203	64	[	[	X
dpc-4022	203	65	22	22	NUM
dpc-4022	203	66	]	]	PUNCT
dpc-4022	203	67	.	.	PUNCT
dpc-4022	204	1	in	in	ADP
dpc-4022	204	2	the	the	DET
dpc-4022	204	3	context	context	NOUN
dpc-4022	204	4	of	of	ADP
dpc-4022	204	5	global	global	ADJ
dpc-4022	204	6	melanoma	melanoma	PROPN
dpc-4022	204	7	survival	survival	PROPN
dpc-4022	204	8	studies	study	NOUN
dpc-4022	204	9	,	,	PUNCT
dpc-4022	204	10	several	several	ADJ
dpc-4022	204	11	factors	factor	NOUN
dpc-4022	204	12	consistently	consistently	ADV
dpc-4022	204	13	emerge	emerge	VERB
dpc-4022	204	14	as	as	ADP
dpc-4022	204	15	adverse	adverse	ADJ
dpc-4022	204	16	prognostic	prognostic	ADJ
dpc-4022	204	17	indicators	indicator	NOUN
dpc-4022	204	18	for	for	ADP
dpc-4022	204	19	survival	survival	NOUN
dpc-4022	204	20	,	,	PUNCT
dpc-4022	204	21	including	include	VERB
dpc-4022	204	22	age	age	NOUN
dpc-4022	204	23	,	,	PUNCT
dpc-4022	204	24	male	male	ADJ
dpc-4022	204	25	gender	gender	NOUN
dpc-4022	204	26	,	,	PUNCT
dpc-4022	204	27	breslow	breslow	NOUN
dpc-4022	204	28	thickness	thickness	NOUN
dpc-4022	204	29	,	,	PUNCT
dpc-4022	204	30	advanced	advanced	ADJ
dpc-4022	204	31	disease	disease	NOUN
dpc-4022	204	32	stage	stage	NOUN
dpc-4022	204	33	,	,	PUNCT
dpc-4022	204	34	the	the	DET
dpc-4022	204	35	presence	presence	NOUN
dpc-4022	204	36	of	of	ADP
dpc-4022	204	37	ulceration	ulceration	NOUN
dpc-4022	204	38	,	,	PUNCT
dpc-4022	204	39	and	and	CCONJ
dpc-4022	204	40	the	the	DET
dpc-4022	204	41	localization	localization	NOUN
dpc-4022	204	42	of	of	ADP
dpc-4022	204	43	tumors	tumor	NOUN
dpc-4022	204	44	on	on	ADP
dpc-4022	204	45	the	the	DET
dpc-4022	204	46	trunk	trunk	NOUN
dpc-4022	204	47	and	and	CCONJ
dpc-4022	204	48	head	head	NOUN
dpc-4022	204	49	-	-	PUNCT
dpc-4022	204	50	neck	neck	NOUN
dpc-4022	204	51	regions	region	NOUN
dpc-4022	204	52	[	[	X
dpc-4022	204	53	12	12	NUM
dpc-4022	204	54	]	]	PUNCT
dpc-4022	204	55	.	.	PUNCT
dpc-4022	205	1	however	however	ADV
dpc-4022	205	2	,	,	PUNCT
dpc-4022	205	3	the	the	DET
dpc-4022	205	4	results	result	NOUN
dpc-4022	205	5	of	of	ADP
dpc-4022	205	6	our	our	PRON
dpc-4022	205	7	study	study	NOUN
dpc-4022	205	8	deviate	deviate	NOUN
dpc-4022	205	9	from	from	ADP
dpc-4022	205	10	this	this	DET
dpc-4022	205	11	established	establish	VERB
dpc-4022	205	12	pattern	pattern	NOUN
dpc-4022	205	13	,	,	PUNCT
dpc-4022	205	14	as	as	SCONJ
dpc-4022	205	15	we	we	PRON
dpc-4022	205	16	found	find	VERB
dpc-4022	205	17	no	no	DET
dpc-4022	205	18	statistically	statistically	ADV
dpc-4022	205	19	significant	significant	ADJ
dpc-4022	205	20	difference	difference	NOUN
dpc-4022	205	21	in	in	ADP
dpc-4022	205	22	5	5	NUM
dpc-4022	205	23	-	-	PUNCT
dpc-4022	205	24	year	year	NOUN
dpc-4022	205	25	survival	survival	NOUN
dpc-4022	205	26	rates	rate	NOUN
dpc-4022	205	27	concerning	concern	VERB
dpc-4022	205	28	gender	gender	NOUN
dpc-4022	205	29	and	and	CCONJ
dpc-4022	205	30	localization	localization	NOUN
dpc-4022	205	31	characteristics	characteristic	NOUN
dpc-4022	205	32	of	of	ADP
dpc-4022	205	33	pcm	pcm	NOUN
dpc-4022	205	34	.	.	PUNCT
dpc-4022	206	1	instead	instead	ADV
dpc-4022	206	2	,	,	PUNCT
dpc-4022	206	3	the	the	DET
dpc-4022	206	4	results	result	NOUN
dpc-4022	206	5	align	align	VERB
dpc-4022	206	6	with	with	ADP
dpc-4022	206	7	existing	exist	VERB
dpc-4022	206	8	literature	literature	NOUN
dpc-4022	206	9	,	,	PUNCT
dpc-4022	206	10	underscoring	underscore	VERB
dpc-4022	206	11	the	the	DET
dpc-4022	206	12	significance	significance	NOUN
dpc-4022	206	13	of	of	ADP
dpc-4022	206	14	breslow	breslow	ADJ
dpc-4022	206	15	thickness	thickness	NOUN
dpc-4022	206	16	,	,	PUNCT
dpc-4022	206	17	the	the	DET
dpc-4022	206	18	presence	presence	NOUN
dpc-4022	206	19	of	of	ADP
dpc-4022	206	20	ulceration	ulceration	NOUN
dpc-4022	206	21	,	,	PUNCT
dpc-4022	206	22	advanced	advanced	ADJ
dpc-4022	206	23	disease	disease	NOUN
dpc-4022	206	24	stage	stage	NOUN
dpc-4022	206	25	,	,	PUNCT
dpc-4022	206	26	and	and	CCONJ
dpc-4022	206	27	patient	patient	ADJ
dpc-4022	206	28	age	age	NOUN
dpc-4022	206	29	as	as	ADP
dpc-4022	206	30	critical	critical	ADJ
dpc-4022	206	31	criteria	criterion	NOUN
dpc-4022	206	32	for	for	ADP
dpc-4022	206	33	predicting	predict	VERB
dpc-4022	206	34	poor	poor	ADJ
dpc-4022	206	35	prognosis	prognosis	NOUN
dpc-4022	206	36	.	.	PUNCT
dpc-4022	207	1	on	on	ADP
dpc-4022	207	2	the	the	DET
dpc-4022	207	3	other	other	ADJ
dpc-4022	207	4	hand	hand	NOUN
dpc-4022	207	5	,	,	PUNCT
dpc-4022	207	6	relatively	relatively	ADV
dpc-4022	207	7	higher	high	ADJ
dpc-4022	207	8	overall	overall	ADJ
dpc-4022	207	9	survival	survival	NOUN
dpc-4022	207	10	(	(	PUNCT
dpc-4022	207	11	35	35	NUM
dpc-4022	207	12	%	%	NOUN
dpc-4022	207	13	)	)	PUNCT
dpc-4022	207	14	for	for	ADP
dpc-4022	207	15	stage	stage	NOUN
dpc-4022	207	16	iv	iv	NUM
dpc-4022	207	17	patients	patient	NOUN
dpc-4022	207	18	may	may	AUX
dpc-4022	207	19	depend	depend	VERB
dpc-4022	207	20	on	on	ADP
dpc-4022	207	21	the	the	DET
dpc-4022	207	22	launch	launch	NOUN
dpc-4022	207	23	of	of	ADP
dpc-4022	207	24	new	new	ADJ
dpc-4022	207	25	therapeutic	therapeutic	ADJ
dpc-4022	207	26	agents	agent	NOUN
dpc-4022	207	27	(	(	PUNCT
dpc-4022	207	28	immunotherapies	immunotherapy	NOUN
dpc-4022	207	29	and	and	CCONJ
dpc-4022	207	30	targeted	target	VERB
dpc-4022	207	31	therapies	therapy	NOUN
dpc-4022	207	32	)	)	PUNCT
dpc-4022	207	33	in	in	ADP
dpc-4022	207	34	2015	2015	NUM
dpc-4022	207	35	,	,	PUNCT
dpc-4022	207	36	which	which	PRON
dpc-4022	207	37	positively	positively	ADV
dpc-4022	207	38	affected	affect	VERB
dpc-4022	207	39	the	the	DET
dpc-4022	207	40	survival	survival	NOUN
dpc-4022	207	41	of	of	ADP
dpc-4022	207	42	our	our	PRON
dpc-4022	207	43	patients	patient	NOUN
dpc-4022	207	44	whose	whose	DET
dpc-4022	207	45	data	datum	NOUN
dpc-4022	207	46	between	between	ADP
dpc-4022	207	47	2016	2016	NUM
dpc-4022	207	48	and	and	CCONJ
dpc-4022	207	49	2021	2021	NUM
dpc-4022	207	50	were	be	AUX
dpc-4022	207	51	studied	study	VERB
dpc-4022	207	52	.	.	PUNCT
dpc-4022	208	1	among	among	ADP
dpc-4022	208	2	the	the	DET
dpc-4022	208	3	recent	recent	ADJ
dpc-4022	208	4	studies	study	NOUN
dpc-4022	208	5	reported	report	VERB
dpc-4022	208	6	from	from	ADP
dpc-4022	208	7	the	the	DET
dpc-4022	208	8	uk	uk	PROPN
dpc-4022	208	9	,	,	PUNCT
dpc-4022	208	10	the	the	DET
dpc-4022	208	11	5	5	NUM
dpc-4022	208	12	-	-	PUNCT
dpc-4022	208	13	year	year	NOUN
dpc-4022	208	14	overall	overall	ADJ
dpc-4022	208	15	survival	survival	NOUN
dpc-4022	208	16	increases	increase	VERB
dpc-4022	208	17	up	up	ADV
dpc-4022	208	18	to	to	PART
dpc-4022	208	19	52	52	NUM
dpc-4022	208	20	%	%	NOUN
dpc-4022	208	21	in	in	ADP
dpc-4022	208	22	patients	patient	NOUN
dpc-4022	208	23	using	use	VERB
dpc-4022	208	24	current	current	ADJ
dpc-4022	208	25	promising	promising	ADJ
dpc-4022	208	26	treatments	treatment	NOUN
dpc-4022	208	27	such	such	ADJ
dpc-4022	208	28	as	as	ADP
dpc-4022	208	29	ipilimumab	ipilimumab	NOUN
dpc-4022	208	30	and	and	CCONJ
dpc-4022	208	31	nivolumab	nivolumab	NOUN
dpc-4022	208	32	[	[	X
dpc-4022	208	33	23	23	NUM
dpc-4022	208	34	]	]	PUNCT
dpc-4022	208	35	.	.	PUNCT
dpc-4022	209	1	it	it	PRON
dpc-4022	209	2	is	be	AUX
dpc-4022	209	3	predicted	predict	VERB
dpc-4022	209	4	that	that	SCONJ
dpc-4022	209	5	in	in	ADP
dpc-4022	209	6	the	the	DET
dpc-4022	209	7	future	future	NOUN
dpc-4022	209	8	,	,	PUNCT
dpc-4022	209	9	more	more	ADV
dpc-4022	209	10	updated	update	VERB
dpc-4022	209	11	seer	seer	NOUN
dpc-4022	209	12	data	datum	NOUN
dpc-4022	209	13	will	will	AUX
dpc-4022	209	14	report	report	VERB
dpc-4022	209	15	an	an	DET
dpc-4022	209	16	increase	increase	NOUN
dpc-4022	209	17	in	in	ADP
dpc-4022	209	18	the	the	DET
dpc-4022	209	19	5	5	NUM
dpc-4022	209	20	-	-	PUNCT
dpc-4022	209	21	year	year	NOUN
dpc-4022	209	22	survival	survival	NOUN
dpc-4022	209	23	rate	rate	NOUN
dpc-4022	209	24	of	of	ADP
dpc-4022	209	25	iv	iv	NUM
dpc-4022	209	26	stage	stage	NOUN
dpc-4022	209	27	melanoma	melanoma	NOUN
dpc-4022	209	28	patients	patient	NOUN
dpc-4022	209	29	[	[	X
dpc-4022	209	30	22	22	NUM
dpc-4022	209	31	]	]	PUNCT
dpc-4022	209	32	.	.	PUNCT
dpc-4022	210	1	the	the	DET
dpc-4022	210	2	results	result	NOUN
dpc-4022	210	3	of	of	ADP
dpc-4022	210	4	this	this	DET
dpc-4022	210	5	study	study	NOUN
dpc-4022	210	6	show	show	VERB
dpc-4022	210	7	that	that	SCONJ
dpc-4022	210	8	patients	patient	NOUN
dpc-4022	210	9	with	with	ADP
dpc-4022	210	10	pcm	pcm	NOUN
dpc-4022	210	11	followed	follow	VERB
dpc-4022	210	12	up	up	ADP
dpc-4022	210	13	in	in	ADP
dpc-4022	210	14	one	one	NUM
dpc-4022	210	15	of	of	ADP
dpc-4022	210	16	the	the	DET
dpc-4022	210	17	referral	referral	ADJ
dpc-4022	210	18	health	health	NOUN
dpc-4022	210	19	centers	center	NOUN
dpc-4022	210	20	of	of	ADP
dpc-4022	210	21	turkey	turkey	PROPN
dpc-4022	210	22	have	have	VERB
dpc-4022	210	23	a	a	DET
dpc-4022	210	24	relatively	relatively	ADV
dpc-4022	210	25	young	young	ADJ
dpc-4022	210	26	age	age	NOUN
dpc-4022	210	27	at	at	ADP
dpc-4022	210	28	melanoma	melanoma	ADJ
dpc-4022	210	29	diagnosis	diagnosis	NOUN
dpc-4022	210	30	,	,	PUNCT
dpc-4022	210	31	frequent	frequent	ADJ
dpc-4022	210	32	presence	presence	NOUN
dpc-4022	210	33	of	of	ADP
dpc-4022	210	34	thick	thick	ADJ
dpc-4022	210	35	tumor	tumor	NOUN
dpc-4022	210	36	(	(	PUNCT
dpc-4022	210	37	>	>	SYM
dpc-4022	210	38	4	4	NUM
dpc-4022	210	39	mm	mm	NOUN
dpc-4022	210	40	)	)	PUNCT
dpc-4022	210	41	,	,	PUNCT
dpc-4022	210	42	and	and	CCONJ
dpc-4022	210	43	frequent	frequent	ADJ
dpc-4022	210	44	alm	alm	NOUN
dpc-4022	210	45	subtype	subtype	NOUN
dpc-4022	210	46	.	.	PUNCT
dpc-4022	211	1	all	all	DET
dpc-4022	211	2	these	these	DET
dpc-4022	211	3	data	datum	NOUN
dpc-4022	211	4	suggest	suggest	VERB
dpc-4022	211	5	that	that	SCONJ
dpc-4022	211	6	patients	patient	NOUN
dpc-4022	211	7	might	might	AUX
dpc-4022	211	8	have	have	AUX
dpc-4022	211	9	experienced	experience	VERB
dpc-4022	211	10	critical	critical	ADJ
dpc-4022	211	11	environmental	environmental	ADJ
dpc-4022	211	12	triggers	trigger	NOUN
dpc-4022	211	13	such	such	ADJ
dpc-4022	211	14	as	as	ADP
dpc-4022	211	15	intense	intense	ADJ
dpc-4022	211	16	ultraviolet	ultraviolet	ADJ
dpc-4022	211	17	exposure	exposure	NOUN
dpc-4022	211	18	from	from	ADP
dpc-4022	211	19	a	a	DET
dpc-4022	211	20	very	very	ADV
dpc-4022	211	21	young	young	ADJ
dpc-4022	211	22	age	age	NOUN
dpc-4022	211	23	,	,	PUNCT
dpc-4022	211	24	living	live	VERB
dpc-4022	211	25	in	in	ADP
dpc-4022	211	26	a	a	DET
dpc-4022	211	27	country	country	NOUN
dpc-4022	211	28	with	with	ADP
dpc-4022	211	29	relatively	relatively	ADV
dpc-4022	211	30	long	long	ADJ
dpc-4022	211	31	and	and	CCONJ
dpc-4022	211	32	sunny	sunny	ADJ
dpc-4022	211	33	days	day	NOUN
dpc-4022	211	34	,	,	PUNCT
dpc-4022	211	35	climate	climate	NOUN
dpc-4022	211	36	changes	change	NOUN
dpc-4022	211	37	,	,	PUNCT
dpc-4022	211	38	and	and	CCONJ
dpc-4022	211	39	ignorance	ignorance	NOUN
dpc-4022	211	40	of	of	ADP
dpc-4022	211	41	effective	effective	ADJ
dpc-4022	211	42	protective	protective	ADJ
dpc-4022	211	43	behaviors	behavior	NOUN
dpc-4022	211	44	from	from	ADP
dpc-4022	211	45	sunlight	sunlight	NOUN
dpc-4022	211	46	.	.	PUNCT
dpc-4022	212	1	future	future	ADJ
dpc-4022	212	2	studies	study	NOUN
dpc-4022	212	3	comprehensively	comprehensively	ADV
dpc-4022	212	4	analyzing	analyze	VERB
dpc-4022	212	5	the	the	DET
dpc-4022	212	6	risk	risk	NOUN
dpc-4022	212	7	factors	factor	NOUN
dpc-4022	212	8	of	of	ADP
dpc-4022	212	9	the	the	DET
dpc-4022	212	10	patients	patient	NOUN
dpc-4022	212	11	are	be	AUX
dpc-4022	212	12	needed	need	VERB
dpc-4022	212	13	especially	especially	ADV
dpc-4022	212	14	for	for	ADP
dpc-4022	212	15	alm	alm	NOUN
dpc-4022	212	16	,	,	PUNCT
dpc-4022	212	17	that	that	PRON
dpc-4022	212	18	is	be	AUX
dpc-4022	212	19	an	an	DET
dpc-4022	212	20	histopathological	histopathological	ADJ
dpc-4022	212	21	subtype	subtype	NOUN
dpc-4022	212	22	with	with	ADP
dpc-4022	212	23	an	an	DET
dpc-4022	212	24	etiology	etiology	NOUN
dpc-4022	212	25	less	less	ADV
dpc-4022	212	26	related	relate	VERB
dpc-4022	212	27	to	to	ADP
dpc-4022	212	28	acute	acute	VERB
dpc-4022	212	29	and	and	CCONJ
dpc-4022	212	30	chronic	chronic	ADJ
dpc-4022	212	31	sun	sun	NOUN
dpc-4022	212	32	exposure	exposure	NOUN
dpc-4022	212	33	.	.	PUNCT
dpc-4022	213	1	references	reference	NOUN
dpc-4022	213	2	1	1	NUM
dpc-4022	213	3	.	.	PUNCT
dpc-4022	214	1	surveillance	surveillance	NOUN
dpc-4022	214	2	,	,	PUNCT
dpc-4022	214	3	epidemiology	epidemiology	NOUN
dpc-4022	214	4	,	,	PUNCT
dpc-4022	214	5	and	and	CCONJ
dpc-4022	214	6	end	end	VERB
dpc-4022	214	7	results	result	NOUN
dpc-4022	214	8	(	(	PUNCT
dpc-4022	214	9	seer	seer	NOUN
dpc-4022	214	10	)	)	PUNCT
dpc-4022	215	1	[	[	X
dpc-4022	215	2	internet	internet	NOUN
dpc-4022	215	3	]	]	PUNCT
dpc-4022	215	4	.	.	PUNCT
dpc-4022	216	1	accessed	access	VERB
dpc-4022	216	2	november	november	PROPN
dpc-4022	216	3	1st	1st	NOUN
dpc-4022	216	4	,	,	PUNCT
dpc-4022	216	5	2023	2023	NUM
dpc-4022	216	6	.	.	PUNCT
dpc-4022	217	1	available	available	ADJ
dpc-4022	217	2	from	from	ADP
dpc-4022	217	3	:	:	PUNCT
dpc-4022	217	4	https://seer	https://seer	PRON
dpc-4022	217	5	.cancer.gov	.cancer.gov	ADJ
dpc-4022	217	6	/	/	SYM
dpc-4022	217	7	statfacts	statfact	NOUN
dpc-4022	217	8	/	/	SYM
dpc-4022	217	9	html	html	NOUN
dpc-4022	217	10	/	/	SYM
dpc-4022	217	11	melan.html	melan.html	NOUN
dpc-4022	217	12	.	.	PUNCT
dpc-4022	218	1	2	2	X
dpc-4022	218	2	.	.	X
dpc-4022	218	3	abali	abali	PROPN
dpc-4022	218	4	h	h	PROPN
dpc-4022	218	5	,	,	PUNCT
dpc-4022	218	6	celik	celik	VERB
dpc-4022	218	7	i	i	PRON
dpc-4022	218	8	,	,	PUNCT
dpc-4022	218	9	karaca	karaca	PROPN
dpc-4022	218	10	b	b	PROPN
dpc-4022	218	11	,	,	PUNCT
dpc-4022	218	12	et	et	PROPN
dpc-4022	218	13	al	al	PROPN
dpc-4022	218	14	.	.	PUNCT
dpc-4022	219	1	cutaneous	cutaneous	ADJ
dpc-4022	219	2	melanoma	melanoma	NOUN
dpc-4022	219	3	in	in	ADP
dpc-4022	219	4	turkey	turkey	NOUN
dpc-4022	219	5	:	:	PUNCT
dpc-4022	219	6	analysis	analysis	NOUN
dpc-4022	219	7	of	of	ADP
dpc-4022	219	8	1157	1157	NUM
dpc-4022	219	9	patients	patient	NOUN
dpc-4022	219	10	in	in	ADP
dpc-4022	219	11	the	the	DET
dpc-4022	219	12	melanoma	melanoma	NOUN
dpc-4022	219	13	turkish	turkish	ADJ
dpc-4022	219	14	study	study	NOUN
dpc-4022	219	15	.	.	PUNCT
dpc-4022	220	1	j	j	NOUN
dpc-4022	220	2	 	 	SPACE
dpc-4022	220	3	buon	buon	NOUN
dpc-4022	220	4	.	.	PUNCT
dpc-4022	221	1	2015;20(4):1137	2015;20(4):1137	NUM
dpc-4022	221	2	-	-	SYM
dpc-4022	221	3	41	41	NUM
dpc-4022	221	4	.	.	PUNCT
dpc-4022	222	1	pmid	pmid	NOUN
dpc-4022	222	2	:	:	PUNCT
dpc-4022	222	3	26416068	26416068	NUM
dpc-4022	222	4	.	.	PUNCT
dpc-4022	223	1	8	8	NUM
dpc-4022	223	2	original	original	ADJ
dpc-4022	223	3	article	article	NOUN
dpc-4022	223	4	|	|	ADV
dpc-4022	223	5	dermatol	dermatol	ADJ
dpc-4022	223	6	pract	pract	NOUN
dpc-4022	223	7	concept	concept	NOUN
dpc-4022	223	8	.	.	PUNCT
dpc-4022	224	1	2024;14(3):e2024135	2024;14(3):e2024135	NUM
dpc-4022	224	2	22	22	NUM
dpc-4022	224	3	.	.	PUNCT
dpc-4022	225	1	survival	survival	NOUN
dpc-4022	225	2	rates	rate	NOUN
dpc-4022	225	3	for	for	ADP
dpc-4022	225	4	melanoma	melanoma	NOUN
dpc-4022	225	5	skin	skin	NOUN
dpc-4022	225	6	cancer	cancer	NOUN
dpc-4022	226	1	[	[	X
dpc-4022	226	2	internet	internet	NOUN
dpc-4022	226	3	]	]	PUNCT
dpc-4022	226	4	.	.	PUNCT
dpc-4022	227	1	2023	2023	NUM
dpc-4022	227	2	.	.	PUNCT
dpc-4022	228	1	available	available	ADJ
dpc-4022	228	2	from	from	ADP
dpc-4022	228	3	:	:	PUNCT
dpc-4022	228	4	https://www.cancer.org/cancer/types/melanoma-skin-cancer/	https://www.cancer.org/cancer/types/melanoma-skin-cancer/	PROPN
dpc-4022	228	5	detection	detection	NOUN
dpc-4022	228	6	-	-	PUNCT
dpc-4022	228	7	diagnosis	diagnosis	NOUN
dpc-4022	228	8	-	-	PUNCT
dpc-4022	228	9	staging	staging	NOUN
dpc-4022	228	10	/	/	SYM
dpc-4022	228	11	survival	survival	NOUN
dpc-4022	228	12	-	-	PUNCT
dpc-4022	228	13	rates	rate	NOUN
dpc-4022	228	14	-	-	PUNCT
dpc-4022	228	15	for	for	ADP
dpc-4022	228	16	-	-	PUNCT
dpc-4022	228	17	melanoma	melanoma	NOUN
dpc-4022	228	18	-	-	PUNCT
dpc-4022	228	19	skin	skin	NOUN
dpc-4022	228	20	cancer-by-stage.html	cancer-by-stage.html	X
dpc-4022	228	21	.	.	PUNCT
dpc-4022	229	1	accessed	access	VERB
dpc-4022	229	2	november	november	PROPN
dpc-4022	229	3	1st	1st	NOUN
dpc-4022	229	4	,	,	PUNCT
dpc-4022	229	5	2023	2023	NUM
dpc-4022	229	6	23	23	NUM
dpc-4022	229	7	.	.	PUNCT
dpc-4022	230	1	james	james	PROPN
dpc-4022	230	2	larkin	larkin	PROPN
dpc-4022	230	3	frcp	frcp	PROPN
dpc-4022	230	4	,	,	PUNCT
dpc-4022	230	5	ph.d	ph.d	PROPN
dpc-4022	230	6	.	.	PROPN
dpc-4022	230	7	,	,	PUNCT
dpc-4022	230	8	vanna	vanna	PROPN
dpc-4022	230	9	chiarion	chiarion	NOUN
dpc-4022	230	10	-	-	PUNCT
dpc-4022	230	11	sileni	sileni	NOUN
dpc-4022	230	12	,	,	PUNCT
dpc-4022	230	13	m.d	m.d	PROPN
dpc-4022	230	14	.	.	PROPN
dpc-4022	230	15	,	,	PUNCT
dpc-4022	230	16	rene	rene	PROPN
dpc-4022	230	17	gonzalez	gonzalez	PROPN
dpc-4022	230	18	,	,	PUNCT
dpc-4022	230	19	m.d	m.d	PROPN
dpc-4022	230	20	.	.	PROPN
dpc-4022	230	21	,	,	PUNCT
dpc-4022	230	22	jean	jean	PROPN
dpc-4022	230	23	-	-	PUNCT
dpc-4022	230	24	jacques	jacques	PROPN
dpc-4022	230	25	grob	grob	PROPN
dpc-4022	230	26	,	,	PUNCT
dpc-4022	230	27	m.d	m.d	PROPN
dpc-4022	230	28	.	.	PROPN
dpc-4022	230	29	five	five	NUM
dpc-4022	230	30	-	-	PUNCT
dpc-4022	230	31	year	year	NOUN
dpc-4022	230	32	survival	survival	NOUN
dpc-4022	230	33	with	with	ADP
dpc-4022	230	34	combined	combined	ADJ
dpc-4022	230	35	nivolumab	nivolumab	NOUN
dpc-4022	230	36	and	and	CCONJ
dpc-4022	230	37	ipilimumab	ipilimumab	VERB
dpc-4022	230	38	in	in	ADP
dpc-4022	230	39	advanced	advanced	ADJ
dpc-4022	230	40	melanoma	melanoma	NOUN
dpc-4022	230	41	.	.	PUNCT
dpc-4022	231	1	the	the	DET
dpc-4022	231	2	new	new	PROPN
dpc-4022	231	3	england	england	PROPN
dpc-4022	231	4	journal	journal	PROPN
dpc-4022	231	5	of	of	ADP
dpc-4022	231	6	medicine	medicine	NOUN
dpc-4022	231	7	.	.	PUNCT
dpc-4022	232	1	2019;381.pmid	2019;381.pmid	NUM
dpc-4022	232	2	:	:	PUNCT
dpc-4022	232	3	31562797	31562797	NUM
dpc-4022	232	4	20	20	NUM
dpc-4022	232	5	.	.	PUNCT
dpc-4022	233	1	grant	grant	VERB
dpc-4022	233	2	a	a	DET
dpc-4022	233	3	mcarthur	mcarthur	PROPN
dpc-4022	233	4	1	1	PROPN
dpc-4022	233	5	pbc	pbc	PROPN
dpc-4022	233	6	,	,	PUNCT
dpc-4022	233	7	caroline	caroline	PROPN
dpc-4022	233	8	robert	robert	PROPN
dpc-4022	233	9	3	3	PROPN
dpc-4022	233	10	,	,	PUNCT
dpc-4022	233	11	james	james	PROPN
dpc-4022	233	12	larkin	larkin	PROPN
dpc-4022	233	13	4	4	NUM
dpc-4022	233	14	,	,	PUNCT
dpc-4022	233	15	john	john	PROPN
dpc-4022	233	16	b	b	PROPN
dpc-4022	233	17	haanen	haanen	PROPN
dpc-4022	233	18	5	5	NUM
dpc-4022	233	19	,	,	PUNCT
dpc-4022	233	20	reinhard	reinhard	NOUN
dpc-4022	233	21	dummer	dummer	NOUN
dpc-4022	233	22	6	6	NUM
dpc-4022	233	23	.	.	PUNCT
dpc-4022	233	24	safety	safety	NOUN
dpc-4022	233	25	and	and	CCONJ
dpc-4022	233	26	efficacy	efficacy	NOUN
dpc-4022	233	27	of	of	ADP
dpc-4022	233	28	vemurafenib	vemurafenib	PROPN
dpc-4022	233	29	in	in	ADP
dpc-4022	233	30	braf(v600e	braf(v600e	PROPN
dpc-4022	233	31	)	)	PUNCT
dpc-4022	233	32	and	and	CCONJ
dpc-4022	233	33	braf(v600k	braf(v600k	NOUN
dpc-4022	233	34	)	)	PUNCT
dpc-4022	233	35	mutation	mutation	NOUN
dpc-4022	233	36	-	-	PUNCT
dpc-4022	233	37	positive	positive	ADJ
dpc-4022	233	38	melanoma	melanoma	NOUN
dpc-4022	233	39	(	(	PUNCT
dpc-4022	233	40	brim-3	brim-3	NUM
dpc-4022	233	41	):	):	PUNCT
dpc-4022	233	42	extended	extended	ADJ
dpc-4022	233	43	follow	follow	NOUN
dpc-4022	233	44	-	-	PUNCT
dpc-4022	233	45	up	up	NOUN
dpc-4022	233	46	of	of	ADP
dpc-4022	233	47	a	a	DET
dpc-4022	233	48	phase	phase	NOUN
dpc-4022	233	49	3	3	NUM
dpc-4022	233	50	,	,	PUNCT
dpc-4022	233	51	randomised	randomise	VERB
dpc-4022	233	52	,	,	PUNCT
dpc-4022	233	53	open	open	ADJ
dpc-4022	233	54	-	-	PUNCT
dpc-4022	233	55	label	label	NOUN
dpc-4022	233	56	study	study	NOUN
dpc-4022	233	57	.	.	PUNCT
dpc-4022	234	1	the	the	DET
dpc-4022	234	2	lancet	lancet	PROPN
dpc-4022	234	3	oncology	oncology	NOUN
dpc-4022	234	4	.	.	PUNCT
dpc-4022	235	1	2014;15(3):323	2014;15(3):323	NUM
dpc-4022	235	2	-	-	PUNCT
dpc-4022	235	3	32.pmid	32.pmid	NUM
dpc-4022	235	4	:	:	PUNCT
dpc-4022	235	5	24508103	24508103	NUM
dpc-4022	235	6	21	21	NUM
dpc-4022	235	7	.	.	PUNCT
dpc-4022	236	1	davies	davies	PROPN
dpc-4022	236	2	h	h	PROPN
dpc-4022	236	3	,	,	PUNCT
dpc-4022	236	4	bignell	bignell	VERB
dpc-4022	236	5	gr	gr	PROPN
dpc-4022	236	6	,	,	PUNCT
dpc-4022	236	7	cox	cox	PROPN
dpc-4022	236	8	c	c	X
dpc-4022	236	9	,	,	PUNCT
dpc-4022	236	10	al	al	PROPN
dpc-4022	236	11	.	.	PROPN
dpc-4022	236	12	e.	e.	PROPN
dpc-4022	236	13	mutations	mutation	NOUN
dpc-4022	236	14	of	of	ADP
dpc-4022	236	15	the	the	DET
dpc-4022	236	16	braf	braf	NOUN
dpc-4022	236	17	gene	gene	NOUN
dpc-4022	236	18	in	in	ADP
dpc-4022	236	19	human	human	ADJ
dpc-4022	236	20	cancer	cancer	NOUN
dpc-4022	236	21	.	.	PUNCT
dpc-4022	237	1	nature	nature	NOUN
dpc-4022	237	2	.	.	PUNCT
dpc-4022	238	1	2002;417(6892):949	2002;417(6892):949	NUM
dpc-4022	238	2	-	-	PUNCT
dpc-4022	238	3	54.pmid	54.pmid	NUM
dpc-4022	238	4	:	:	PUNCT
dpc-4022	238	5	12068308	12068308	NUM